<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:af282533-c896-4fb9-9da3-766af0d1bdb0,g:d3325778-8762-43ce-a5e0-bdf9ce12fd8d,d:9e47bb9f386840418b8747094912ba95--><html xml:lang="en-US" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mrna="http://www.modernatx.com/20220930" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><head><meta content="text/html" http-equiv="Content-Type"/>
<title>mrna-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80L2ZyYWc6MWI5YmNkOTc4ODg5NGZmYjg2MGFlZWUyNGRiOTdhOWMvdGFibGU6NjZiYTM2ODA0NDkzNDNjMzg1YjU4OWJlYjk3MTQzODQvdGFibGVyYW5nZTo2NmJhMzY4MDQ0OTM0M2MzODViNTg5YmViOTcxNDM4NF8wLTEtMS0xLTE3NzQ5OQ_afd9747c-7a5e-4ffb-bddc-a740aaf45769" name="dei:AmendmentFlag">false</ix:nonnumeric><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80L2ZyYWc6MWI5YmNkOTc4ODg5NGZmYjg2MGFlZWUyNGRiOTdhOWMvdGFibGU6NjZiYTM2ODA0NDkzNDNjMzg1YjU4OWJlYjk3MTQzODQvdGFibGVyYW5nZTo2NmJhMzY4MDQ0OTM0M2MzODViNTg5YmViOTcxNDM4NF8xLTEtMS0xLTE3NzQ5OQ_ddec5585-2abc-42dc-8eb7-eb45dac68240" name="dei:DocumentFiscalYearFocus">2022</ix:nonnumeric><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80L2ZyYWc6MWI5YmNkOTc4ODg5NGZmYjg2MGFlZWUyNGRiOTdhOWMvdGFibGU6NjZiYTM2ODA0NDkzNDNjMzg1YjU4OWJlYjk3MTQzODQvdGFibGVyYW5nZTo2NmJhMzY4MDQ0OTM0M2MzODViNTg5YmViOTcxNDM4NF8yLTEtMS0xLTE3NzQ5OQ_7b4b74b1-537f-4d0a-a478-8971c921eb17" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonnumeric><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80L2ZyYWc6MWI5YmNkOTc4ODg5NGZmYjg2MGFlZWUyNGRiOTdhOWMvdGFibGU6NjZiYTM2ODA0NDkzNDNjMzg1YjU4OWJlYjk3MTQzODQvdGFibGVyYW5nZTo2NmJhMzY4MDQ0OTM0M2MzODViNTg5YmViOTcxNDM4NF8zLTEtMS0xLTE3NzQ5OQ_c4d762c3-87fa-4989-aa5b-226c956253fd" name="dei:EntityCentralIndexKey">0001682852</ix:nonnumeric><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80L2ZyYWc6MWI5YmNkOTc4ODg5NGZmYjg2MGFlZWUyNGRiOTdhOWMvdGFibGU6NjZiYTM2ODA0NDkzNDNjMzg1YjU4OWJlYjk3MTQzODQvdGFibGVyYW5nZTo2NmJhMzY4MDQ0OTM0M2MzODViNTg5YmViOTcxNDM4NF80LTEtMS0xLTE3NzQ5OQ_414861de-7c86-4d2d-806c-9c9ad1001abd" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonnumeric><ix:nonnumeric contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS0wLTEtMS0xNzc0OTk_63bc6e23-3da9-42b3-a848-5bc0391847ef" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonnumeric><ix:nonnumeric contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS0wLTEtMS0xNzc0OTk_e716b09f-3fa4-4675-81dc-de6d128f2571" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonnumeric><ix:nonnumeric contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtMC0xLTEtMTc3NDk5_5d47a644-16e7-4224-8fe0-0ed593507be1" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonnumeric><ix:nonnumeric contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtMC0xLTEtMTc3NDk5_9a7351ff-9d66-4bd9-99be-15fa6c2c8fd3" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonnumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaref xlink:href="mrna-20220930.xsd" xlink:type="simple"></link:schemaref></ix:references><ix:resources><xbrli:context id="i59b47d9694194e9b8d272194eb633600_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9ba818c7455b4128b492bbf8c0a295a7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i7713f51c155d41bd94ee6586b1354a57_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie7c252d307fe48d68a9165a4306b367b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:context id="i38b2ccc325f1439e8a81e0c3f7be5e48_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i75523142f4a34f91af32a4b619d5f876_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2825268232174cd49a36dc4e6b636b75_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib583c5df28854d598e1660840e096793_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i29fb96562ce9488c9ff23b503aacf987_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9f5c8710d84842a9b3a98fb292d7be59_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i520e0eee9473493e9b84200f966551a6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2cb6086e753845599054921ec5661040_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4185bba63eba436e9eeb5c8034c6dd3a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i22020cfe4f324b478a1083d5d4b6f820_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i15aeaadcbb4f4464bc324b97ba7aaf25_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7f5405d313c6451b85214e64342530f0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i53c9adc3e80a4f91a0e8aa5b52521ad8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70bab7d1a29c45b1943b86cbb303eb97_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia117a5b2904d49e685347f90cf03dc63_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd63fbdc6fa4e71ba5d569169fe7e2a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22c92b775c9b47f88c9025bc7daf45b5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6c933198b14cf29e697f7adf83d6e7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i61390da75a5843ca8a6ad26c705c16a2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie152289a8729470ba1c27037872ec7b2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i03dccc309b6a484cbd2d2646fd5f60fd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9bea0fbf4b6847008cbed15c247fd567_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia274cd2680744f08bb0d5974251a676d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122e8a3f97504248aaf7e3cd4fb4143e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib342e036d02842b3a67a8bf74e521ca2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i694c0c150d5043d8989f3eac8dabc6a1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1170b85b1746f99c691491376e34a9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02ad6c305cb341fa93990daa5d13560e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ca3c2c29fd24c22ac9e7cf2f7a008dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e1f6321d9a54927bf211d1213d7fa86_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ba4407730fe44b1938c65769076f4fd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iac527886f9074dbe9300eae26fda7e81_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia9cb1b5be2a249c8a7639d5f897767ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i94df1f1de90143b7afd2dae8ddcd3603_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib31edffc055b4e84969e5de0f150a15d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79f6f788b4e94ecdb19f344b598a5baa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782270e7a13d448baa6dc9788cfe145e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d49e55fc18746acbc838219b403e21d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef8149173fa4598a695643682628d34_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd9f4dd415c941189b8b084da19b318b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf932ee5bf954085aff8c5b5bfd774f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0990fad2c0a64ba5857845d17c59244b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07b7f133ef7c49979819a21477dd2d35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i399a0bc5ac9c408fb8a426767fd4846c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i15e32273960f4cbdac4db90e54c81713_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i30d19a7153514aa8968937176d0ba53f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iebd5cc74069f42b1a4c2980d4bec1f0c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9d4beb637a0a4fc9bd284843f38ed95f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb6fc4a2c7c4ecaabad61fdb03ec18e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i612bca90824c4ae49aae6082058e312e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b1f7c35c1f54dafbdd9759f2aaa82f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b5dd65ec72c4aaaa79ad4306fa05131_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce22e41716c404badbfe9d609e33b40_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id64bc1d58e7d4d2daaf1609061ef31d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i03bc6d0074264668bafef4bde4a546a7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib7e9c72120be42739b402a4fac1726d6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic3dd5649fecf45b3adf1f116bddfd641_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic18e378236c644fa90c6cacc6e7e58b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf01f0f2682e4747872b2b55767aa607_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i99c7ad65efd846d28e535f10fdd45ded_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9231c594cb38499ca0b2fe42bb0a0c6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i59f01b5e75824f9381e337f5f84f0bc0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ac9c392d2e4475a575b6d2ace65074_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74dd61bcb31548ac8e26efb4c2455b76_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78fe5794f2204d9594c5ff8d92aa1e3a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-04-01</xbrli:startdate><xbrli:enddate>2022-06-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i88592508dec6409598ac4e6bfd562213_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-04-01</xbrli:startdate><xbrli:enddate>2022-06-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i07d2e74693cf4ac881c3c41091f3b591_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-04-01</xbrli:startdate><xbrli:enddate>2022-06-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i22af7a5fdd5e43489926b9e0d80070c9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24acf93504ca4b61b88d0d898da23e3d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d8cf23810124a4d89dd554526a835ff_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i166b816abd2247c4a0cf0474deb78b88_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i19e751a008c047199aa19f46a22ed873_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie40ba6e0e55b4717bebcd9569347adc4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic128fe4c726248f78848c2c69adab0c2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8f4a65445c7241cdb01f04b3497959da_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iec89e625bb1940cb9e9db4b244db97b3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iac887fdb035945ccb3f0437bfd392e7b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia5fd8f1d8c0a447daee285c20cbefc30_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i30f6bcf52976462096784289d7c471fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i09d60e1608194b39ad1c52be7d9cf1b1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iaaec8ad1b7fb4468808c7291f36d2947_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9e578a110e9143e9b428c27bb7ec2662_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:RestOfTheWorldMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia3c83c59cd8d4f0ab851829a84fa2079_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:RestOfTheWorldMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie1c8209e2b094ce09ba565f7560681bc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:RestOfTheWorldMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idcd30bf779d441398ed7ff9f612dd3ad_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:RestOfTheWorldMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i09e609fc9ed243109f9df0a5e539b574_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc81e71b9e784d99a75bfc6a17069c49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id30e42d35052465fb924786006680c85_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-09-01</xbrli:startdate><xbrli:enddate>2020-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i26a286b08bcf4b29a64c0f78c465043e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafbe3ab17ae84770ad3506ae754b900d_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-04-01</xbrli:startdate><xbrli:enddate>2020-04-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="participant"><xbrli:measure>mrna:participant</xbrli:measure></xbrli:unit><xbrli:context id="ica35c13d0a2d488bac59d3f2595e2565_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-03-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie0747a8925944645921bbcb8ffbd0362_D20200401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2020-04-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9087d9277ced40c1badd8d1113357422_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a041812b2ae4b7da3f2e9de4ff42b00_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2016-09-01</xbrli:startdate><xbrli:enddate>2016-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i27030d89cc4144e6956cb4a86c7c6508_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if9288d7477834dcf8f58bea6ac375454_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34a7b362cde0435da7c9ab0fbbcc838e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:TheBillAndMelindaGatesFoundationMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:InitialProjectMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie92694f56fa8480881199dc7a6553d92_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ice289ed817444a8998f68bb92f4eba05_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i05fc8e89852c4138a27156392adb93e5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6cbe63ffca7b4aef8c879737702050a8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i242678657770432b917487b16f97548b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic7805e1b5a9c4138805d7d16232efba0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i94f93fe4160f43ee95cd52bf264a681f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibd72c1fddfaf4d21b62e2ccb7da37ec6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idc7d3c17c3c343b9b43de74ba0ba0e1a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8ad953ae80fa462a98e281bda15183c4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5f69e3300c724bb3948f7acc12a47701_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i538754d294294906822309ed97500048_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie1031924258045f7861109a5575c62f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6168fcf649114479b08c4bebb291bd07_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i415bc9fe32754c159e157ba74a0ca59a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibbfc9c00c7704304ba161a61d0966556_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i150d291b4cbf407286f1cbeb4dabdb9b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i68cf3bc33acd4225804a01c259df5d27_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i90a0e733c613414b85f6664f2a9a6e98_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i283daa14eb3b4318abd6b40ae27fe95a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifefc9875a2654c13b53ecb40e82e6b68_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:OtherCollaborativePartiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i85f5878495a943c7bd2d73d51475c1cf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:OtherCollaborativePartiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2febd330dd094632bcf374ae9c4a6a09_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:OtherCollaborativePartiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iffd92cb276364aadaeb43a0a22abfc8b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">mrna:OtherCollaborativePartiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i52d1941a7d7341f5a702c3db48689cf1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iec705f1bf51148d497e9d496eb7224dd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia60f77bb95e74f2cad9964c5c3adb040_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2ab4456fcf5445a6817fcae45bbe734a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i021a912bd08b4136a44dbb1243377e71_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16716b58a4849959129b0cbaa77416f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i477c7fdb28e1416ba60a74a780b8d96d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i634adc1ff28b482cbbde05c3dff041c4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i190c365a11cd49cdb9c83d725f4d2733_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cae3c8daa6747918508dfb455ef4a0a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac61dcb875dd4d2eb5a01d994298b5f2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196327fceedb4074b04603b655848ae8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f6f6d002ff404bbdd00785180ceb24_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6804115097ee426cacfd0c169bfc18b4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a2e488d6c034139995efe5f51025918_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd3ceb69a8c4446965dea5defd410ac_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3698f19bc5a3458a94f4166c52cafcd2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ce50139fc744775be66bcd4b29f3f32_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39164e8d4b443349cdcc91e6891cf29_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1076ffa5a23c4d599d6de1d154cef8d7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6771091d74c4e70b733b0a43b964d38_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id865df0d2b7845e78e017c4804acb75e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic11ad3652cb04f4f82680fe03b6007d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c2a7f6abe2433e8e6675632c633b76_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925c1badc0994d05b339f63929078957_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c0cc36a87244f1abc849f17a19c839_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73b4c90893114b06b884cf69be209e93_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b76c99272c74a34b856374a5cc734aa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e938e50b4ed4724bfddc1d45455b6d9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4812199d85254244b887bb42a5148ab2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a67eace02044549181e0353748ad4c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5707e57c42ee4b249daef3004bdd90a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b82b72ecd854cc29022aca1d219faf5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1585735434b40448c2c820b1909cd2a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc60230a01f4e0ab036037dc7c74a3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd49271fac584a0ea4bca7b5be2d8fd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c8d433354a4a66a6df220159afdb93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7aa813f7de4428a25f1b4543007679_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b36c63ec12d4e47a96b4d1bd0e07b8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a910a49c2f488d84e3d862aae8e638_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb7b328b5e0463599a0b71d4db4f595_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da2c8c0a2e84649b94c88a2f57637d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69defb4c1b484786a48b54d1cf2e1f8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia967afaba8374f4db40140c0a97ac55c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64785a9c25e7439b8b3f3a802f7db766_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie058442c88dd40e4aa7b512c252e2d0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1d729059af44726ada0899cef9f79e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1724ce23109451cb9ce451af062d45c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58f3dcba53d0483d9fd88a51d1f1050d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c2115464b64e9da54c559d020d7207_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211102e93af445499a0b637edc705dfc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5320222082e945fbbc3371e65de0b20f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677c2653422c451dbf66bcc82b835da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc9733301274631828798d602e8bc8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic350e7f011e140399cd0dc4e000be76f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5cfad4ed9a64a439f9ea0deb247b1fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe3771447d214224ad95139538d6b12d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e6e6edc5f140b7af062e2677ec4f0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92973fa43c774ebba350e60c55640dba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7be685d78786434da48ed1683b77affe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9eecfaf7b9e42549082ead8e922255a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407bf3bc0c824b05b0b260d59836cf06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4a9d73d3904d60817b19e1588aa823_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097fc6716d3549d2adfa7284454a95b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd4870a34a34135bac5af63a2eec8fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb86706f08046f79ffc65a508a65521_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>mrna:security</xbrli:measure></xbrli:unit><xbrli:context id="ida3dde2ff5d64d60b7553efe4e4c2d3d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7135b8b8df5b4075a613bda58280fb3f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1f15d69f164867b5743468d41113ba_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c850f21d05f40b38240925cf8345a2f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e50688439c4edb82c400f3390e3fb1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839964c244274dba804e482844ea7b39_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i011c62f01b1d4967b9595242f6f658b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1983dcd645464c94c0821bcff86fbd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i258464e565d34c078885055519237bb7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8366fd495a824350ad51bd08ac4e6c0f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea07d0825234c5480276ba1bd0cc2a0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3ac3617fba94444822b6cda811d1249_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic39ebfb28a5b4035b7225fd6c9e537ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d92f8c1a58e49119bc3e85cdeb2e810_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic29e8f2ade564ff2a4e8ffd439fbbd9a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee4192014a764152af105b73d0fe420b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a0499df6224d49bbaf0ac61a26a73a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bb13ef13f4441881a7f73c3ed99b54_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fa74c3ce3164030844dfdff1a4efb9b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd5c4f8d05449aa9e566cea041aeb6a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb9bfa43713d4d16904fdd3012566158_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62562d434b5f47c384a6d94dd5fe1d53_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c58aac1ea6b4b8382a89e01ee04951c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id950879642ba444eab03b507bed707b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ce7ba9f513c4e60bfee1fbbbcc93f16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4179e3e3ad4c8aaef5a36c41b219c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a5d3436d204169ac69a1d50051d7d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b1f47bfaa040779043d794f090ec23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88af5cd39d554f97926b95f76b32efcd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba7828cc18444b7befe9088b776fa0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib235f424563f4a47930e142d28b37683_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478dd8954a7744c6ba4b36346a848e04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47696c7596f42698f6ba273f8860fb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb0508598e24d7f894c03f715dc3eac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e5e44728fd4452da07985dd78ab046a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fdfa24a81f48568588503523296352_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04fd7f1cf5e4b81b693d636bfdd5c48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12d5e3bff24e431a972a3173f42fb76f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a82ae8948446cdb85750d5be59a3f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c2d96d72b4c477c96864711ebcdb0f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2254ca8fd397429eb443e596a667399c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8010829c22074131940685702c66cfe3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bcf293f6c1e4500abf112cd8d57560d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02cd293df5b04727a0d9c76474421137_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51b88bec3ba7480e861f6dd273dc04e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i320c88cd83354a5da6789edbd31bbffa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i507b7eb2dc9541bb91ef82a5042ca1ac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6848a7b26a564abf8de6896740f8fde2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iced0b2295c0848f1892ca7aa2a7ec064_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i924eb2e676214b7f9eb252e5787c7325_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i46e44c79f45e4e6d960bdf236ea501f6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib412ac789b604276ae380b0f24f33aa2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if86136e626eb43eebb383b6de603bb5d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i19d0b2e9184c4525867e8a363293954f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i17c30799804c4954a85aae813e48b539_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2135690b7cc4964aae5d94b864cd570_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iede3a740030e4ec89d3532d1f16721bc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07b0bba8bc7a459a990908142354d88b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1c796ce23c483385b156af2292590f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed2780eb4034b539a660615f608c2db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84357de901a34ed7b8e1d69cfe534dd0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i740fea2392774a5db643ec29b58d8a30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb6a7b869bd4ba8ad8e38dfba6ab7b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4a1185ceee4458ae10f28d781f5bdb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58781399ae548b3af55b7d5db4008fa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d7763d012f94e328d9ec4824365870a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52befc0ca95441a6b6364a6b33c53802_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52e15a691134dac86ab79105b2a0669_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5e5021002234ef2ab9badcda9d18f6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec7ec2c40ba3453486827e1df91bae41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853249c02e5c455a9b179af2153eb1bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc31d7c5471411290cf62d763c852be_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="campus"><xbrli:measure>mrna:campus</xbrli:measure></xbrli:unit><xbrli:context id="ie9034417678a4c7cada3e41d5223153a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i3dca3fd0c2004511b3bfe06f5a8967f0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCSouthMTCNorthAndMTCEastMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofbuilding"><xbrli:measure>mrna:numberOfBuilding</xbrli:measure></xbrli:unit><xbrli:context id="i22babd4a5b2a48eba7e496277e9b8f31_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCSouthMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a76029db19c4f39b6f386b4f547c005_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCNorthMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739f5ec9f83a4fd186320d2099fc3be7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCEastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29feed86eef546c3803626f63212f7e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCSouthMTCNorthAndMTCEastMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofextensionperiod"><xbrli:measure>mrna:numberOfExtensionPeriod</xbrli:measure></xbrli:unit><xbrli:context id="ice049e97694d429c886345f11a164fbc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LeaseContractualTermAxis">mrna:EmbeddedLeasesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87eb76882a154ae09e6b8b5798c5ca19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LeaseContractualTermAxis">mrna:EmbeddedLeasesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceb89e8ede0444089b3fb792fd5ca92d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:SupplyAndManufacturingAgreementsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a322f1992648f9a9860e7d4c522085_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalServicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ed47b05fcd467eaf9b0123e9bd76c9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalOperationsAndSupportCommitmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:ModernaScienceCentreMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4203b6020dbe48ea939f42b58051c22d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:ModernaScienceCentreMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="numberofoption"><xbrli:measure>mrna:numberOfOption</xbrli:measure></xbrli:unit><xbrli:context id="id8fa3b2d98bc44b9a82aa71312d2b496_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i191ff6caafcd49b2903f1d4ddbc910b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibf76cb4302514bb493b0549b76dcef1b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cecb9f9dcc64a3aa0f1eb99a85234a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i78f48f5fe86643c6a210a22022cc43f0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0ab25603f7f74bdebdb3b89605b422d6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i90af8c6a89d3424d9989a349abbb333e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="icbe31b20b39343f9b19288e929bb95f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iac54e32b74be443ca002d7bb49be1581_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i31b2a25af5094b4eaf70ab5cdbfcb903_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i794309fb1add48838369d48aeda44c68_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc12427415fa44f98b4f35dc38d10980_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3262345fa3994caeb03b2670e86e8c4e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7e5a263cbd404a9b88fdb681a681367d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib7a0725d470544d8b7325ffc65f6b837_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i869e9d23c84e447aad9d284fd5e3410d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i42b23a44541740f8a33ee413a8126998_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1ed7a877238e481284ef8ca19e289cd5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i659b1956b33b4a1c92e71a7838047793_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9f34a708873644a38a02797354e9510b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i878b2dbb3a0c4281817703e5c75899ac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-07-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if3e5425a2fa645a280b170ae2cd3673a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-07-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iea3628e168b0408eb5140b455599ba81_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3f4a07a427024cdf83b4e9bb14b5d198_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2021-01-01</xbrli:startdate><xbrli:enddate>2021-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iebf7f7b6db364d9099d104a33951e9ac_I20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2021RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6636b09b2dc4b208d5fc43d0e99eaf1_I20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2022RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0f687a00734672a85b3a4e7b078175_I20220801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2022RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic942cbc2fa484a0cbf8eb0e80bc009e4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2021RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id129f6cc36ce41478c928857e7a58190_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2022RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7f7271a4a08e4cbe89d4f17b81188469_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:ShareRepurchaseProgramAxis">mrna:A2022RepurchaseProgramMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="i9e47bb9f386840418b8747094912ba95_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:0.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-bottom:1pt;margin-top:0.35pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:11.111%"><tr><td style="width:1.0%"></td><td style="width:56.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6NWYzOWVkZGFiNzI4NDM0MWI2ZmM1MDYwNmI0Y2MyNjEvdGFibGVyYW5nZTo1ZjM5ZWRkYWI3Mjg0MzQxYjZmYzUwNjA2YjRjYzI2MV8wLTEtMS0xLTE3NzQ5OQ_964c2d9e-5aad-4eaa-a86f-bca5e47c967a" name="dei:DocumentType">10-Q</ix:nonnumeric></span></td></tr></table></div><div style="margin-bottom:3.5pt;padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTEw_add54c5b-2ceb-4c67-b677-d38ae7510dcc" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonnumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:0.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA_fcac5ad8-2f68-40f2-a637-08b6726405f6" name="dei:DocumentPeriodEndDate">September 30, 2022</ix:nonnumeric> </span></div><div style="margin-top:3.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTAz_af7262e0-15d9-444a-ab3e-37032e533933" name="dei:DocumentTransitionReport">&#9744;</ix:nonnumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from _ to _ </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA0_544ec4c5-d176-4fff-90cd-527cd0b5a169" name="dei:EntityFileNumber">001-38753</ix:nonnumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img alt="mrna-20220930_g1.jpg" src="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/mrna-20220930_g1.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:212px"/></div><div style="margin-top:1.35pt;text-align:center"><span><br/></span></div><div style="margin-top:1.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA1_50e6a787-b298-4f8f-8f02-8ad2fb28e243" name="dei:EntityRegistrantName">Moderna, Inc.</ix:nonnumeric> </span></div><div style="margin-top:0.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:1pt;margin-top:0.5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.572%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM18wLTAtMS0xLTE3NzQ5OQ_43aef8e3-432c-4e70-a5f8-e0f6f17ef87f" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonnumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM18wLTMtMS0xLTE3NzQ5OQ_142b9059-645b-4886-9305-88f671296a62" name="dei:EntityTaxIdentificationNumber">81-3467528</ix:nonnumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM18zLTAtMS0xLTE3NzQ5OQ_06219977-2eb3-4e95-a981-b6c71360d070" name="dei:EntityAddressAddressLine1">200 Technology Square</ix:nonnumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM180LTAtMS0xLTE3NzQ5OQ_591125eb-547f-4531-99e5-8c78f450e3b4" name="dei:EntityAddressCityOrTown">Cambridge,</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM180LTEtMS0xLTE3NzQ5OQ_24109c5f-e526-424c-969c-4bb18162f10e" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonnumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6YjI5MTVmYWJiZTI3NDY0ZTk2ODFlYWRmMjU3ODE4MDMvdGFibGVyYW5nZTpiMjkxNWZhYmJlMjc0NjRlOTY4MWVhZGYyNTc4MTgwM180LTMtMS0xLTE3NzQ5OQ_1c7e0455-03d4-4aa4-b242-ef973f0849d6" name="dei:EntityAddressPostalZipCode">02139</ix:nonnumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA2_b9154c5f-e93e-45c7-a751-3098d0f15314" name="dei:CityAreaCode">617</ix:nonnumeric>) <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA3_0264005f-2960-42a4-9734-c07b697d34b6" name="dei:LocalPhoneNumber">714-6500</ix:nonnumeric> </span></div><div style="margin-top:0.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:0.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZWZmZWNmZWE5Yjc0NDllYWI3OGEzYzM0NGU5Yzg2ZTIvdGFibGVyYW5nZTplZmZlY2ZlYTliNzQ0OWVhYjc4YTNjMzQ0ZTljODZlMl8xLTAtMS0xLTE3NzQ5OQ_cb4d0d9e-5359-40f9-9052-f55392ef86ae" name="dei:Security12bTitle">Common stock, par value $0.0001 per share</ix:nonnumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZWZmZWNmZWE5Yjc0NDllYWI3OGEzYzM0NGU5Yzg2ZTIvdGFibGVyYW5nZTplZmZlY2ZlYTliNzQ0OWVhYjc4YTNjMzQ0ZTljODZlMl8xLTEtMS0xLTE3NzQ5OQ_2c6bac12-3239-4c1f-80c8-15d639c0630f" name="dei:TradingSymbol">MRNA</ix:nonnumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZWZmZWNmZWE5Yjc0NDllYWI3OGEzYzM0NGU5Yzg2ZTIvdGFibGVyYW5nZTplZmZlY2ZlYTliNzQ0OWVhYjc4YTNjMzQ0ZTljODZlMl8xLTItMS0xLTE3NzQ5OQ_1e9ed24b-b253-458d-bc00-570105265640" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonnumeric></span></td></tr></table></div><div style="padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA4_f4b8d3c4-bb39-4746-a496-5f84a23e9573" name="dei:EntityCurrentReportingStatus">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">No  &#9744;</span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTA5_1f1e6407-0040-4086-ad0b-73540fe4c51b" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">No  &#9744;</span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.737%"><tr><td style="width:1.0%"></td><td style="width:19.396%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.396%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZTY3OWVjYjRjNDM2NDg4Mjg1Y2ZmMmExMjRmMzU1NjUvdGFibGVyYW5nZTplNjc5ZWNiNGM0MzY0ODgyODVjZmYyYTEyNGYzNTU2NV8wLTAtMS0xLTE3NzQ5OQ_02c078c1-07b6-4fec-8af5-8762cce93bde" name="dei:EntityFilerCategory">Large accelerated filer</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZTY3OWVjYjRjNDM2NDg4Mjg1Y2ZmMmExMjRmMzU1NjUvdGFibGVyYW5nZTplNjc5ZWNiNGM0MzY0ODgyODVjZmYyYTEyNGYzNTU2NV8wLTgtMS0xLTE3NzQ5OQ_5837eb02-98b6-48a8-a22b-040280ad1b1c" name="dei:EntitySmallBusiness">&#9744;</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGFibGU6ZTY3OWVjYjRjNDM2NDg4Mjg1Y2ZmMmExMjRmMzU1NjUvdGFibGVyYW5nZTplNjc5ZWNiNGM0MzY0ODgyODVjZmYyYTEyNGYzNTU2NV8xLTgtMS0xLTE3NzQ5OQ_fb628ff9-07da-44c7-add3-f548eef9ee4a" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonnumeric></span></td></tr></table></div><div style="padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.5pt;padding-left:9pt;padding-right:33.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> No  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMTEx_2cf8b55c-fc41-49ff-ad5d-94b97f5dad2d" name="dei:EntityShellCompany">&#9746;</ix:nonnumeric></span></div><div style="padding-left:10.12pt;padding-right:10.12pt;text-align:center"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, there were <ix:nonfraction contextref="i9ba818c7455b4128b492bbf8c0a295a7_I20221031" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xL2ZyYWc6MWE0MDRjMWY2MWU0NGEzNTk4NTNjODI2ZmViOTljOGQvdGV4dHJlZ2lvbjoxYTQwNGMxZjYxZTQ0YTM1OTg1M2M4MjZmZWI5OWM4ZF8yMDE4_5f246ccb-d344-470c-afd6-2de4eb484738" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitref="shares">384,180,469</ix:nonfraction> shares of the registrant&#8217;s common stock, par value $0.0001 per share, outstanding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (Form 10-Q) contains express or implied forward-looking statements. All statements other than those of historical facts contained in this Form 10-Q are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. Forward-looking statements in this Form 10-Q include, but are not limited to, statements about:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our activities with respect to our COVID-19 vaccines, and our plans and expectations regarding future generations of our COVID-19 vaccines, including boosters, that we may develop in response to variants of the SARS-CoV-2 virus, ongoing clinical development, manufacturing and supply, pricing, commercialization, regulatory matters (including dosage for vaccines and authorization or approval for boosters), demand for COVID-19 vaccines, and third-party and governmental arrangements and potential arrangements;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of product sales of our Omicron-targeting bivalent booster vaccines against COVID-19;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to contract with third-party suppliers, distributors and manufacturers and their ability to perform adequately, particularly with respect to the timely production, release and delivery of our COVID-19 vaccines, including variant-specific booster vaccines;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability and the ability of third parties with whom we contract to successfully manufacture our commercial products at scale, as well as drug substances, delivery vehicles, development candidates, and investigational medicines for preclinical and clinical use;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">internal and external costs associated with manufacturing for our products, including our COVID-19 vaccines, as well as costs associated with winding down or terminating relationships or agreements with third-party manufacturers or suppliers in connection with the production of our COVID-19 vaccines;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our commercial products, investigational medicines and technology;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, timing, progress, results, and cost of our research and development programs and our current and future preclinical studies and clinical trials, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work and the period during which the results of the trials will become available;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the direct or indirect impact of COVID-19 or any future large-scale adverse health event, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays in diagnoses, initiation or continuation of treatment for diseases that may be addressed by our development candidates and investigational medicines, or in patient enrollment in clinical trials, potential clinical trials, regulatory review or supply chain disruptions, and other potential impacts to our business, the effectiveness or timeliness of steps taken by us to mitigate the impact of COVID-19, and our ability to execute business continuity plans to address disruptions caused by COVID-19 or any future large-scale adverse health event;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our anticipated next steps for our development candidates and investigational medicines that may be slowed down due to the impact of COVID-19, including our resources being significantly diverted towards our COVID-19 vaccine efforts;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify research priorities and apply a risk-mitigated strategy to efficiently discover and develop development candidates and investigational medicines, including by applying learnings from one program to our other programs and from one modality to our other modalities;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain regulatory approval of our investigational medicines;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to commercialize our COVID-19 vaccines and any other products, if approved;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing and reimbursement of our medicines, if approved;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model, and strategic plans for our business, investigational medicines, and technology;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our future expenses, revenues and capital requirements;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential benefits of strategic collaboration agreements, our ability to enter into strategic collaborations or arrangements, and our ability to attract collaborators with development, regulatory, and commercialization expertise;</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future agreements with third parties in connection with the commercialization of our investigational medicines, if approved;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the size and growth potential of the markets for our investigational medicines, and our ability to serve those markets;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate and degree of market acceptance of our investigational medicines;</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to produce our products or investigational medicines with advantages in turnaround times or manufacturing cost; and</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements often contain words such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;aims,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our operational or financial performance, and involve risks, uncertainties, and other factors that may cause our actual results to differ materially from any future results expressed or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section entitled &#8220;Risk Factors&#8221; and elsewhere in this Form 10-Q. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual results could differ materially from those expressed or implied by the forward-looking statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Form 10-Q represent our views as of the date of this Form 10-Q. We undertake no obligation to update any forward-looking statements, except as required by applicable securities law. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Form 10-Q. However, any further disclosures made on related subjects in our subsequent reports filed with the Securities and Exchange Commission should be consulted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Form 10-Q contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to may appear without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or &#8482; symbols, but such references are not intended to indicate that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our reference to other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING COMPANY REFERENCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, the terms &#8220;Moderna,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; in this Form 10-Q refer to Moderna, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website, www.modernatx.com, including the Investor Relations section, www.investors.modernatx.com; and corporate blog www.modernatx.com/moderna-blog; as well as our social media channels: Facebook, www.facebook.com/modernatx; Twitter, www.twitter.com/modernatx; and LinkedIn, www.linkedin.com/company/modernatx; contain a significant amount of information about us, including financial and other information for investors. We encourage investors to visit these websites and social media channels as information is frequently updated and new information is shared. Information contained on our website, corporate blog and social media channels shall not be deemed incorporated into, or be a part of, this Form 10-Q.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.974%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.15pt"><span><br/></span></div><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Balance Sheets as of </a><a href="#i9e47bb9f386840418b8747094912ba95_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September</a><a href="#i9e47bb9f386840418b8747094912ba95_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Statements of Income for the three and </a><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">nine</a><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> months ended </a><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Septe</a><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">mber</a><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Statements of Comprehensive Income for the three and </a><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">nine</a><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> months ended </a><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September</a><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Statements of Stockholders' Equity for the three and </a><a href="#i9e47bb9f386840418b8747094912ba95_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">nine</a><a href="#i9e47bb9f386840418b8747094912ba95_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> months ended </a><a href="#i9e47bb9f386840418b8747094912ba95_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September</a><a href="#i9e47bb9f386840418b8747094912ba95_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Condensed Consolidated Statements of Cash Flows for the </a><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">nine</a><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> months ended </a><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September</a><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt;padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART II.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_136" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_136" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_142" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_142" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i9e47bb9f386840418b8747094912ba95_145" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">47</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in millions, except per share data)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNC0xLTEtMS0xNzc0OTk_6c88894d-1bba-4713-b00a-56e5bd1d1ec5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNC0zLTEtMS0xNzc0OTk_e49198e7-e7d8-4594-a611-e0a751fe77d3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">6,848</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNS0xLTEtMS0xNzc0OTk_85079e1e-f846-445a-b987-4f59e57feef4" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">5,321</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNS0zLTEtMS0xNzc0OTk_601c2393-6c44-47af-a2f2-1e50e6a114e5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" unitref="usd">3,879</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNi0xLTEtMS0xNzc0OTk_75289c9e-91c8-425d-9445-f79d2ec55311" name="us-gaap:AccountsReceivableNetCurrent" scale="6" unitref="usd">2,695</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNi0zLTEtMS0xNzc0OTk_32ba9185-5693-42b1-b25e-4ea4f476c886" name="us-gaap:AccountsReceivableNetCurrent" scale="6" unitref="usd">3,175</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNy0xLTEtMS0xNzc0OTk_798661c6-2b1e-48e9-bba4-a5be70451f9f" name="us-gaap:InventoryNet" scale="6" unitref="usd">2,077</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfNy0zLTEtMS0xNzc0OTk_acbef468-bab7-464a-ac7b-482048539c95" name="us-gaap:InventoryNet" scale="6" unitref="usd">1,441</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfOC0xLTEtMS0xNzc0OTk_0989ec28-74d8-4582-bd4d-4a8ee40589a3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" unitref="usd">1,177</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfOC0zLTEtMS0xNzc0OTk_eb34a425-a05b-4ef1-a194-8d527231dfa5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" unitref="usd">728</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfOS0xLTEtMS0xNzc0OTk_3a2e168e-bfce-43a1-a546-e5457f1c60c5" name="us-gaap:AssetsCurrent" scale="6" unitref="usd">14,297</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfOS0zLTEtMS0xNzc0OTk_280d1fd0-a6bb-48f1-87ec-327b00c477e8" name="us-gaap:AssetsCurrent" scale="6" unitref="usd">16,071</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, non-current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTAtMS0xLTEtMTc3NDk5_d2748030-073a-40c4-858a-e3d3b57ec791" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">8,655</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTAtMy0xLTEtMTc3NDk5_67c770d6-3d3a-4cee-9b20-dc8ce3967ec6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" unitref="usd">6,843</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTEtMS0xLTEtMTc3NDk5_68685e39-12b8-4282-a291-7185243e6b98" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">2,019</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTEtMy0xLTEtMTc3NDk5_86b73003-4d2b-4606-8f82-7bf0a2b33924" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">1,241</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTItMS0xLTEtMTc3NDk5_3b8a1182-37e8-4556-8a06-9d57e6543d1e" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">113</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTItMy0xLTEtMTc3NDk5_042d8026-35d5-41f2-8b12-b587150d0745" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">142</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTMtMS0xLTEtMTc3NDk5_8dd8403f-39ae-4d56-99ad-65197ec67542" name="us-gaap:RestrictedCashNoncurrent" scale="6" unitref="usd">14</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTMtMy0xLTEtMTc3NDk5_0c7dfd01-e822-415a-88dc-85dea43860ef" name="us-gaap:RestrictedCashNoncurrent" scale="6" unitref="usd">12</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTQtMS0xLTEtMTc3NDk5_fe6f7a65-7385-4580-8df8-b0150e80173c" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" unitref="usd">920</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTQtMy0xLTEtMTc3NDk5_3c01b36b-d0e0-4600-a553-8453522ef910" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" unitref="usd">326</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTUtMS0xLTEtMTc3NDk5_3e9710a3-f389-4547-a916-cde10647297e" name="us-gaap:OtherAssetsNoncurrent" scale="6" unitref="usd">38</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTUtMy0xLTEtMTc3NDk5_7a952f71-a3c2-4df8-b8b6-745fff0e6cff" name="us-gaap:OtherAssetsNoncurrent" scale="6" unitref="usd">34</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTYtMS0xLTEtMTc3NDk5_1545f5d1-2ddb-4e79-af5e-602f107d1ee4" name="us-gaap:Assets" scale="6" unitref="usd">26,056</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTYtMy0xLTEtMTc3NDk5_e657546e-c4c4-4b0a-bf03-f1d498324e20" name="us-gaap:Assets" scale="6" unitref="usd">24,669</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTktMS0xLTEtMTc3NDk5_9a1092ab-ff2d-478e-847d-39a04c125924" name="us-gaap:AccountsPayableCurrent" scale="6" unitref="usd">330</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMTktMy0xLTEtMTc3NDk5_dd8501f6-7e2b-49df-82af-0cc7b0a89c94" name="us-gaap:AccountsPayableCurrent" scale="6" unitref="usd">302</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjAtMS0xLTEtMTc3NDk5_0c0ea02e-0a9f-40b7-8e98-af00eb74f73b" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" unitref="usd">1,856</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjAtMy0xLTEtMTc3NDk5_82b8c5e2-4a12-4ea4-ad4d-9e25a485031d" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" unitref="usd">1,472</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjEtMS0xLTEtMTc3NDk5_b7094567-336b-45b2-9513-f256570e7e01" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" unitref="usd">4,002</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjEtMy0xLTEtMTc3NDk5_60cb905d-a275-442e-94bd-eb0704c2af0e" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" unitref="usd">6,253</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjItMS0xLTEtMTc3NDk5_44cba8be-5dce-4cf1-bb6f-26e112ada999" name="us-gaap:TaxesPayableCurrent" scale="6" unitref="usd">66</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjItMy0xLTEtMTc3NDk5_3de499f8-3205-4b44-81ec-d375262bfa6b" name="us-gaap:TaxesPayableCurrent" scale="6" unitref="usd">876</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjMtMS0xLTEtMTc3NDk5_9abd49e6-ca8e-46c8-924e-2a30f1e60315" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">553</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjMtMy0xLTEtMTc3NDk5_728e1895-b2fc-43d2-8148-0efb882129ed" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">225</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjQtMS0xLTEtMTc3NDk5_b31c17cf-9936-4852-adba-87e83a49d65d" name="us-gaap:LiabilitiesCurrent" scale="6" unitref="usd">6,807</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjQtMy0xLTEtMTc3NDk5_ed822c7f-9529-4808-a950-3fa3573c06ee" name="us-gaap:LiabilitiesCurrent" scale="6" unitref="usd">9,128</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjUtMS0xLTEtMTc3NDk5_36424eff-6fc4-4ce9-81aa-86449952a8c4" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" unitref="usd">175</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjUtMy0xLTEtMTc3NDk5_249b4ea8-34ee-4ff7-a24a-ea5410b383f2" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" unitref="usd">615</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjYtMS0xLTEtMTc3NDk5_76129e27-4317-4a8e-86a4-f77f306c47e5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" unitref="usd">79</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjYtMy0xLTEtMTc3NDk5_19eb4775-c7d4-4f50-8cd9-17065a5aa33d" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" unitref="usd">106</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjctMS0xLTEtMTc3NDk5_6cba71de-51f9-42f4-8ec6-28dbc1ec2ffd" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">922</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjctMy0xLTEtMTc3NDk5_752d187b-2219-4fdc-b432-6907483f1850" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">599</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjgtMS0xLTEtMTc3NDk5_4b832b5b-8c13-48d2-a6dc-c73c859dc4d6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" unitref="usd">81</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjgtMy0xLTEtMTc3NDk5_b9dba633-b4f8-44fd-867b-ae113325aeb1" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" unitref="usd">76</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjktMS0xLTEtMTc3NDk5_6409ef26-d600-4070-b51c-30dafc0f5fa3" name="us-gaap:Liabilities" scale="6" unitref="usd">8,064</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMjktMy0xLTEtMTc3NDk5_988c3efd-2a0d-4475-936f-1efe1bc28287" name="us-gaap:Liabilities" scale="6" unitref="usd">10,524</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzAtMS0xLTEtMTc3NDk5_9891ad6d-f026-4d5c-9b1a-3392039e2197" name="us-gaap:CommitmentsAndContingencies" unitref="usd" xsi:nil="true"></ix:nonfraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzAtMy0xLTEtMTc3NDk5_d0246366-2cea-4cc1-ab2c-04227913a4e4" name="us-gaap:CommitmentsAndContingencies" unitref="usd" xsi:nil="true"></ix:nonfraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfMzE_1e08a84e-5322-4d03-9f35-afb99313b9ac" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitref="usdPerShare"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfMzE_f6163b04-4759-47e0-a762-284eeebf7592" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitref="usdPerShare">0.0001</ix:nonfraction></ix:nonfraction>; <ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfMzU_b1f97158-0c5d-4144-aa7e-c4da8e5efdfd" name="us-gaap:PreferredStockSharesAuthorized" scale="6" unitref="shares"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfMzU_fd423428-d509-41f5-b2cf-f3d7965f7f15" name="us-gaap:PreferredStockSharesAuthorized" scale="6" unitref="shares">162</ix:nonfraction></ix:nonfraction>&#160;shares authorized as of September 30, 2022 and December 31, 2021; <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfNzM_3b9c7afe-8b29-46e2-af65-a476ffb0d35e" name="us-gaap:PreferredStockSharesIssued" scale="6" unitref="shares"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfNzM_42ede563-7157-4d07-9a13-90d8150d82bb" name="us-gaap:PreferredStockSharesOutstanding" scale="6" unitref="shares"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfNzM_5aa47770-093e-47d7-ac14-c04070b1b5fd" name="us-gaap:PreferredStockSharesIssued" scale="6" unitref="shares"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MTI0NzZhMjAzNjdjNDAxNWJhMmZkNzI0ZjRmNWViYTNfNzM_686f9948-4d44-4ed4-8d25-c87d94b4179c" name="us-gaap:PreferredStockSharesOutstanding" scale="6" unitref="shares">no</ix:nonfraction></ix:nonfraction></ix:nonfraction></ix:nonfraction> shares issued or outstanding at September 30, 2022 and December 31, 2021 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMS0xLTEtMTc3NDk5_0f5fc783-70e8-4e8e-9de0-f167dbff4e42" name="us-gaap:PreferredStockValue" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzItMy0xLTEtMTc3NDk5_ebe70ed1-e20e-46de-9113-ae60e3cc825e" name="us-gaap:PreferredStockValue" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfMjg_d42678fd-6934-48f4-8bf9-74bab0eb3d7e" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitref="usdPerShare"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfMjg_e7d4a068-28d7-4b54-be0f-c0ea3595b5d4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitref="usdPerShare">0.0001</ix:nonfraction></ix:nonfraction>; <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfMzI_d30d108f-70c3-4316-b8c1-02708793c2ba" name="us-gaap:CommonStockSharesAuthorized" scale="6" unitref="shares"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfMzI_d9b68ab1-244b-40b7-91b0-6b2e02ca5cfc" name="us-gaap:CommonStockSharesAuthorized" scale="6" unitref="shares">1,600</ix:nonfraction></ix:nonfraction> shares authorized as of September 30, 2022 and December 31, 2021; <ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfNzA_d1a3b82c-7b46-4167-93f1-90540d94ca77" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfNzA_d86b5e65-44b5-40e1-bbae-f6ebcd9acd94" name="us-gaap:CommonStockSharesIssued" scale="6" unitref="shares">387</ix:nonfraction></ix:nonfraction> and <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfNzc_18b2ec78-3fb9-49d2-b67c-6475233e887a" name="us-gaap:CommonStockSharesIssued" scale="6" unitref="shares"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMC0xLTEtMTc3NDk5L3RleHRyZWdpb246MDZhYWE1MWY1MmJkNDZiMzlkOTk1ZWQ3MGVhYTVkM2JfNzc_8b9f7a5e-2877-48ac-af61-c43defc53545" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">403</ix:nonfraction></ix:nonfraction> shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMS0xLTEtMTc3NDk5_b190a08a-1ca9-4617-84df-8545171545d7" name="us-gaap:CommonStockValue" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzMtMy0xLTEtMTc3NDk5_e018f117-5fe4-4bb9-ab24-07fbe2331a68" name="us-gaap:CommonStockValue" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzQtMS0xLTEtMTc3NDk5_4a1f90b5-c404-4fb9-a2da-c145f6445ec9" name="us-gaap:AdditionalPaidInCapital" scale="6" unitref="usd">1,488</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzQtMy0xLTEtMTc3NDk5_f5ed0231-59ce-4fc1-8193-317923cc7903" name="us-gaap:AdditionalPaidInCapital" scale="6" unitref="usd">4,211</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzUtMS0xLTEtMTc3NDk5_1ceaadc1-79c9-4dd2-8c6d-fb842702ce2d" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">351</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzUtMy0xLTEtMTc3NDk5_89882a4c-eb2b-42ea-8120-839a0a34ae68" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" sign="-" unitref="usd">24</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzYtMS0xLTEtMTc3NDk5_23f8eaeb-0217-4820-942a-7400fb5602ec" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitref="usd">16,855</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzYtMy0xLTEtMTc3NDk5_07e6d266-e6f7-4f2c-aecb-8f81b63d9886" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitref="usd">9,958</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzctMS0xLTEtMTc3NDk5_158dec87-2c6e-4113-9c68-a3694e7c49fe" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">17,992</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzctMy0xLTEtMTc3NDk5_a11cf12d-7e22-4749-85ed-4fb6a8d8d6d4" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">14,145</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzgtMS0xLTEtMTc3NDk5_86eeb085-fa17-433c-9404-7cdd18dc5c1a" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" unitref="usd">26,056</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xNi9mcmFnOjY4MTg2ZGM2MDRkODRjZTI4ZmE5MTEwNzFlM2U1MWI1L3RhYmxlOjhhZTcxOGE2ZTFmYjQ0NTViNTdkZjdhMWNjMzMwMDEwL3RhYmxlcmFuZ2U6OGFlNzE4YTZlMWZiNDQ1NWI1N2RmN2ExY2MzMzAwMTBfMzgtMy0xLTEtMTc3NDk5_35470c9a-3933-49a1-a9c7-4050d81b1edf" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" unitref="usd">24,669</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in millions, except per share data)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i38b2ccc325f1439e8a81e0c3f7be5e48_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMy0yLTEtMS0xNzc0OTk_dabc0b45-a950-494c-a950-61374dff26e5" name="us-gaap:Revenues" scale="6" unitref="usd">3,120</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i75523142f4a34f91af32a4b619d5f876_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMy00LTEtMS0xNzc0OTk_4facf541-d4c2-45dd-8ffc-1d94646f331e" name="us-gaap:Revenues" scale="6" unitref="usd">4,810</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2825268232174cd49a36dc4e6b636b75_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMy02LTEtMS0xNzc0OTk_cdca0065-3ee9-49de-8149-304721729629" name="us-gaap:Revenues" scale="6" unitref="usd">13,576</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib583c5df28854d598e1660840e096793_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMy04LTEtMS0xNzc0OTk_0aea467a-91d5-430e-9470-2c4f810e0ff7" name="us-gaap:Revenues" scale="6" unitref="usd">10,740</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i29fb96562ce9488c9ff23b503aacf987_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNC0yLTEtMS0xNzc0OTk_c7d8be92-3b3a-4206-955a-5427fc0525d6" name="us-gaap:Revenues" scale="6" unitref="usd">144</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9f5c8710d84842a9b3a98fb292d7be59_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNC00LTEtMS0xNzc0OTk_322b5ebb-bfed-477d-ab39-0646022407b7" name="us-gaap:Revenues" scale="6" unitref="usd">140</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i520e0eee9473493e9b84200f966551a6_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNC02LTEtMS0xNzc0OTk_20c2e2a0-0178-4426-a9a0-634c0b528486" name="us-gaap:Revenues" scale="6" unitref="usd">453</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2cb6086e753845599054921ec5661040_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNC04LTEtMS0xNzc0OTk_580d2595-bcfb-4bed-ad75-83f05652fe06" name="us-gaap:Revenues" scale="6" unitref="usd">473</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4185bba63eba436e9eeb5c8034c6dd3a_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNS0yLTEtMS0xNzc0OTk_2a693485-1781-4b42-9e86-50d13b93529e" name="us-gaap:Revenues" scale="6" unitref="usd">100</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i22020cfe4f324b478a1083d5d4b6f820_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNS00LTEtMS0xNzc0OTk_c2a04f5a-4849-4adc-928d-b203536a2144" name="us-gaap:Revenues" scale="6" unitref="usd">19</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i15aeaadcbb4f4464bc324b97ba7aaf25_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNS02LTEtMS0xNzc0OTk_175d6099-40f4-4ffa-b232-86401c664496" name="us-gaap:Revenues" scale="6" unitref="usd">150</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7f5405d313c6451b85214e64342530f0_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNS04LTEtMS0xNzc0OTk_38cf99db-0b4c-40c0-8891-587165170040" name="us-gaap:Revenues" scale="6" unitref="usd">47</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNi0yLTEtMS0xNzc0OTk_f3aa074f-0511-4a73-a074-42d5581aaf51" name="us-gaap:Revenues" scale="6" unitref="usd">3,364</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNi00LTEtMS0xNzc0OTk_67d97af7-de24-45d8-8684-fa466591fd46" name="us-gaap:Revenues" scale="6" unitref="usd">4,969</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNi02LTEtMS0xNzc0OTk_308c8a0c-19d5-4eeb-9953-49cf95707f96" name="us-gaap:Revenues" scale="6" unitref="usd">14,179</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfNi04LTEtMS0xNzc0OTk_4dfddb4d-ca56-46ea-9ebb-a0c8edc7fb98" name="us-gaap:Revenues" scale="6" unitref="usd">11,260</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOC0yLTEtMS0xNzc0OTk_286e1868-b828-4a05-b0b5-e72e0e12089d" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">1,100</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOC00LTEtMS0xNzc0OTk_3373677d-7630-4cee-8e1b-cdb6821f76bd" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">722</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOC02LTEtMS0xNzc0OTk_01996e54-bb44-4d6f-ac24-b1f440937544" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">3,498</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOC04LTEtMS0xNzc0OTk_a2d3e56d-8b05-463f-8ef4-5b29bf284ed6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitref="usd">1,665</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOS0yLTEtMS0xNzc0OTk_f0430aaa-6a9d-493b-992d-aa4cb72c1410" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">820</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOS00LTEtMS0xNzc0OTk_61fc37f9-1098-4318-ad25-bc44da8011be" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">521</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOS02LTEtMS0xNzc0OTk_c72e557d-572e-434a-8c52-52bcc587f0e2" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">2,084</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfOS04LTEtMS0xNzc0OTk_9abd3dc3-b374-49c3-b5aa-2b992f1ea106" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitref="usd">1,343</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTAtMi0xLTEtMTc3NDk5_4a73e6f1-762c-4400-b0c1-a754719d4167" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" unitref="usd">278</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTAtNC0xLTEtMTc3NDk5_d60f6a73-11cd-42bb-8202-99250edb66d4" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" unitref="usd">168</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTAtNi0xLTEtMTc3NDk5_9be25309-2759-43f7-a56a-11150034678f" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" unitref="usd">757</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTAtOC0xLTEtMTc3NDk5_de8496dc-bb61-406e-866a-2ccb266c0b83" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" unitref="usd">366</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTEtMi0xLTEtMTc3NDk5_2c92ecb2-b62f-4231-a529-5b52c79f3fa4" name="us-gaap:CostsAndExpenses" scale="6" unitref="usd">2,198</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTEtNC0xLTEtMTc3NDk5_f6c996cf-4733-4832-bb68-9f05742d3025" name="us-gaap:CostsAndExpenses" scale="6" unitref="usd">1,411</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTEtNi0xLTEtMTc3NDk5_dfac96b1-3bbe-477e-ad67-b772ecb45064" name="us-gaap:CostsAndExpenses" scale="6" unitref="usd">6,339</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTEtOC0xLTEtMTc3NDk5_51a5abfc-3102-4c57-a7aa-f923e6476960" name="us-gaap:CostsAndExpenses" scale="6" unitref="usd">3,374</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTItMi0xLTEtMTc3NDk5_c9cf1074-dca3-4d5e-9d64-cea1b13f7c25" name="us-gaap:OperatingIncomeLoss" scale="6" unitref="usd">1,166</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTItNC0xLTEtMTc3NDk5_f46693fc-b4c0-4d44-8281-333f0b7d1d5a" name="us-gaap:OperatingIncomeLoss" scale="6" unitref="usd">3,558</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTItNi0xLTEtMTc3NDk5_3cec1c4f-cf1d-433d-9854-65d192ae59db" name="us-gaap:OperatingIncomeLoss" scale="6" unitref="usd">7,840</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTItOC0xLTEtMTc3NDk5_adc523c6-50aa-4842-a4db-bf6129438eb5" name="us-gaap:OperatingIncomeLoss" scale="6" unitref="usd">7,886</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTMtMi0xLTEtMTc3NDk5_614a5b98-f7f7-4b2a-b227-a6976117c601" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">58</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTMtNC0xLTEtMTc3NDk5_65f87b4c-e9f6-4007-86fa-26464acb18fd" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTMtNi0xLTEtMTc3NDk5_f65eeb66-7c28-486b-8e78-059ec9237558" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">113</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTMtOC0xLTEtMTc3NDk5_f8b8971c-3839-46ac-8285-5c355618f184" name="us-gaap:InvestmentIncomeInterest" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTQtMi0xLTEtMTc3NDk5_86380e09-112c-41cd-9186-c87c80a1ad2d" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTQtNC0xLTEtMTc3NDk5_768dd45e-5e0d-451d-8abb-47eca541c71e" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">10</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTQtNi0xLTEtMTc3NDk5_d2852dd3-b559-477d-bc5b-387faafe2ad7" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">33</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTQtOC0xLTEtMTc3NDk5_77b67e3b-c439-4879-9ef4-c2ad525da1f7" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" sign="-" unitref="usd">22</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTUtMi0xLTEtMTc3NDk5_e53f3e5f-5ca7-42ca-8c73-424bfea7d5a2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">1,217</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTUtNC0xLTEtMTc3NDk5_fb968b6f-fc67-4162-9f41-af28e3743a89" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">3,552</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTUtNi0xLTEtMTc3NDk5_61c21b06-44f5-4e2b-8866-abc1404580ce" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">7,920</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTUtOC0xLTEtMTc3NDk5_4d04bd45-90a4-447c-ac4c-96c2c0669871" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">7,875</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTYtMi0xLTEtMTc3NDk5_5c0c18de-194c-492c-90be-79fa65c4ea78" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">174</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTYtNC0xLTEtMTc3NDk5_823d684f-7fb3-4d36-aa74-78040dcf48f9" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">219</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTYtNi0xLTEtMTc3NDk5_59f1c59f-e47e-47a8-9fb2-14c9df9c511b" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">1,023</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTYtOC0xLTEtMTc3NDk5_532d0375-9302-4252-be88-ec7e1b674f35" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">541</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTctMi0xLTEtMTc3NDk5_b9e48bf1-cdd8-4ad5-a4dc-b4b02bda0a1b" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,043</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTctNC0xLTEtMTc3NDk5_740cbfa6-bd21-4403-9fe8-a34860c84a7e" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,333</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTctNi0xLTEtMTc3NDk5_ad03432b-20da-4ca0-b2d3-d3a2d2f93ff8" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMTctOC0xLTEtMTc3NDk5_22481e41-ea58-45c4-9599-a40e12beac6c" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjAtMi0xLTEtMTc3NDk5_f3c101a8-41f2-4778-a734-38733f282838" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">2.67</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjAtNC0xLTEtMTc3NDk5_b980daa5-7275-457b-945d-7039407b1147" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">8.27</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjAtNi0xLTEtMTc3NDk5_8a8acd9a-4481-4750-afcc-60de0fbe35d7" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">17.41</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjAtOC0xLTEtMTc3NDk5_750b79bb-941b-456e-b784-c3acb1572e9a" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">18.25</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjEtMi0xLTEtMTc3NDk5_954cb593-4cee-4a15-8fc5-44eec639d518" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">2.53</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjEtNC0xLTEtMTc3NDk5_58d51977-cce1-478a-8a23-b9046b358b93" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">7.70</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjEtNi0xLTEtMTc3NDk5_1a8adb27-208f-4283-96fa-30eb2e6fae83" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">16.46</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjEtOC0xLTEtMTc3NDk5_ca0ec887-037c-40cf-86d6-51b3513c06c9" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">17.00</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used in calculation of earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjQtMi0xLTEtMTc3NDk5_c81bb77e-19c7-4d57-b7b6-bec37c629260" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">390</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjQtNC0xLTEtMTc3NDk5_cbad97e1-04fb-44c0-9a1c-2ac053a28a09" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">404</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjQtNi0xLTEtMTc3NDk5_72fc931c-81ed-40bd-aa09-17e7a52c3f8e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">396</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjQtOC0xLTEtMTc3NDk5_09a8d0e8-1103-4119-8490-cd71ae4c9aa1" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">402</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjUtMi0xLTEtMTc3NDk5_f708ef86-1f94-466d-891c-fbe242d45dcd" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">412</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjUtNC0xLTEtMTc3NDk5_eabed4e0-5aca-4f2d-9c35-717416589243" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">434</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjUtNi0xLTEtMTc3NDk5_114b1fd0-dc3b-4c49-b190-acf0cf10c74f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">419</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xOS9mcmFnOmU2MWYwMTBmMWYzNDRiZjNhZGMyOGFlNWI4ZjNhZDBiL3RhYmxlOjFlNGI4MDk3NWZkYjQ2YWU5N2JmZmVlMzVlMTE2NjVmL3RhYmxlcmFuZ2U6MWU0YjgwOTc1ZmRiNDZhZTk3YmZmZWUzNWUxMTY2NWZfMjUtOC0xLTEtMTc3NDk5_e025280e-e8a1-4d6a-acda-d3ec9a8e5b21" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">431</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in millions)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt 0 10pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.098%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMi0yLTEtMS0xNzc0OTk_417c1691-22d0-45e0-bd41-4a04d64ef197" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,043</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMi00LTEtMS0xNzc0OTk_b8594a1a-a518-45a9-b605-16e732f1c126" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,333</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMi02LTEtMS0xNzc0OTk_b0c5b0e0-23a9-451e-bdcf-96621983b7dc" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMi04LTEtMS0xNzc0OTk_6ff3e0e7-0a11-42c5-bda0-342b4ab39a38" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sales securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on available-for-sale debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNS0yLTEtMS0xNzc0OTk_a3174627-5e29-47fb-9237-28fc466f53c7" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" sign="-" unitref="usd">126</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNS00LTEtMS0xNzc0OTk_b52ffff6-c768-4db4-ba3c-30d257c791be" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" sign="-" unitref="usd">3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNS02LTEtMS0xNzc0OTk_c86a511a-c665-4cb4-9fb1-f2654693fa4a" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" sign="-" unitref="usd">384</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNS04LTEtMS0xNzc0OTk_fc8f53df-1b70-42d3-96aa-7173b3f0198b" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" sign="-" unitref="usd">10</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net realized losses (gains) on available-for-sale securities reclassified in net income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNi0yLTEtMS0xNzc0OTk_882ea59c-9fb2-4d31-ae19-15456a002212" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" sign="-" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNi00LTEtMS0xNzc0OTk_a56e54d6-0b5a-4c3b-aa20-55e467a40758" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNi02LTEtMS0xNzc0OTk_2f9fbb7a-c7a9-459d-99a7-af8655753c9b" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" sign="-" unitref="usd">18</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNi04LTEtMS0xNzc0OTk_bd4ee6a6-01c1-45ab-8932-c2132587a95a" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" unitref="usd">2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease from available-for-sale debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNy0yLTEtMS0xNzc0OTk_979d2a97-fe64-49d1-b3a6-849cffd566a7" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">123</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNy00LTEtMS0xNzc0OTk_8ef85db7-3a82-4473-84f0-3ba74978abe4" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">4</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNy02LTEtMS0xNzc0OTk_8f925572-996f-487c-aa95-0dbc23a19f8c" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">366</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfNy04LTEtMS0xNzc0OTk_c51823fd-362f-441e-8ee8-ef4fe8f0b7bb" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">12</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains on derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfOS0yLTEtMS0xNzc0OTk_a0c289fd-b7c8-43d5-81d2-e2a7086f0cb3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">62</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfOS00LTEtMS0xNzc0OTk_e6207fda-460f-4291-9d38-38580dcd7b63" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">30</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfOS02LTEtMS0xNzc0OTk_34f63e72-344e-423c-baf2-0e895980c2a7" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">133</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfOS04LTEtMS0xNzc0OTk_6da584cc-927f-485a-8546-dae7755b1319" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">51</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net realized (gains) on derivative instruments reclassified in net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTAtMi0xLTEtMTc3NDk5_0bd7708f-5615-4916-b5e5-c55108950218" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">50</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTAtNC0xLTEtMTc3NDk5_031768e7-2f34-4be8-b632-4c3ceb19a126" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">11</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTAtNi0xLTEtMTc3NDk5_bf9324c6-f97a-40ee-ae1d-eda9718027c7" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">94</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTAtOC0xLTEtMTc3NDk5_f210cda1-6308-491b-98d2-c9c3005a4f60" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">11</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase from derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTEtMi0xLTEtMTc3NDk5_6347e31c-0208-4231-b0a3-85b523b2514c" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" unitref="usd">12</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTEtNC0xLTEtMTc3NDk5_04df2938-cfbf-4110-ac4e-fe77386610e1" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" unitref="usd">19</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTEtNi0xLTEtMTc3NDk5_e5ce5524-c9fa-4bd9-8607-70272f7c2cb7" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" unitref="usd">39</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTEtOC0xLTEtMTc3NDk5_e5f1a391-d5c5-4556-bc8a-f66a7dd23779" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTItMi0xLTEtMTc3NDk5_4b777d6a-cb63-412c-af24-168fda468842" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">111</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTItNC0xLTEtMTc3NDk5_0fd5a2d3-c44b-43fd-b1eb-8daad94b5506" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">15</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTItNi0xLTEtMTc3NDk5_27b8fe62-7d20-45bc-9351-5a266b4d8780" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">327</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTItOC0xLTEtMTc3NDk5_bfe8a88b-54d6-422d-a02a-e8f8694f236a" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">28</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTMtMi0xLTEtMTc3NDk5_e1ffe89c-fb14-4f11-95a5-990ee64b9bc0" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">932</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTMtNC0xLTEtMTc3NDk5_e9f4243d-9676-4b76-881e-c6a05f69eb72" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">3,348</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTMtNi0xLTEtMTc3NDk5_f6e35083-7f17-4178-916b-ec74def4359c" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">6,570</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yNS9mcmFnOmExYTgxMTcyYWUyNDQyYjFiYWFjNDU3YzEwYzk2Mzg4L3RhYmxlOjczNDhlYmRiODQxYTQzNDQ4ZWQxMGU1ZDJjYWQ1MDkwL3RhYmxlcmFuZ2U6NzM0OGViZGI4NDFhNDM0NDhlZDEwZTVkMmNhZDUwOTBfMTMtOC0xLTEtMTc3NDk5_81d8f951-e3db-43c4-8709-2fc20f6e336a" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" unitref="usd">7,362</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in millions)</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.345%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i53c9adc3e80a4f91a0e8aa5b52521ad8_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi0xLTEtMS0xNzc0OTk_1fbab543-4153-477a-91f5-d72ddada4ebc" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">392</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i53c9adc3e80a4f91a0e8aa5b52521ad8_I20220630" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi0zLTEtMS0xNzc0OTk_810413a6-034d-4b32-8023-105f65b8b76d" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i70bab7d1a29c45b1943b86cbb303eb97_I20220630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi01LTEtMS0xNzc0OTk_74287fe4-19a6-4b23-9d7b-e6fa59073e91" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">2,413</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ia117a5b2904d49e685347f90cf03dc63_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi03LTEtMS0xNzc0OTk_f27a8dc0-6fb8-476b-ba26-e8efbbbb21e8" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">240</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1dd63fbdc6fa4e71ba5d569169fe7e2a_I20220630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi05LTEtMS0xNzc0OTk_87b6a758-0b24-41cd-ad23-c8a4da538dcf" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">15,812</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i22c92b775c9b47f88c9025bc7daf45b5_I20220630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMi0xMS0xLTEtMTc3NDk5_8fbec2a1-1bba-4a49-9a79-68166b2f597b" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">17,985</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted common stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1e6c933198b14cf29e697f7adf83d6e7_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMy0xLTEtMS0xNzc0OTk_b158fdf5-c782-4b8d-9ccd-b875d996d55b" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="6" unitref="shares">1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1e6c933198b14cf29e697f7adf83d6e7_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfNC0xLTEtMS0xNzc0OTk_a46643b6-414a-4541-a718-685384cbd5a7" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" unitref="shares">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i61390da75a5843ca8a6ad26c705c16a2_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfNC01LTEtMS0xNzc0OTk_3fcbe085-d4e6-4d0b-97ca-371806a6bb1e" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfNC0xMS0xLTEtMTc3NDk5_2f105ddb-0148-4a85-863c-fcba4c84a0fd" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i61390da75a5843ca8a6ad26c705c16a2_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfNy01LTEtMS0xNzc0OTk_5a3b3ec4-fa20-42ec-9800-745acddd8b6a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">70</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfNy0xMS0xLTEtMTc3NDk5_63113f75-f2dd-41a0-af1a-386effee7798" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">70</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie152289a8729470ba1c27037872ec7b2_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfOC03LTEtMS0xNzc0OTk_f43e97c3-a9c4-4bb9-be25-e7c5f6e8484a" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">111</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfOC0xMS0xLTEtMTc3NDk5_0fe03ba4-3cff-4f99-8f1e-253c14654c59" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">111</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i1e6c933198b14cf29e697f7adf83d6e7_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfOS0xLTEtMS0xNzc0OTk_eba5d566-446d-447d-9030-6f1b0b9d0a1f" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" unitref="shares">7</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i61390da75a5843ca8a6ad26c705c16a2_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfOS01LTEtMS0xNzc0OTk_e20eec76-7dea-4a7a-b81e-6b21ec8691e1" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" unitref="usd">1,006</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfOS0xMS0xLTEtMTc3NDk5_a66a2d38-6792-456a-9d33-dd05c9a860bc" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" unitref="usd">1,006</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i03dccc309b6a484cbd2d2646fd5f60fd_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTAtOS0xLTEtMTc3NDk5_afb5e4f0-a18d-42d6-b673-6b952dd1cda2" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,043</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTAtMTEtMS0xLTE3NzQ5OQ_eb5229be-6755-45e6-a459-0d6259e922d9" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,043</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9bea0fbf4b6847008cbed15c247fd567_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtMS0xLTEtMTc3NDk5_480be47c-4d96-45da-85a1-434ee7c2bd56" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">387</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9bea0fbf4b6847008cbed15c247fd567_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtMy0xLTEtMTc3NDk5_f336db47-96b8-4c7b-8822-f06c64de8497" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia274cd2680744f08bb0d5974251a676d_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtNS0xLTEtMTc3NDk5_c214a90c-6d35-4f3d-a462-012cf518b694" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">1,488</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i122e8a3f97504248aaf7e3cd4fb4143e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtNy0xLTEtMTc3NDk5_5cd7bc80-979c-4d64-b14a-dc351f3911bf" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">351</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib342e036d02842b3a67a8bf74e521ca2_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtOS0xLTEtMTc3NDk5_0fe7fba4-2a94-4c68-8bc4-7098e256c747" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">16,855</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOmFiMDAzMzdjYzUwNDRkNWZiNGUyOTRlYjVjZTY3YjhlL3RhYmxlcmFuZ2U6YWIwMDMzN2NjNTA0NGQ1ZmI0ZTI5NGViNWNlNjdiOGVfMTEtMTEtMS0xLTE3NzQ5OQ_46b899fc-afdf-4912-945a-6c363987e408" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">17,992</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.345%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i694c0c150d5043d8989f3eac8dabc6a1_I20210630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi0xLTEtMS0xNzc0OTk_89f8d9f1-851e-4b16-b846-75d0437f5bb8" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">403</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i694c0c150d5043d8989f3eac8dabc6a1_I20210630" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi0zLTEtMS0xNzc0OTk_464de72c-a294-415a-9283-ac16ea0568da" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0a1170b85b1746f99c691491376e34a9_I20210630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi01LTEtMS0xNzc0OTk_d036887d-0fca-4a0e-b149-5ac47d284b0b" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">4,931</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02ad6c305cb341fa93990daa5d13560e_I20210630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi03LTEtMS0xNzc0OTk_0e42bbbc-b92f-424b-80f8-e2e09f32ca79" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7ca3c2c29fd24c22ac9e7cf2f7a008dd_I20210630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi05LTEtMS0xNzc0OTk_4234ed81-b787-4811-9ea5-74cfa3679eef" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">1,757</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6e1f6321d9a54927bf211d1213d7fa86_I20210630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMi0xMS0xLTEtMTc3NDk5_772f0e16-08f5-4b9f-8ebf-b3e230b1ef6a" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">6,704</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8ba4407730fe44b1938c65769076f4fd_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfNS0xLTEtMS0xNzc0OTk_28c09794-d83a-4862-ba30-42c2f24a6d0e" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" unitref="shares">2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac527886f9074dbe9300eae26fda7e81_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfNS01LTEtMS0xNzc0OTk_c9e36ef2-206b-4039-afef-9553b1cd2b82" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">32</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfNS0xMS0xLTEtMTc3NDk5_40b54444-8d89-46d1-9133-a2040f1f35f6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">32</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac527886f9074dbe9300eae26fda7e81_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfNy01LTEtMS0xNzc0OTk_4032383d-d822-431e-99c3-9bfc90eec875" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfNy0xMS0xLTEtMTc3NDk5_33abe80f-2330-4288-b352-4cc0d20ab996" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia9cb1b5be2a249c8a7639d5f897767ac_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfOC03LTEtMS0xNzc0OTk_06296606-1fee-4479-90cc-745571d1eae9" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">15</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfOC0xMS0xLTEtMTc3NDk5_0ec091fe-fe2b-435e-9eb0-e6651dbf7240" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">15</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i94df1f1de90143b7afd2dae8ddcd3603_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfOS05LTEtMS0xNzc0OTk_591af0a5-09aa-4f7b-8ad8-dcf4c6be76a3" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,333</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfOS0xMS0xLTEtMTc3NDk5_682863ff-eb52-4ca2-85b8-687fd1c3f2c1" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,333</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib31edffc055b4e84969e5de0f150a15d_I20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtMS0xLTEtMTc3NDk5_91c5f67e-563a-4a4e-a373-bafc7b576fc8" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">405</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib31edffc055b4e84969e5de0f150a15d_I20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtMy0xLTEtMTc3NDk5_37626aea-f037-42dc-98e3-e84958789bf5" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i79f6f788b4e94ecdb19f344b598a5baa_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtNS0xLTEtMTc3NDk5_7a20eb2f-372a-4bb0-bf80-4002592d8088" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">5,003</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i782270e7a13d448baa6dc9788cfe145e_I20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtNy0xLTEtMTc3NDk5_5fda0084-7725-40a9-8442-5a394dc2f4d3" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">31</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7d49e55fc18746acbc838219b403e21d_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtOS0xLTEtMTc3NDk5_37a98e37-bd9c-48eb-ac14-d0692d910c2c" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">5,090</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8yOC9mcmFnOjI1ZTEwMjJhNWIyZjRiN2I5Mjk0NWQ0MjgyYTA4N2Q5L3RhYmxlOjk5YWI5YmUyMzMwMjQ2MGFiZjZiNjkxZDcwMWZlZmU3L3RhYmxlcmFuZ2U6OTlhYjliZTIzMzAyNDYwYWJmNmI2OTFkNzAxZmVmZTdfMTAtMTEtMS0xLTE3NzQ5OQ_af66ad68-8d63-46a0-8108-0ef248738124" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">10,124</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.345%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icd9f4dd415c941189b8b084da19b318b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi0xLTEtMS0xNzc0OTk_e980aa58-2570-43c7-aa15-e499b7a5357f" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">403</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icd9f4dd415c941189b8b084da19b318b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi0zLTEtMS0xNzc0OTk_54819a56-7099-4850-82f1-a12c81bf7d4c" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idf932ee5bf954085aff8c5b5bfd774f7_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi01LTEtMS0xNzc0OTk_852a9eb2-c8d6-4a15-a3be-aa13318d9da9" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">4,211</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0990fad2c0a64ba5857845d17c59244b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi03LTEtMS0xNzc0OTk_0683bbe8-18cb-43a8-b6f8-5dde16342757" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">24</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i07b7f133ef7c49979819a21477dd2d35_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi05LTEtMS0xNzc0OTk_0f56812f-3137-4d31-abdc-332e9075fb54" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">9,958</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMi0xMS0xLTEtMTc3NDk5_77583707-33a8-4e0e-a2f5-b461a697cfa9" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">14,145</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted common stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i399a0bc5ac9c408fb8a426767fd4846c_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMy0xLTEtMS0xNzc0OTk_8033c0fe-8f73-47ad-a276-1b30d847383a" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="6" unitref="shares">1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i399a0bc5ac9c408fb8a426767fd4846c_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNC0xLTEtMS0xNzc0OTk_1c2c0d0a-4095-471a-8959-0dc6e0452e9f" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" unitref="shares">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i15e32273960f4cbdac4db90e54c81713_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNC01LTEtMS0xNzc0OTk_7606472d-31a3-4a2d-98cd-57078a26e1b3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">31</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNC0xMS0xLTEtMTc3NDk5_c4819582-c6fd-4419-8e07-4a2ea3b0233a" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">31</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i15e32273960f4cbdac4db90e54c81713_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNi01LTEtMS0xNzc0OTk_4a041bd5-5ab9-4380-b2fc-349f533019e6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNi0xMS0xLTEtMTc3NDk5_5a722c74-b86f-443f-9c73-a7fc7edfe51b" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNi0xMS0xLTEtMTc3NDk5_6f022a9e-9366-49b8-b385-73758fb40b33" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">9</ix:nonfraction></ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i15e32273960f4cbdac4db90e54c81713_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNy01LTEtMS0xNzc0OTk_a4d6e0bc-f35c-4c24-885d-21275c3a41ce" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">164</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfNy0xMS0xLTEtMTc3NDk5_cdde454e-662d-4e96-ace0-5479b4e3e1f9" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">164</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i30d19a7153514aa8968937176d0ba53f_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfOC03LTEtMS0xNzc0OTk_f77c564d-89e9-4f93-bcba-8d08c97ea685" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">327</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfOC0xMS0xLTEtMTc3NDk5_80894ddd-2f52-415c-b27d-42f346a12408" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">327</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i399a0bc5ac9c408fb8a426767fd4846c_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfOS0xLTEtMS0xNzc0OTk_54e749e0-3756-4e98-afab-b82a1dbdfb76" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" unitref="shares">20</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i15e32273960f4cbdac4db90e54c81713_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfOS01LTEtMS0xNzc0OTk_bba006c8-be51-4721-8245-80abc89ae11d" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" unitref="usd">2,927</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfOS0xMS0xLTEtMTc3NDk5_b32a0145-dcdd-48ab-ba1a-f84435023809" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" unitref="usd">2,927</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iebd5cc74069f42b1a4c2980d4bec1f0c_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTAtOS0xLTEtMTc3NDk5_5ffe5bc5-324b-4851-b09b-d239e803d794" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTAtMTEtMS0xLTE3NzQ5OQ_9e0ae1db-431e-49cc-93b1-a565a2068f33" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9bea0fbf4b6847008cbed15c247fd567_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtMS0xLTEtMTc3NDk5_dbaadcf1-29e3-4734-80e0-f9ba6c5caa20" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">387</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9bea0fbf4b6847008cbed15c247fd567_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtMy0xLTEtMTc3NDk5_c5e93263-7008-4d79-8dc4-3be4254d76b3" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia274cd2680744f08bb0d5974251a676d_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtNS0xLTEtMTc3NDk5_9b1ac759-b00d-4900-b2b7-88258ab1f574" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">1,488</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i122e8a3f97504248aaf7e3cd4fb4143e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtNy0xLTEtMTc3NDk5_4c4c1bd4-706d-4591-a6b1-af09ebed6335" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">351</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib342e036d02842b3a67a8bf74e521ca2_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtOS0xLTEtMTc3NDk5_3363272c-1c4f-4d44-a190-87fcd308bc24" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">16,855</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOjQ0YzE2Y2FmZjBkZjQ5ZmY4MTczMDU5MWJjMjUxNmI0L3RhYmxlcmFuZ2U6NDRjMTZjYWZmMGRmNDlmZjgxNzMwNTkxYmMyNTE2YjRfMTEtMTEtMS0xLTE3NzQ5OQ_304ce7ad-8db7-4505-afc5-d289bfd209ae" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">17,992</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.345%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings<br/>(Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9d4beb637a0a4fc9bd284843f38ed95f_I20201231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi0xLTEtMS0xNzc0OTk_d31cca96-9560-4c80-9131-db6f9938b925" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">399</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9d4beb637a0a4fc9bd284843f38ed95f_I20201231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi0zLTEtMS0xNzc0OTk_b9cbd180-fba8-4d9f-b40b-ee85d9c41f18" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6fb6fc4a2c7c4ecaabad61fdb03ec18e_I20201231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi01LTEtMS0xNzc0OTk_b2edec62-24c4-483e-a560-f06f5954e642" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">4,802</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i612bca90824c4ae49aae6082058e312e_I20201231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi03LTEtMS0xNzc0OTk_94e31366-fef9-4dbc-806e-a8e6c8675870" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i6b1f7c35c1f54dafbdd9759f2aaa82f3_I20201231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi05LTEtMS0xNzc0OTk_ef27d490-2d18-4edb-9da9-10984c1c0067" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">2,244</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b5dd65ec72c4aaaa79ad4306fa05131_I20201231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMi0xMS0xLTEtMTc3NDk5_e6b8e089-5905-416d-aaa5-cdb03d6aa901" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">2,561</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1ce22e41716c404badbfe9d609e33b40_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNS0xLTEtMS0xNzc0OTk_0878fc24-98ea-4c99-8272-560b4d976d37" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" unitref="shares">6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id64bc1d58e7d4d2daaf1609061ef31d5_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNS01LTEtMS0xNzc0OTk_52d81285-14f1-45a9-9510-74dc67a2df3d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">91</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNS0xMS0xLTEtMTc3NDk5_2f5de216-06d9-4875-89c1-8f27f97db3f8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" unitref="usd">91</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id64bc1d58e7d4d2daaf1609061ef31d5_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNi01LTEtMS0xNzc0OTk_95558d61-b7e5-4ec8-a5b1-f33a1fc43f1b" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNi0xMS0xLTEtMTc3NDk5_bd466506-dca8-4699-8d15-7c343d2894e9" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id64bc1d58e7d4d2daaf1609061ef31d5_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNy01LTEtMS0xNzc0OTk_0a66e102-ad61-4cbe-a8af-d03a24e86d12" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">105</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfNy0xMS0xLTEtMTc3NDk5_739533ba-cb92-4603-ae60-7cbecf8b08da" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" unitref="usd">105</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i03bc6d0074264668bafef4bde4a546a7_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfOC03LTEtMS0xNzc0OTk_ce2679a9-48df-4d9a-bee7-0ad5aa145f77" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">28</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfOC0xMS0xLTEtMTc3NDk5_afdc6952-26b7-4c92-a84f-89b60415ab55" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">28</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib7e9c72120be42739b402a4fac1726d6_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfOS05LTEtMS0xNzc0OTk_a7468c9a-3ce3-4f0e-94eb-09bcc46e6120" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfOS0xMS0xLTEtMTc3NDk5_477d39b5-8257-4042-a2e1-0290fdbd3189" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib31edffc055b4e84969e5de0f150a15d_I20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtMS0xLTEtMTc3NDk5_9dcaaa21-3eb2-43af-8e66-4956efc98585" name="us-gaap:CommonStockSharesOutstanding" scale="6" unitref="shares">405</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib31edffc055b4e84969e5de0f150a15d_I20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtMy0xLTEtMTc3NDk5_9a1503f2-8c91-4655-9918-a0d5109ba5fe" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i79f6f788b4e94ecdb19f344b598a5baa_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtNS0xLTEtMTc3NDk5_88799649-a16e-4ab3-8e9c-b9d38e14d610" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">5,003</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i782270e7a13d448baa6dc9788cfe145e_I20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtNy0xLTEtMTc3NDk5_bdcb9a63-749b-477a-8307-e748942faafd" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">31</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7d49e55fc18746acbc838219b403e21d_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtOS0xLTEtMTc3NDk5_ac25ab9d-a82c-4040-885c-35c90d08f2a9" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">5,090</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zMS9mcmFnOmM2ODAyMzM1NGE5YTQyMDJhZTU2OGZlYWI4NTM4N2JiL3RhYmxlOmI3YTMyYjQwYWQxNzQ0NjU4NTk1ZjU0ZGVmZWZhOWY3L3RhYmxlcmFuZ2U6YjdhMzJiNDBhZDE3NDQ2NTg1OTVmNTRkZWZlZmE5ZjdfMTAtMTEtMS0xLTE3NzQ5OQ_f9b581a0-c8cc-4330-813c-ca3bde0d85f4" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">10,124</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in millions)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMy0xLTEtMS0xNzc0OTk_b352dd04-f3b2-40c5-930d-f59e7336ae59" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMy0zLTEtMS0xNzc0OTk_0c011ca9-15c2-4e75-8a1e-14d9da72fae5" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNS0xLTEtMS0xNzc0OTk_8f172665-0199-49c3-9631-f894404f6c5a" name="us-gaap:ShareBasedCompensation" scale="6" unitref="usd">164</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNS0zLTEtMS0xNzc0OTk_4f2d6265-90f2-41a1-a15c-d373c73267b0" name="us-gaap:ShareBasedCompensation" scale="6" unitref="usd">105</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNi0xLTEtMS0xNzc0OTk_120929c1-b2cf-49b2-a52c-a5b9676e8cd2" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">268</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNi0zLTEtMS0xNzc0OTk_eae673eb-e5fb-4d5e-bb53-bb68cb7ae788" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">154</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization/accretion of investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNy0xLTEtMS0xNzc0OTk_f3167a52-a5c9-4bb4-b282-b02d3aa0a056" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="6" sign="-" unitref="usd">35</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNy0zLTEtMS0xNzc0OTk_c75041aa-511a-4a3b-833f-30b99c9b76e6" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="6" sign="-" unitref="usd">33</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfOS0xLTEtMS0xNzc0OTk_0f536b03-c0a5-4e08-8d45-9dbca7f83199" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" sign="-" unitref="usd">473</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfOS0zLTEtMS0xNzc0OTk_4e51de2c-4408-4759-821f-c393e902c81e" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" sign="-" unitref="usd">89</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTAtMS0xLTEtMTc3NDk5_5cc68567-5db8-4fd2-a909-54579cd361b1" name="us-gaap:OtherNoncashIncomeExpense" scale="6" sign="-" unitref="usd">36</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTAtMy0xLTEtMTc3NDk5_12fe219f-8da1-4aad-9e3d-51c4590aa94d" name="us-gaap:OtherNoncashIncomeExpense" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTItMS0xLTEtMTc3NDk5_b74cdd5f-b262-4521-beff-92bc6b6194a6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" sign="-" unitref="usd">480</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTItMy0xLTEtMTc3NDk5_c5dfb35f-a1ac-4d75-9ced-07055332f451" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" unitref="usd">1,751</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTMtMS0xLTEtMTc3NDk5_762f0e63-27db-4640-a532-4b77220b564a" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" unitref="usd">669</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTMtMy0xLTEtMTc3NDk5_94a8ec2a-6b3d-4e34-9de1-c06c1fb44cb1" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" unitref="usd">186</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-27pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTQtMS0xLTEtMTc3NDk5_d76a8c5d-741b-47ed-85f3-175240c83858" name="us-gaap:IncreaseDecreaseInInventories" scale="6" unitref="usd">636</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTQtMy0xLTEtMTc3NDk5_de3a962f-b560-4bd4-a847-225d0d63ee26" name="us-gaap:IncreaseDecreaseInInventories" scale="6" unitref="usd">918</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets, operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTUtMS0xLTEtMTc3NDk5_f662f5ff-c2cd-469e-8f9c-54de382c4596" name="mrna:IncreaseDecreaseInRightOfUseAssetOperatingLeases" scale="6" sign="-" unitref="usd">29</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTUtMy0xLTEtMTc3NDk5_26646921-4bc0-49e4-9ab7-43c1b399870c" name="mrna:IncreaseDecreaseInRightOfUseAssetOperatingLeases" scale="6" unitref="usd">25</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTYtMS0xLTEtMTc3NDk5_5d80d216-a06d-4a8f-b2a0-bf4e9916d516" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" unitref="usd">89</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTYtMy0xLTEtMTc3NDk5_c9ce6b4d-3cc6-465c-b8b6-382007c28c6b" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" unitref="usd">26</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTctMS0xLTEtMTc3NDk5_3af89d62-f712-4bcd-839c-c332d1833ea1" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" unitref="usd">354</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTctMy0xLTEtMTc3NDk5_09875989-22a7-4f58-9f89-7d7846149962" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" unitref="usd">600</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTgtMS0xLTEtMTc3NDk5_59979ddb-ae95-4b66-91b1-2c51301d0545" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" sign="-" unitref="usd">2,691</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTgtMy0xLTEtMTc3NDk5_3d7ccddd-0a36-47b0-8747-6569a82d78ef" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" unitref="usd">4,431</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-27pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTktMS0xLTEtMTc3NDk5_b75cf7ba-6705-44ce-893e-c2a8e6c5be80" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" sign="-" unitref="usd">810</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMTktMy0xLTEtMTc3NDk5_1bfe8bf6-9715-414d-bce4-f14630fe25ca" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" unitref="usd">565</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjAtMS0xLTEtMTc3NDk5_e6855625-1aa7-42bd-84e8-e6b1390023b3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" sign="-" unitref="usd">27</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjAtMy0xLTEtMTc3NDk5_62540308-d263-4422-baa6-599cbbb56d62" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" unitref="usd">8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjEtMS0xLTEtMTc3NDk5_db220b14-0a7d-48ad-beab-7acc2d2d1998" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" unitref="usd">273</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjEtMy0xLTEtMTc3NDk5_32ab2932-163c-49c4-9de2-99935f081b52" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" unitref="usd">23</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjItMS0xLTEtMTc3NDk5_fc0c0db1-53ee-4c71-a599-86a6e22f8210" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" unitref="usd">3,319</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjItMy0xLTEtMTc3NDk5_0d66233d-6de1-4aba-bfd0-8fb1d2656a63" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" unitref="usd">10,310</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjQtMS0xLTEtMTc3NDk5_e9aa9232-443c-4fd3-8df4-652a395a859f" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" unitref="usd">8,925</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjQtMy0xLTEtMTc3NDk5_82b608a1-2131-4cfd-af34-75cde9886f89" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" unitref="usd">10,279</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjUtMS0xLTEtMTc3NDk5_3fd03022-33f7-407b-9f13-056656e506b4" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" unitref="usd">2,222</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjUtMy0xLTEtMTc3NDk5_2de20ad1-a858-465a-84cf-b6dece53381e" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" unitref="usd">1,075</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjYtMS0xLTEtMTc3NDk5_dbc0788d-647e-422e-92da-b7a4d0d06bd1" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" unitref="usd">2,918</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjYtMy0xLTEtMTc3NDk5_f62584bd-6170-4a83-ad27-5cee5319adba" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" unitref="usd">1,983</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjctMS0xLTEtMTc3NDk5_2ab23e5e-a711-4def-889c-909796762687" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" unitref="usd">308</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjctMy0xLTEtMTc3NDk5_ad13b4c4-685a-47fc-b6bc-a9ca743da95b" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" unitref="usd">164</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjgtMS0xLTEtMTc3NDk5_f275dbbc-e6a9-42df-af04-d49066e4a1d7" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="6" unitref="usd">35</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjgtMy0xLTEtMTc3NDk5_df6ad7d5-34e9-4d79-a1b4-6fea4072bb9b" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjktMS0xLTEtMTc3NDk5_4fa37247-6903-4cd6-afac-742f66a0b44f" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" sign="-" unitref="usd">4,128</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMjktMy0xLTEtMTc3NDk5_499180e5-b58c-4f94-88b3-0f5512b7d071" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" sign="-" unitref="usd">7,385</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock through equity plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzItMS0xLTEtMTc3NDk5_a3c572e7-d922-4474-8714-e283e3f98812" name="us-gaap:ProceedsFromStockPlans" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzItMy0xLTEtMTc3NDk5_18e22dcd-66ac-4dcc-b3b9-62dd6776f7c7" name="us-gaap:ProceedsFromStockPlans" scale="6" unitref="usd">96</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzQtMS0xLTEtMTc3NDk5_5bbc0134-4108-40b0-b3b1-0b675e973a3e" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" unitref="usd">2,927</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzQtMy0xLTEtMTc3NDk5_66f5a130-73d2-4bca-896c-798cd98faf65" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzUtMS0xLTEtMTc3NDk5_ea49f63a-9255-422a-82b7-29367d917b4d" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" unitref="usd">123</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzUtMy0xLTEtMTc3NDk5_f398940a-d436-4a77-ae7e-1eda56e23583" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" unitref="usd">96</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzYtMS0xLTEtMTc3NDk5_59447e95-eceb-461d-ad08-46b218eda615" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" sign="-" unitref="usd">3,010</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzYtMy0xLTEtMTc3NDk5_776dd0f0-10dc-4b0f-b2bb-bf86c7ef8887" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzctMS0xLTEtMTc3NDk5_473e349a-c819-49c9-9870-f2be80c9ac33" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" sign="-" unitref="usd">3,819</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzctMy0xLTEtMTc3NDk5_47911f73-d1c8-4103-a52f-64a2c339b256" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" unitref="usd">2,925</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzgtMS0xLTEtMTc3NDk5_fa87a862-84f0-4fe1-b08c-4422607a8158" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">6,860</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b5dd65ec72c4aaaa79ad4306fa05131_I20201231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzgtMy0xLTEtMTc3NDk5_69d72338-ae90-4505-97d5-5ae3514133e5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">2,636</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzktMS0xLTEtMTc3NDk5_b0f3e7d0-3d8a-41be-bc2a-319ce0f60351" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">3,041</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfMzktMy0xLTEtMTc3NDk5_38eecd16-6677-46b8-bf41-851ed3b45f07" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">5,561</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-cash investing and financing activities</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment included in accounts payable and accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDEtMS0xLTEtMTc3NDk5_4a27499d-9aee-4859-9131-a39daafac063" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDEtMy0xLTEtMTc3NDk5_7aac26c3-6897-453e-8288-242c5db142e3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" unitref="usd">66</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained through finance lease modifications and reassessments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDItMS0xLTEtMTc3NDk5_cef645dd-af72-434b-87ae-b6826b244bdf" name="mrna:RightOfUseAssetsObtainedThroughFinanceLeaseModificationsAndReassessments" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDItMy0xLTEtMTc3NDk5_635e2079-452b-4833-b054-a83a4f320bdc" name="mrna:RightOfUseAssetsObtainedThroughFinanceLeaseModificationsAndReassessments" scale="6" unitref="usd">364</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for financing lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDMtMS0xLTEtMTc3NDk5_58105ec1-000c-4e81-a373-f4b09ef50af1" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" unitref="usd">781</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8zNC9mcmFnOjc5YmQ4NjY2ZTlmYTRkNTY4MDg0YWNmNWQ5YzIzYmMwL3RhYmxlOjI2Y2M2N2JmNGFhZjQ0ZTNhOGEwZDViMmU4YjJlMzE3L3RhYmxlcmFuZ2U6MjZjYzY3YmY0YWFmNDRlM2E4YTBkNWIyZThiMmUzMTdfNDMtMy0xLTEtMTc3NDk5_9ff4025a-3a4f-4d38-ae48-b1feb52d8f77" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" unitref="usd">126</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_40"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>(Unaudited)</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i483b9751eafb488e86229a8769e98a04" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80MC9mcmFnOmQ1NmYyZDJhNGY4ZTQyMjdhODk0MjA1MmExYzgwMjEyL3RleHRyZWdpb246ZDU2ZjJkMmE0ZjhlNDIyN2E4OTQyMDUyYTFjODAyMTJfMjMyMw_e4e3bd09-692c-4e4a-991d-d724288db482" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">Description of the Business</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation id="i483b9751eafb488e86229a8769e98a04"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moderna, Inc. (collectively, with its consolidated subsidiaries, any of Moderna, we, us, our, or the Company) is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines to improve the lives of patients. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with our strategic collaborators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the emergency use of the Moderna COVID-19 Vaccine (also referred to as mRNA-1273 and marketed under the brand name Spikevax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) as a two-dose, 100 &#181;g primary series in individuals 18 years of age or older. In January 2022, we received full commercial approval for Spikevax as a two-dose, 100 &#181;g primary series to prevent COVID-19 in individuals 18 years of age and older in the United States. Spikevax is approved or authorized in individuals 18 years and older in more than 70 countries. In addition, Spikevax is authorized by the FDA and global regulators in more than 50 countries as a two-dose, 100 &#181;g primary series in adolescents aged 12 to 17 years old and as a two-dose, 50 &#181;g primary series in children ages 6 to 11 years old. Additionally, a two-dose, 25 &#181;g primary series of Spikevax is authorized in young children aged 6 months to 5 years old in the United States, Canada, Australia, and other jurisdictions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, European Medicines Agency (EMA), Swissmedic and other health agencies around the world have authorized a booster dose of Spikevax at the 50 &#181;g dose level for adults ages 18 years and older. The FDA and other health agencies have also authorized a second booster dose at the 50 &#181;g dose level for adults 50 years and older and adults 18 years of age and older with certain kinds of immunocompromise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2022, we received the first authorization for our BA.1 Omicron-targeting bivalent COVID-19 booster vaccine (Spikevax Bivalent Original/Omicron, mRNA-1273.214) from the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, given as a 50 &#181;g booster dose for individuals 18 years of age and older who have received either a primary series or an initial booster of any of the authorized or approved COVID-19 vaccines. The EMA in the European Union provided a similar authorization for mRNA-1273.214 as a booster vaccine for individuals 12 years and older on September 2, 2022. During the third quarter of 2022, we received authorizations for mRNA-1273.214 as a booster vaccine in the United Kingdom, the European Union, Japan, Australia, Canada, and Switzerland.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, we received an EUA from the FDA for our BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine (mRNA-1273.222), given as a 50 &#181;g booster dose for individuals 18 years of age and older who have received either a primary series or an initial booster of any of the authorized or approved COVID-19 vaccines. On October 12, 2022, we received an EUA from the FDA for mRNA-1273.222 as a 50 &#181;g booster dose for adolescents 12 to 17 years old and as a 25 &#181;g booster dose for children 6 to 11 years old, each following a completed primary series of any authorized COVID-19 vaccine or a previous booster. The EMA in the European Union, the MHRA in the United Kingdom and other countries worldwide have provided similar authorizations for mRNA-1273.222.</span></div></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="ia3d97253b0f44c589f7a38deac5060ed" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA5NA_80d125e8-41cc-422d-a269-7c2c2827e5db" name="us-gaap:SignificantAccountingPoliciesTextBlock">Summary of Basis of Presentation and Recent Accounting Standards</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="ie3a69283e2444adba453344e0dbd3041" id="ia3d97253b0f44c589f7a38deac5060ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDEwMg_3fa7bbda-cb6c-4fc0-bdb5-bc9bea1b559e" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock">The accompanying unaudited condensed consolidated financial statements that accompany these notes have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 31, 2021 (2021 Form 10-K). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Update (ASU) of the Financial Accounting Standards Board (FASB). This report should be read in conjunction with the audited consolidated financial statements in our 2021 Form 10-K.</ix:nonnumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation continuedat="idab76cf70f604fc68c94635fb15c493b" id="ie3a69283e2444adba453344e0dbd3041"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA4Mg_d88c8f47-e852-4fc7-91a1-5e73cc0da971" name="us-gaap:ConsolidationPolicyTextBlock">The condensed consolidated financial statements include Moderna, Inc. and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</ix:nonnumeric> The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2022 are consistent with those described in our 2021 Form 10-K. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results to be expected for the full fiscal year or future operating periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA3OQ_41ddefff-d8e3-424e-98b7-7530552ba944" name="us-gaap:UseOfEstimates">We have made estimates and judgments affecting the amounts reported in our condensed consolidated financial statements and the accompanying notes. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods that are not readily apparent from other sources. Significant estimates relied upon in preparing these financial statements include, but are not limited to, critical accounting policies or estimates related to revenue recognition, income taxes, valuation allowance on deferred tax assets, leases, fair value of financial instruments, derivative financial instruments, inventory, firm purchase commitment liabilities, useful lives of property and equipment, research and development expenses, and stock-based compensation. The actual results that we experience may differ materially from our estimates.</ix:nonnumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA3Ng_11245d78-9cf4-4afc-b803-7997d58e2ef8" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock">Comprehensive income includes net income and other comprehensive income/loss for the period. Other comprehensive income/loss consists of unrealized gains/losses on our investments and derivatives designated as hedging instruments. Total comprehensive income for all periods presented has been disclosed in the condensed consolidated statements of comprehensive income.</ix:nonnumeric></span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA5MQ_8848f2cc-e32c-4504-8630-eca4f2fcd8df" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive loss for the three and nine months ended September 30, 2022 were as follows (in millions):&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized Loss on Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Unrealized Gains on Derivatives Designated As Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic3dd5649fecf45b3adf1f116bddfd641_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMS0xLTEtMS0xNzc0OTk_9e6ab22d-ace6-4653-a857-bf8ae306579a" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">40</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic18e378236c644fa90c6cacc6e7e58b0_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMS0zLTEtMS0xNzc0OTk_52a2c2dc-5973-43ad-b146-357fd6519cf3" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i0990fad2c0a64ba5857845d17c59244b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMS01LTEtMS0xNzc0OTk_2b63d45d-6e98-484f-bcf7-a2d5737d6ec8" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">24</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="idf01f0f2682e4747872b2b55767aa607_D20220101-20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMi0xLTEtMS0xNzc0OTk_86136832-b719-43fc-9c7d-7ef7e99c5630" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">171</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i99c7ad65efd846d28e535f10fdd45ded_D20220101-20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMi0zLTEtMS0xNzc0OTk_28cbd397-ee3e-407f-8c44-bb352ac9b1b0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9231c594cb38499ca0b2fe42bb0a0c6d_D20220101-20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMi01LTEtMS0xNzc0OTk_2e682ed0-4c5d-4a7e-98e0-07d8588d738f" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">160</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59f01b5e75824f9381e337f5f84f0bc0_I20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMy0xLTEtMS0xNzc0OTk_a074de8f-19a1-4297-b7f3-c3da9ff142fd" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">211</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i22ac9c392d2e4475a575b6d2ace65074_I20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMy0zLTEtMS0xNzc0OTk_1445d1c6-e055-4bf3-91b0-66e6e2d31985" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">27</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i74dd61bcb31548ac8e26efb4c2455b76_I20220331" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfMy01LTEtMS0xNzc0OTk_32c2aaed-8e8e-4d41-ab61-2348d2fe0759" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">184</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i78fe5794f2204d9594c5ff8d92aa1e3a_D20220401-20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNC0xLTEtMS0xNzc0OTk_83e0f43a-af27-4d95-8c4a-508713ba62da" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">72</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i88592508dec6409598ac4e6bfd562213_D20220401-20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNC0zLTEtMS0xNzc0OTk_efebec9d-c748-4cdb-9f20-785ba4cbb9ec" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i07d2e74693cf4ac881c3c41091f3b591_D20220401-20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNC01LTEtMS0xNzc0OTk_7c917f9a-ede4-4403-a8b7-451ffa51420f" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">56</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i22af7a5fdd5e43489926b9e0d80070c9_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNS0xLTEtMS0xNzc0OTk_0b3ddf69-02cf-4629-bd4a-032d30551b10" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">283</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24acf93504ca4b61b88d0d898da23e3d_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNS0zLTEtMS0xNzc0OTk_771af912-2f08-4afc-a248-4a7c6b802c54" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">43</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ia117a5b2904d49e685347f90cf03dc63_I20220630" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNS01LTEtMS0xNzc0OTk_2a346451-349a-451a-8a3b-4d65d4103435" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">240</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i1d8cf23810124a4d89dd554526a835ff_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNi0xLTEtMS0xNzc0OTk_78629018-82c1-42c2-b172-c3d2e40481f6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">123</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i166b816abd2247c4a0cf0474deb78b88_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNi0zLTEtMS0xNzc0OTk_23a59e2b-b4c2-4377-9291-714c3b2293db" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" unitref="usd">12</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNi01LTEtMS0xNzc0OTk_a2a3f85c-ebb4-41d7-aa5e-ee57209f8850" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" sign="-" unitref="usd">111</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i19e751a008c047199aa19f46a22ed873_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNy0xLTEtMS0xNzc0OTk_d0a4d2d5-dd83-40c1-8aa9-9128db6a61d1" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">406</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie40ba6e0e55b4717bebcd9569347adc4_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNy0zLTEtMS0xNzc0OTk_7114a1b7-5561-4801-aa17-b6e8c20cc89a" name="us-gaap:StockholdersEquity" scale="6" unitref="usd">55</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i122e8a3f97504248aaf7e3cd4fb4143e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOmYzNmZhY2ExNDdmNTRhNzNhN2MyN2JlYjA1M2Q2ZDkyL3RhYmxlcmFuZ2U6ZjM2ZmFjYTE0N2Y1NGE3M2E3YzI3YmViMDUzZDZkOTJfNy01LTEtMS0xNzc0OTk_cdd443fa-32b3-4d1e-a153-8bddf75f62a5" name="us-gaap:StockholdersEquity" scale="6" sign="-" unitref="usd">351</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA5Mg_9c3427c3-0a61-4611-93f5-db41bf0f2f8c" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">We include our restricted cash balance in the cash, cash equivalents and restricted cash reconciliation of operating, investing and financing activities in the condensed consolidated statements of cash flows.</ix:nonnumeric>&#160;</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA4Nw_f01c4e06-8c9f-488a-a2e8-bbd3d7d90ac8" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDEwNA_efbded37-af16-4d03-99a6-47d29cf33db6" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows (in millions):</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:69.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfMi0yLTEtMS0xNzc0OTk_8dac15d9-1bb8-40ff-994e-7511019d4310" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfMi00LTEtMS0xNzc0OTk_1b2dff7f-ec03-430f-9575-96d91a4c18ad" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitref="usd">5,550</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfNC0yLTEtMS0xNzc0OTk_5a27d92c-15d1-4587-b6c9-67c87c99e2cc" name="us-gaap:RestrictedCashNoncurrent" scale="6" unitref="usd">14</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfNC00LTEtMS0xNzc0OTk_9b73cd9c-5c6d-4a93-b9a2-0432579a11d8" name="us-gaap:RestrictedCashNoncurrent" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the condensed consolidated<br/>&#160;&#160;&#160;&#160;statements of cash flows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfNS0yLTEtMS0xNzc0OTk_d21c2a8a-3cb3-429b-ae24-7e92357ff12b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">3,041</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icef8149173fa4598a695643682628d34_I20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RhYmxlOjczZjIyMjQxZDlkMTQ4ZTdiYjk1NTFiYWQ5NDBiZjQwL3RhYmxlcmFuZ2U6NzNmMjIyNDFkOWQxNDhlN2JiOTU1MWJhZDk0MGJmNDBfNS00LTEtMS0xNzc0OTk_811758d4-1bdb-4ea2-9a23-a877a1e7e47f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" unitref="usd">5,561</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:nonnumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation id="idab76cf70f604fc68c94635fb15c493b"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80My9mcmFnOjQ5OTQ1MDEyOTRlZjRlY2FiOGNlZTAyNGU3MzMzMzlhL3RleHRyZWdpb246NDk5NDUwMTI5NGVmNGVjYWI4Y2VlMDI0ZTczMzMzOWFfNDA4Ng_11edbc3d-3fb7-458b-9a36-162da68ac381" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our condensed consolidated financial statements and disclosures.</span></div></ix:nonnumeric></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="ia40aa6a04ab0476fb99aa189010909a2" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RleHRyZWdpb246MDAyMTgwZGJmOGQyNGQzZjg2NmY1NDZjMzY2M2YyODlfOTg5_ffa85060-d817-4b53-9d4b-2cc64237967f" name="us-gaap:RevenueFromContractWithCustomerTextBlock">Product Sales</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="i24e6b6283c4e451a85970fcb8b482ff2" id="ia40aa6a04ab0476fb99aa189010909a2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales are primarily associated with our COVID-19 vaccine supply agreements with the U.S. Government, other international governments and Gavi (on behalf of the COVAX Facility). </span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RleHRyZWdpb246MDAyMTgwZGJmOGQyNGQzZjg2NmY1NDZjMzY2M2YyODlfOTkw_8b3a41c5-7cb0-4eb5-9451-bc6a2734a628" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location were as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic128fe4c726248f78848c2c69adab0c2_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMi0yLTEtMS0xNzc0OTk_b002de92-bc53-42fc-8abc-defea4ebc3cf" name="us-gaap:Revenues" scale="6" unitref="usd">985</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8f4a65445c7241cdb01f04b3497959da_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMi00LTEtMS0xNzc0OTk_64f021a2-daad-40f7-9dc3-dbc6c49a5e65" name="us-gaap:Revenues" scale="6" unitref="usd">1,197</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iec89e625bb1940cb9e9db4b244db97b3_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMi02LTEtMS0xNzc0OTk_97390acd-a71a-474e-b809-db8c6617fb28" name="us-gaap:Revenues" scale="6" unitref="usd">3,380</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac887fdb035945ccb3f0437bfd392e7b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMi04LTEtMS0xNzc0OTk_7134178a-7c54-4713-9844-970c49bea748" name="us-gaap:Revenues" scale="6" unitref="usd">4,648</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia5fd8f1d8c0a447daee285c20cbefc30_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMy0yLTEtMS0xNzc0OTk_194f66ad-c693-463b-963e-b67c397938e1" name="us-gaap:Revenues" scale="6" unitref="usd">1,045</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i30f6bcf52976462096784289d7c471fb_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMy00LTEtMS0xNzc0OTk_1e66d51c-11ac-48b5-9bd1-c74d41038551" name="us-gaap:Revenues" scale="6" unitref="usd">1,688</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i09d60e1608194b39ad1c52be7d9cf1b1_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMy02LTEtMS0xNzc0OTk_4b590715-5328-4fa4-bc73-a41d72ea6fa6" name="us-gaap:Revenues" scale="6" unitref="usd">4,511</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iaaec8ad1b7fb4468808c7291f36d2947_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfMy04LTEtMS0xNzc0OTk_687f4d8f-2f52-404e-a204-ed4b52a60f16" name="us-gaap:Revenues" scale="6" unitref="usd">3,028</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9e578a110e9143e9b428c27bb7ec2662_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNC0yLTEtMS0xNzc0OTk_25f2b70c-04f0-4afb-942f-90929fc0f25e" name="us-gaap:Revenues" scale="6" unitref="usd">1,090</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia3c83c59cd8d4f0ab851829a84fa2079_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNC00LTEtMS0xNzc0OTk_ec1e3137-1d34-4416-b593-417a5fdb7da5" name="us-gaap:Revenues" scale="6" unitref="usd">1,925</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie1c8209e2b094ce09ba565f7560681bc_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNC02LTEtMS0xNzc0OTk_ff0525c1-9523-49c9-9620-25ac34065f62" name="us-gaap:Revenues" scale="6" unitref="usd">5,685</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idcd30bf779d441398ed7ff9f612dd3ad_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNC04LTEtMS0xNzc0OTk_bb5925e5-fc7e-4225-9879-6dcd678b0b35" name="us-gaap:Revenues" scale="6" unitref="usd">3,064</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i38b2ccc325f1439e8a81e0c3f7be5e48_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNS0yLTEtMS0xNzc0OTk_e744da3b-c610-4d20-b77a-57ccca51de76" name="us-gaap:Revenues" scale="6" unitref="usd">3,120</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i75523142f4a34f91af32a4b619d5f876_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNS00LTEtMS0xNzc0OTk_45b18a40-76dd-4309-aec8-495ed9405dc6" name="us-gaap:Revenues" scale="6" unitref="usd">4,810</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2825268232174cd49a36dc4e6b636b75_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNS02LTEtMS0xNzc0OTk_2a1e1ef8-9303-41c2-89a2-a37b0f11c59d" name="us-gaap:Revenues" scale="6" unitref="usd">13,576</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib583c5df28854d598e1660840e096793_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RhYmxlOjliYzgyY2Q4MDI2ZTQ3NmQ5YzdjZTZhMWM4ZTk1ZTQ0L3RhYmxlcmFuZ2U6OWJjODJjZDgwMjZlNDc2ZDljN2NlNmExYzhlOTVlNDRfNS04LTEtMS0xNzc0OTk_d94eafd8-4a04-4dd3-91ce-c552d469b458" name="us-gaap:Revenues" scale="6" unitref="usd">10,740</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes product sales recognized under the agreement with Gavi, which facilitates the allocation and distribution of our COVID-19 vaccines around the world, particularly for low- and middle-income countries.</span></div></ix:nonnumeric><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, our COVID-19 vaccine (marketed under the brand name Spikevax) and Omicron-targeting bivalent boosters (mRNA-1273.214 and mRNA-1273.222) were our only commercial products authorized for use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, we had deferred revenue of $<ix:nonfraction contextref="i09e609fc9ed243109f9df0a5e539b574_I20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RleHRyZWdpb246MDAyMTgwZGJmOGQyNGQzZjg2NmY1NDZjMzY2M2YyODlfNjc5_14e35abe-e00e-41e7-aa34-913bdf3cdebf" name="us-gaap:ContractWithCustomerLiability" scale="9" unitref="usd">4.1</ix:nonfraction> billion and $<ix:nonfraction contextref="ifc81e71b9e784d99a75bfc6a17069c49_I20211231" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RleHRyZWdpb246MDAyMTgwZGJmOGQyNGQzZjg2NmY1NDZjMzY2M2YyODlfNjg2_a0700bbd-5a5a-4d4d-845b-754cde2ef2fe" name="us-gaap:ContractWithCustomerLiability" scale="9" unitref="usd">6.7</ix:nonfraction> billion, respectively, related to customer deposits. We expect $<ix:nonfraction contextref="i09e609fc9ed243109f9df0a5e539b574_I20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV80Ni9mcmFnOjAwMjE4MGRiZjhkMjRkM2Y4NjZmNTQ2YzM2NjNmMjg5L3RleHRyZWdpb246MDAyMTgwZGJmOGQyNGQzZjg2NmY1NDZjMzY2M2YyODlfNzQ0_91e7b8c3-e1a5-474b-a176-edfbda1b6ffd" name="us-gaap:RevenueRemainingPerformanceObligation" scale="9" unitref="usd">3.9</ix:nonfraction>&#160;billion of our deferred revenue related to customer deposits as of September 30, 2022 to be realized in less than one year. Timing of product manufacturing, delivery, and receipt of marketing approval will determine the period in which product sales are recognized.</span></div></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:continuation continuedat="ic0dd191ee83f4588b786b4733551193d" id="i24e6b6283c4e451a85970fcb8b482ff2">Grant Revenue</ix:continuation></span></div><div><span><br/></span></div><ix:continuation continuedat="i8d847bd9d11b4c1d88b43e33347ed3a4" id="ic0dd191ee83f4588b786b4733551193d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $<ix:nonfraction contextref="id30e42d35052465fb924786006680c85_D20200901-20200930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTUy_039f0e27-1b23-4236-915f-a81b26dd2632" name="mrna:RevenueFromGrantsMaximumAward" scale="6" unitref="usd">56</ix:nonfraction>&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing therapeutics and vaccines. As of September 30, 2022, the committed funding, net of revenue earned was $<ix:nonfraction contextref="i26a286b08bcf4b29a64c0f78c465043e_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMzgz_6e91f736-ab78-4838-9bf2-1d1d7d22c906" name="mrna:RevenueFromGrantsCurrentFundingCapacity" scale="6" unitref="usd">5</ix:nonfraction>&#160;million. An additional $<ix:nonfraction contextref="i26a286b08bcf4b29a64c0f78c465043e_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfNDAx_924d4d84-934f-4103-b446-4e00b6aabdd6" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" unitref="usd">30</ix:nonfraction>&#160;million of funding will be available if DARPA exercises additional contract options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services (HHS), for an award of up to $<ix:nonfraction contextref="iafbe3ab17ae84770ad3506ae754b900d_D20200401-20200430" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfNzY2_c80abeda-f0f0-418f-bcb0-be99108a7ce1" name="mrna:RevenueFromGrantsMaximumAward" scale="6" unitref="usd">483</ix:nonfraction>&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. The agreement was amended in both 2020 and 2021 to provide for additional commitments to support various late-stage clinical development efforts of mRNA-1273, including a <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTAyMA_3263bb85-4963-45df-b7ed-1f82bb781908" name="mrna:NumberOfParticipants" scale="0" unitref="participant">30,000</ix:nonfraction> participant Phase 3 study, pediatric clinical trials and pharmacovigilance studies. In March 2022, we entered into a further amendment to the BARDA agreement, increasing the amount of potential reimbursements by $<ix:nonfraction contextref="ica35c13d0a2d488bac59d3f2595e2565_D20220301-20220331" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTIzNQ_693c275b-1063-436f-b135-8222935116c2" name="mrna:RevenueFromGrantsPotentialReimbursement" scale="6" unitref="usd">308</ix:nonfraction>&#160;million, in connection with costs associated with the clinical development for the adolescent and pediatric studies and the Phase 3 pivotal study. The maximum award from BARDA, inclusive of the 2020, 2021 and 2022 amendments, was approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonfraction contextref="ie0747a8925944645921bbcb8ffbd0362_D20200401-20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTQ3NA_7a8962f6-5512-47d5-bba6-0a1d90dcd750" name="mrna:RevenueFromGrantsMaximumAward" scale="9" unitref="usd">1.7</ix:nonfraction>&#160;billion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All contract options have been exercised. As of September 30, 2022, the remaining available funding, net of revenue earned was $<ix:nonfraction contextref="i9087d9277ced40c1badd8d1113357422_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTU4OQ_a708b24d-3088-488f-83d6-cc0d08da70b4" name="mrna:RevenueFromGrantsCurrentFundingCapacity" scale="6" unitref="usd">67</ix:nonfraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received from BARDA an award of up to $<ix:nonfraction contextref="i2a041812b2ae4b7da3f2e9de4ff42b00_D20160901-20160930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTY1NA_ddc43483-6a53-47cd-b654-5925d6ac0ad7" name="mrna:RevenueFromGrantsMaximumAward" scale="6" unitref="usd">126</ix:nonfraction>&#160;million, subsequently adjusted to $<ix:nonfraction contextref="i27030d89cc4144e6956cb4a86c7c6508_D20210101-20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMTY4Mw_f277c677-d20a-4897-8625-9fe95ef1836e" name="mrna:RevenueFromGrantsMaximumAward" scale="6" unitref="usd">117</ix:nonfraction>&#160;million in 2021, to help fund our Zika vaccine program. In September 2022, the performance period of the grant expired, and BARDA was released of the obligation to fund the remaining $<ix:nonfraction contextref="if9288d7477834dcf8f58bea6ac375454_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfNTQ5NzU1ODE3NTQy_b8ea805a-0931-4dcc-8cfe-efa11070cc1f" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" unitref="usd">36</ix:nonfraction>&#160;million of the award.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation id="i8d847bd9d11b4c1d88b43e33347ed3a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Bill and Melinda Gates Foundation (Gates Foundation) to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of September 30, 2022, the available funding, net of revenue earned was $<ix:nonfraction contextref="i34a7b362cde0435da7c9ab0fbbcc838e_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMjM3NA_d4514105-0756-4537-86f6-e8503bf78968" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" unitref="usd">7</ix:nonfraction>&#160;million, with up to an additional $<ix:nonfraction contextref="i34a7b362cde0435da7c9ab0fbbcc838e_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMjQwMw_a5f231e6-30f8-4555-bb0a-0ff42dd6a8b5" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">80</ix:nonfraction>&#160;million available if additional follow-on projects are approved. </span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="if877f05a869c4a1487265265dc8f8500" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RleHRyZWdpb246NGYyM2VlZjQ0NmVkNGM1ZjlhM2M3YmRmMzI0YjUxMmFfMjU1NA_e848ce9b-00d1-4068-9589-dd8cbf7b9058" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes grant revenue for the periods presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie92694f56fa8480881199dc7a6553d92_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMi0xLTEtMS0xNzc0OTk_ca76f8c5-2a56-49c7-bf58-bfad4e0244fb" name="us-gaap:Revenues" scale="6" unitref="usd">141</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ice289ed817444a8998f68bb92f4eba05_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMi0zLTEtMS0xNzc0OTk_33dedf51-2c73-4989-84cd-f99e3957661a" name="us-gaap:Revenues" scale="6" unitref="usd">128</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i05fc8e89852c4138a27156392adb93e5_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMi01LTEtMS0xNzc0OTk_70fca381-008e-41ee-b2f5-ad6ec6248e0f" name="us-gaap:Revenues" scale="6" unitref="usd">442</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6cbe63ffca7b4aef8c879737702050a8_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMi03LTEtMS0xNzc0OTk_cf4e6d0c-3ff6-4f59-9970-5d17752d5566" name="us-gaap:Revenues" scale="6" unitref="usd">454</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i242678657770432b917487b16f97548b_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMy0xLTEtMS0xNzc0OTk_c9bdb851-c9fc-49a2-8618-9e8caded53ac" name="us-gaap:Revenues" scale="6" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic7805e1b5a9c4138805d7d16232efba0_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMy0zLTEtMS0xNzc0OTk_58f92783-0a9a-491c-a4e6-ff50aad301c4" name="us-gaap:Revenues" scale="6" unitref="usd">12</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i94f93fe4160f43ee95cd52bf264a681f_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMy01LTEtMS0xNzc0OTk_bddba5b4-7aeb-4fdb-800b-53dacdd083d4" name="us-gaap:Revenues" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibd72c1fddfaf4d21b62e2ccb7da37ec6_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfMy03LTEtMS0xNzc0OTk_d1292376-fe84-4c6c-ad0c-96c9c9b30f86" name="us-gaap:Revenues" scale="6" unitref="usd">19</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i29fb96562ce9488c9ff23b503aacf987_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfNC0xLTEtMS0xNzc0OTk_4876ab2d-19ee-4cfc-8bf8-df7f8d0dd0fe" name="us-gaap:Revenues" scale="6" unitref="usd">144</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9f5c8710d84842a9b3a98fb292d7be59_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfNC0zLTEtMS0xNzc0OTk_07dceec6-8fda-4e18-9653-b7e21ca87bf4" name="us-gaap:Revenues" scale="6" unitref="usd">140</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i520e0eee9473493e9b84200f966551a6_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfNC01LTEtMS0xNzc0OTk_945f5548-fc05-41cb-8982-9c8652603bab" name="us-gaap:Revenues" scale="6" unitref="usd">453</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2cb6086e753845599054921ec5661040_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81Mi9mcmFnOjRmMjNlZWY0NDZlZDRjNWY5YTNjN2JkZjMyNGI1MTJhL3RhYmxlOjNmYjUyNzJiYzg2OTQyNmFiMmNiYjMwYmYxNDM0YjdjL3RhYmxlcmFuZ2U6M2ZiNTI3MmJjODY5NDI2YWIyY2JiMzBiZjE0MzRiN2NfNC03LTEtMS0xNzc0OTk_08f01c06-9d29-4042-9b30-adcb240a3857" name="us-gaap:Revenues" scale="6" unitref="usd">473</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="ieb3e2b43ded9463dbe7d82444592d6c9" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTgyNA_0d6e4b1b-96d3-4d8d-bd51-ed6c25110140" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">Collaboration Agreements</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="iea92f663ba004dc49fe36a8f2ebafcc6" id="ieb3e2b43ded9463dbe7d82444592d6c9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into collaboration agreements with strategic collaborators to accelerate the discovery and advancement of potential mRNA medicines across therapeutic areas. As of September 30, 2022 and December 31, 2021, we had collaboration agreements with AstraZeneca plc (AstraZeneca), Merck &amp; Co., Inc (Merck), Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals (Europe) Limited (together, Vertex), and others. Please refer to our 2021 Form 10-K under the heading &#8220;Third-Party Strategic Alliances&#8221; and Note 5 to our consolidated financial statements for further description of these collaboration agreements. </span></div><div><span><br/></span></div><ix:continuation id="if877f05a869c4a1487265265dc8f8500"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total consolidated revenue from our strategic collaborators for the periods presented (in millions):</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collaboration Revenue by Strategic Collaborator:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idc7d3c17c3c343b9b43de74ba0ba0e1a_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMi0xLTEtMS0xNzc0OTk_bf27b6dd-abe3-4a80-a343-7ce8d9f27cdb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">76</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8ad953ae80fa462a98e281bda15183c4_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMi0zLTEtMS0xNzc0OTk_390d9379-0af3-4b96-90dd-c3b528aa1be8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5f69e3300c724bb3948f7acc12a47701_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMi01LTEtMS0xNzc0OTk_b31ff8aa-e83b-40d6-8686-ec2724060d8c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i538754d294294906822309ed97500048_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMi03LTEtMS0xNzc0OTk_84e0e69d-d28a-4339-b7f0-23f631152c70" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie1031924258045f7861109a5575c62f3_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMy0xLTEtMS0xNzc0OTk_6f5efc7a-a80d-4950-a200-d9833fdafa82" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">20</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6168fcf649114479b08c4bebb291bd07_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMy0zLTEtMS0xNzc0OTk_5a1c5c26-5072-4602-a9c3-5f35f642c5df" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i415bc9fe32754c159e157ba74a0ca59a_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMy01LTEtMS0xNzc0OTk_525d8bdc-805e-4f81-9043-1aecd9878fac" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">35</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibbfc9c00c7704304ba161a61d0966556_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfMy03LTEtMS0xNzc0OTk_584bdbc7-523d-45c7-acfa-c75eaa08e9cc" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i150d291b4cbf407286f1cbeb4dabdb9b_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNC0xLTEtMS0xNzc0OTk_ee9e2125-1031-4292-ad0a-d52146d96ea3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i68cf3bc33acd4225804a01c259df5d27_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNC0zLTEtMS0xNzc0OTk_1fe41144-a359-497b-88d6-46104aea5a7b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i90a0e733c613414b85f6664f2a9a6e98_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNC01LTEtMS0xNzc0OTk_44441508-80e2-4959-92ad-cb98618c79a0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">33</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i283daa14eb3b4318abd6b40ae27fe95a_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNC03LTEtMS0xNzc0OTk_45ab1ca3-7336-434a-a772-dd5caecca3fc" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">23</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifefc9875a2654c13b53ecb40e82e6b68_D20220701-20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNS0xLTEtMS0xNzc0OTk_abfd0b41-c308-4b41-942e-2179ce268942" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i85f5878495a943c7bd2d73d51475c1cf_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNS0zLTEtMS0xNzc0OTk_4bc16594-0a3d-41a2-9c40-0c84c4e7b4cf" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">4</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2febd330dd094632bcf374ae9c4a6a09_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNS01LTEtMS0xNzc0OTk_bdcd55a0-5def-44db-8034-73ee6e62469d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">2</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iffd92cb276364aadaeb43a0a22abfc8b_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNS03LTEtMS0xNzc0OTk_b0c6050e-42d6-477e-84db-c66541e2aad2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i52d1941a7d7341f5a702c3db48689cf1_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNi0xLTEtMS0xNzc0OTk_9943543e-6763-444a-aa3c-ea473c18389e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">100</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iec705f1bf51148d497e9d496eb7224dd_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNi0zLTEtMS0xNzc0OTk_d11ff35a-926e-4c81-815c-f65eee7a1c13" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">19</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNi01LTEtMS0xNzc0OTk_8af7882d-80a4-4669-9df1-1a41c044216a" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">150</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia60f77bb95e74f2cad9964c5c3adb040_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjhkYTVlYjcyNWQ3NTRiMzZhZjc4ODYzY2UzNWI2MjU4L3RhYmxlcmFuZ2U6OGRhNWViNzI1ZDc1NGIzNmFmNzg4NjNjZTM1YjYyNThfNi03LTEtMS0xNzc0OTk_ea8034be-55a5-4c39-b97c-68bfc4a84afe" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" unitref="usd">47</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="iac7b6cc548e24b8c9853b7321227786b" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTgyOA_9c744d75-74c5-4d83-a00c-b3a13cccea33" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the nine months ended September 30, 2022 (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"></td><td style="width:38.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2ab4456fcf5445a6817fcae45bbe734a_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfMi0yLTEtMS0xNzc0OTk_9820ade3-523f-45c0-8da6-6ce9ffb58a8a" name="us-gaap:ContractWithCustomerAssetNet" scale="6" unitref="usd">9</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfMi00LTEtMS0xNzc0OTk_ba420430-725b-4b13-bd1b-46f0d3fac91a" name="us-gaap:ContractWithCustomerAssetPurchase" scale="6" unitref="usd">287</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfMi02LTEtMS0xNzc0OTk_caab2ebc-254f-466c-b177-8859213799c5" name="mrna:ContractWithCustomerAssetDeductionsDuringPeriod" scale="6" unitref="usd">18</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i021a912bd08b4136a44dbb1243377e71_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfMi04LTEtMS0xNzc0OTk_40f67de4-b326-4d91-85d1-4ccd245c40e5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" unitref="usd">278</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2ab4456fcf5445a6817fcae45bbe734a_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfNC0yLTEtMS0xNzc0OTk_cae3e7e6-7013-4455-b2c4-66621a3e7813" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">204</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfNC00LTEtMS0xNzc0OTk_3b4b0bc5-c8e4-460e-bbfd-f0a96bfa17a0" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" unitref="usd">8</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iba8fa93ee7944c6e8bf3735d67ec174e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfNC02LTEtMS0xNzc0OTk_8615b0a2-c01d-439c-a963-5afc3dba3b0c" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="6" unitref="usd">135</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i021a912bd08b4136a44dbb1243377e71_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RhYmxlOjc2ZThhMzQxNDk1MjQ5NzA4MjczNmM4ZTc2OTk2OTk5L3RhYmxlcmFuZ2U6NzZlOGEzNDE0OTUyNDk3MDgyNzM2YzhlNzY5OTY5OTlfNC04LTEtMS0xNzc0OTk_5dee535d-b215-4afe-8b05-61f34720d672" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="iea92f663ba004dc49fe36a8f2ebafcc6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the aggregated amount of the transaction price allocated to performance obligations under our collaboration agreements that are unsatisfied or partially unsatisfied was $<ix:nonfraction contextref="i021a912bd08b4136a44dbb1243377e71_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTEyOA_3f5cdcb4-8e3e-4066-ac15-bb3aa783c5a0" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" unitref="usd">99</ix:nonfraction>&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, AstraZeneca terminated our collaborations with them, including the development of VEGF-A and IL-12 programs, for which termination will become effective on November 21, 2022. All rights to these two programs will revert to us. As a result of the termination, we recognized the remaining deferred revenue of $<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTY0OTI2NzQ1MTYwMQ_a88ed2dc-540d-4ae4-94ea-7a6dcc146f8f" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" unitref="usd">76</ix:nonfraction>&#160;million as collaboration revenue during the three months ended September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, Merck exercised its option to jointly develop and commercialize PCV mRNA-4157 pursuant to the terms of the PCV Collaboration and License Agreement, as amended and restated (the PCV/SAV Agreement). We concluded that the contractual provisions in the existing arrangement are not sufficiently definitive to identify the rights and obligations of the parties during the Merck Participation Term (as defined in the PCV/SAV Agreement). As such, we recorded a receivable of $<ix:nonfraction contextref="ib16716b58a4849959129b0cbaa77416f_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTA5OTUxMTYzMjc4NQ_20611092-0a0e-46c2-b069-bd3a83e73fff" name="us-gaap:AccountsReceivableNetCurrent" scale="6" unitref="usd">250</ix:nonfraction>&#160;million and other current liabilities of $<ix:nonfraction contextref="ib16716b58a4849959129b0cbaa77416f_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81NS9mcmFnOjA0ZjRkYjg0YTEzNzQwOTVhNmY0YWE5ODFjYzcxYzM5L3RleHRyZWdpb246MDRmNGRiODRhMTM3NDA5NWE2ZjRhYTk4MWNjNzFjMzlfMTA5OTUxMTYzMjc5OQ_96b8c80b-281a-4fd3-829e-7544532ebb7f" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">250</ix:nonfraction>&#160;million on our condensed consolidated financial statements related to Merck's participation election as of September 30, 2022. After receipt of the participation election payment, we and Merck will agree on a joint development plan and budget, and we will reassess the accounting treatment for the participation election payment and the collaboration arrangement at such time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the collaboration agreements mentioned above, we have other collaborative and licensing arrangements that we do not consider to be individually significant to our business at this time. Pursuant to these agreements, we may be required to make upfront payments and payments upon achievement of various development, regulatory and commercial milestones, which in the aggregate could be significant. Future milestone payments, if any, will be reflected in our consolidated financial statements when the corresponding events become probable. In addition, we may be required to pay significant royalties on future sales if products related to these arrangements are commercialized.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i357739a1e95e4ccda1113fc64e685a52" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzcxNQ_1c2d579a-9bff-41e1-9e80-b3ea21058808" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">Financial Instruments</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="i4f109d2610a24d498ccbb863676c28d8" id="i357739a1e95e4ccda1113fc64e685a52"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Investments</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzcwNw_aad44174-5590-4afc-b2a2-48f3a24b6c58" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities by significant investment category at September 30, 2022 and December 31, 2021 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current<br/>Marketable<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>Current<br/>Marketable<br/>Securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i477c7fdb28e1416ba60a74a780b8d96d_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi0yLTEtMS0xNzc0OTk_6392f6de-7e56-4e14-a985-ca3125141fa3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i477c7fdb28e1416ba60a74a780b8d96d_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi00LTEtMS0xNzc0OTk_7f233c12-737c-47f5-b97c-dfa1779a2409" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i477c7fdb28e1416ba60a74a780b8d96d_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi02LTEtMS0xNzc0OTk_716a4d3c-6517-498a-af68-7e3d88402514" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i477c7fdb28e1416ba60a74a780b8d96d_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi04LTEtMS0xNzc0OTk_fc56b855-fba7-4de9-972e-7edf52372b44" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i634adc1ff28b482cbbde05c3dff041c4_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi0xMC0xLTEtMTc3NDk5_c2a9a01f-6fdc-4a01-83f6-46d5f61543b7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i190c365a11cd49cdb9c83d725f4d2733_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi0xMi0xLTEtMTc3NDk5_abb85c4c-3ac8-4af7-b019-3e8d01e4c0e9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3cae3c8daa6747918508dfb455ef4a0a_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMi0xNC0xLTEtMTc3NDk5_a58bcb98-8dac-43ec-a2b7-3832eed851e3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac61dcb875dd4d2eb5a01d994298b5f2_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC0yLTEtMS0xNzc0OTk_52a9de35-e540-4d10-b6fa-a6f06cd0fba0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">208</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac61dcb875dd4d2eb5a01d994298b5f2_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC00LTEtMS0xNzc0OTk_185b9f8a-cf03-4707-8f50-03b1ff0d3cca" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac61dcb875dd4d2eb5a01d994298b5f2_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC02LTEtMS0xNzc0OTk_61e1c9ca-d0b7-4790-8ad5-b026c1764328" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac61dcb875dd4d2eb5a01d994298b5f2_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC04LTEtMS0xNzc0OTk_45f90c6c-8702-4009-8d9a-2c39bb002de0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">208</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i196327fceedb4074b04603b655848ae8_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC0xMC0xLTEtMTc3NDk5_acd6ad36-01ab-46df-9e1f-581acd30845b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i37f6f6d002ff404bbdd00785180ceb24_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC0xMi0xLTEtMTc3NDk5_03b70c93-8f9c-4d5e-9d43-7f1a62d9d077" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">208</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6804115097ee426cacfd0c169bfc18b4_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNC0xNC0xLTEtMTc3NDk5_a787233a-91f5-4f11-a1a5-95a9a2fad27d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a2e488d6c034139995efe5f51025918_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS0yLTEtMS0xNzc0OTk_8c19b40f-eea2-4c08-9087-4da963991b10" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">220</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a2e488d6c034139995efe5f51025918_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS00LTEtMS0xNzc0OTk_811ad4ab-2f22-4ced-bea4-7a468cb27ca1" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i9a2e488d6c034139995efe5f51025918_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS02LTEtMS0xNzc0OTk_144c9f0f-582c-46e8-b1db-aa9562c24f79" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">2</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9a2e488d6c034139995efe5f51025918_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS04LTEtMS0xNzc0OTk_7efcdaad-acc6-4e44-9ba0-be4def881a37" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0dd3ceb69a8c4446965dea5defd410ac_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS0xMC0xLTEtMTc3NDk5_9194eb0b-00ca-40ef-a3e4-7e909868e257" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3698f19bc5a3458a94f4166c52cafcd2_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS0xMi0xLTEtMTc3NDk5_8feed883-1dad-49c3-8869-e8fa0fae8914" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5ce50139fc744775be66bcd4b29f3f32_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNS0xNC0xLTEtMTc3NDk5_e42768f1-0a00-4c91-b442-23e4d9de0e45" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id39164e8d4b443349cdcc91e6891cf29_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi0yLTEtMS0xNzc0OTk_a961f704-f2d8-450e-8412-318d86b330a7" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">7,826</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id39164e8d4b443349cdcc91e6891cf29_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi00LTEtMS0xNzc0OTk_2d7945ae-1406-45ce-89f6-59b96ee87a1f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="id39164e8d4b443349cdcc91e6891cf29_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi02LTEtMS0xNzc0OTk_96453ee9-be3e-4802-bc12-f92bc9ff03f0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">268</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id39164e8d4b443349cdcc91e6891cf29_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi04LTEtMS0xNzc0OTk_46a6ae1c-2e4e-4280-b45c-59c10e46f250" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">7,558</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1076ffa5a23c4d599d6de1d154cef8d7_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi0xMC0xLTEtMTc3NDk5_8f254e3a-2ab9-4407-95ec-f352f1c10082" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia6771091d74c4e70b733b0a43b964d38_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi0xMi0xLTEtMTc3NDk5_a1e72f36-ca9f-4bbf-8c55-d38903fa05c8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,765</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id865df0d2b7845e78e017c4804acb75e_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNi0xNC0xLTEtMTc3NDk5_ca259a28-f6c1-410f-9427-6278c0ecdf09" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,793</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic11ad3652cb04f4f82680fe03b6007d4_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy0yLTEtMS0xNzc0OTk_106a3c27-1cc0-48b5-8855-94107f547dff" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">6,124</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic11ad3652cb04f4f82680fe03b6007d4_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy00LTEtMS0xNzc0OTk_d185e89a-378e-45b3-859e-50f56a23c39b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic11ad3652cb04f4f82680fe03b6007d4_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy02LTEtMS0xNzc0OTk_28ff6ebd-2696-410a-bdef-05c9a8517f09" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">270</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic11ad3652cb04f4f82680fe03b6007d4_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy04LTEtMS0xNzc0OTk_497349cc-b58a-4d04-b8ec-8a9f36125796" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">5,854</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i95c2a7f6abe2433e8e6675632c633b76_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy0xMC0xLTEtMTc3NDk5_caa9206e-4e0d-492b-9590-5247ea6d5f6a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i925c1badc0994d05b339f63929078957_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy0xMi0xLTEtMTc3NDk5_4452aea5-db33-49b4-85c4-90c59c2192a3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">1,130</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia9c0cc36a87244f1abc849f17a19c839_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfNy0xNC0xLTEtMTc3NDk5_eb90f7da-9b34-410f-893d-1719dd8d3af7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">4,724</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i73b4c90893114b06b884cf69be209e93_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC0yLTEtMS0xNzc0OTk_d4d4f920-8995-407e-a500-dffb00f878db" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">147</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i73b4c90893114b06b884cf69be209e93_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC00LTEtMS0xNzc0OTk_7a6ff2c5-3956-4d5e-b760-e26ebd824e80" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i73b4c90893114b06b884cf69be209e93_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC02LTEtMS0xNzc0OTk_b0cfa75c-d3f8-43eb-b731-e211eddcee55" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i73b4c90893114b06b884cf69be209e93_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC04LTEtMS0xNzc0OTk_f6da100e-6f61-4657-9587-e6f02cc9a05d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">138</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4b76c99272c74a34b856374a5cc734aa_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC0xMC0xLTEtMTc3NDk5_177a00f3-1e52-42b9-b20a-9968335b7627" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8e938e50b4ed4724bfddc1d45455b6d9_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC0xMi0xLTEtMTc3NDk5_dbc0800c-fe16-4be1-8625-517cb7938c4e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4812199d85254244b887bb42a5148ab2_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOC0xNC0xLTEtMTc3NDk5_914bbd1d-dfc2-488e-b053-dfc8bfbf8bff" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">138</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib3a67eace02044549181e0353748ad4c_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS0yLTEtMS0xNzc0OTk_1d380682-af04-4f04-9ed2-46d7eb1382f7" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">17,552</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib3a67eace02044549181e0353748ad4c_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS00LTEtMS0xNzc0OTk_cf57ed0b-aa96-402b-9867-5f07257bd6a8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ib3a67eace02044549181e0353748ad4c_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS02LTEtMS0xNzc0OTk_22570c15-0fc3-430c-b83e-99cb1825fd06" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">549</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib3a67eace02044549181e0353748ad4c_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS04LTEtMS0xNzc0OTk_5a0ac07b-5b2a-4302-a0fb-e26d8cec3fb9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">17,003</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5707e57c42ee4b249daef3004bdd90a6_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS0xMC0xLTEtMTc3NDk5_b1ef8c9d-4807-45d3-bc02-33711b7f3b8a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,027</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8b82b72ecd854cc29022aca1d219faf5_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS0xMi0xLTEtMTc3NDk5_fc5111d8-7abb-4fbb-8708-733860cdf266" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">5,321</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id1585735434b40448c2c820b1909cd2a_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfOS0xNC0xLTEtMTc3NDk5_3ae1dbc9-61f5-4e68-a367-054fe84786a0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">8,655</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current<br/>Marketable<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>Current<br/>Marketable<br/>Securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7cc60230a01f4e0ab036037dc7c74a3f_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtMi0xLTEtMTc3NDk5_532fd60d-cd63-496f-8e69-9d717208aee5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">6,848</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7cc60230a01f4e0ab036037dc7c74a3f_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtNC0xLTEtMTc3NDk5_3df08c19-bd14-43b8-9891-0a159571a171" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7cc60230a01f4e0ab036037dc7c74a3f_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtNi0xLTEtMTc3NDk5_b689d28b-501b-4261-8fff-a30172fc7d02" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7cc60230a01f4e0ab036037dc7c74a3f_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtOC0xLTEtMTc3NDk5_1401f8fb-45b7-4802-b2a6-aad59663a79c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,848</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icd49271fac584a0ea4bca7b5be2d8fd9_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtMTAtMS0xLTE3NzQ5OQ_72d6a685-dd38-4640-a709-6dd4b3705926" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,848</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i95c8d433354a4a66a6df220159afdb93_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtMTItMS0xLTE3NzQ5OQ_447b5dc4-0e31-411d-a586-71fa0c5c40a4" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb7aa813f7de4428a25f1b4543007679_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTMtMTQtMS0xLTE3NzQ5OQ_bf11acdd-13a6-42fd-a69c-cac217552a10" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b36c63ec12d4e47a96b4d1bd0e07b8c_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtMi0xLTEtMTc3NDk5_0b6b0714-19bb-4e00-b7aa-ec287951ed60" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b36c63ec12d4e47a96b4d1bd0e07b8c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtNC0xLTEtMTc3NDk5_7e167d12-4118-419f-8165-ea1e5ab0d111" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b36c63ec12d4e47a96b4d1bd0e07b8c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtNi0xLTEtMTc3NDk5_ab4b54db-8c0c-43d3-abb9-7f47a14ee581" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0b36c63ec12d4e47a96b4d1bd0e07b8c_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtOC0xLTEtMTc3NDk5_9b7f4567-37cd-4a8e-be11-e7b6b9919566" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i18a910a49c2f488d84e3d862aae8e638_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtMTAtMS0xLTE3NzQ5OQ_54abf048-4ce5-4879-b558-ec2837f760e5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iebb7b328b5e0463599a0b71d4db4f595_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtMTItMS0xLTE3NzQ5OQ_b0902f27-03d8-41e6-badd-105944b7d589" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5da2c8c0a2e84649b94c88a2f57637d1_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTUtMTQtMS0xLTE3NzQ5OQ_04da038a-6ef3-42a8-a0f2-c98eb22eb0f3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i69defb4c1b484786a48b54d1cf2e1f8b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtMi0xLTEtMTc3NDk5_60fddaa7-5562-4f19-bea7-4277fe67740d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">479</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i69defb4c1b484786a48b54d1cf2e1f8b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtNC0xLTEtMTc3NDk5_370b2045-faff-446a-a547-7e7f0feeb12c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i69defb4c1b484786a48b54d1cf2e1f8b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtNi0xLTEtMTc3NDk5_f5126281-2987-41a7-99aa-01102e14eca5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i69defb4c1b484786a48b54d1cf2e1f8b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtOC0xLTEtMTc3NDk5_db39d639-70c7-4ba2-9578-652b61d4cb22" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">479</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ia967afaba8374f4db40140c0a97ac55c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtMTAtMS0xLTE3NzQ5OQ_68431fcb-51af-481d-8de3-98e322f5b733" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i64785a9c25e7439b8b3f3a802f7db766_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtMTItMS0xLTE3NzQ5OQ_7123ccd5-c15e-4aab-b775-881e1a590e93" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">479</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie058442c88dd40e4aa7b512c252e2d0d_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTYtMTQtMS0xLTE3NzQ5OQ_9a3f22a4-b46b-452e-b2c7-b359c64d7c80" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if1d729059af44726ada0899cef9f79e6_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctMi0xLTEtMTc3NDk5_b349a5f9-d5e4-426c-9d58-3a6cb1e029dd" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">6,595</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if1d729059af44726ada0899cef9f79e6_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctNC0xLTEtMTc3NDk5_f8303d8d-e881-4100-b466-3b28ce01c526" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="if1d729059af44726ada0899cef9f79e6_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctNi0xLTEtMTc3NDk5_ecdd2e83-73d9-49cc-bf69-30bac60a52c7" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">31</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if1d729059af44726ada0899cef9f79e6_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctOC0xLTEtMTc3NDk5_af2151b9-cbb3-4591-9d6c-fd268b8ab386" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,564</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic1724ce23109451cb9ce451af062d45c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctMTAtMS0xLTE3NzQ5OQ_54d811ae-cd03-404f-8b4f-527ae33a8add" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i58f3dcba53d0483d9fd88a51d1f1050d_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctMTItMS0xLTE3NzQ5OQ_ff33519f-891f-4343-9b97-251bb2790694" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">1,984</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i24c2115464b64e9da54c559d020d7207_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTctMTQtMS0xLTE3NzQ5OQ_3c353dac-3cea-4d6d-8580-2cebeaf66923" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">4,580</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i211102e93af445499a0b637edc705dfc_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtMi0xLTEtMTc3NDk5_8802ab75-3c3a-4b01-99a8-bb7144fa9121" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">3,508</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i211102e93af445499a0b637edc705dfc_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtNC0xLTEtMTc3NDk5_86ea87f6-9b7c-4592-b4a9-fe3574e762ce" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i211102e93af445499a0b637edc705dfc_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtNi0xLTEtMTc3NDk5_4907e456-b0d0-48e4-bf48-6ef31d7f2742" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">20</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i211102e93af445499a0b637edc705dfc_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtOC0xLTEtMTc3NDk5_bb3185a9-73f4-49dd-ac63-378bb640a74d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,488</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5320222082e945fbbc3371e65de0b20f_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtMTAtMS0xLTE3NzQ5OQ_72639e76-0530-4840-bfb0-7cd6ecdacc24" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i677c2653422c451dbf66bcc82b835da0_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtMTItMS0xLTE3NzQ5OQ_9faf74f4-55a6-4daf-ad27-57f5a0a65c69" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">1,323</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2cc9733301274631828798d602e8bc8e_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTgtMTQtMS0xLTE3NzQ5OQ_e6e4c701-2caf-4e67-9040-405113f77d6f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">2,165</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic350e7f011e140399cd0dc4e000be76f_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktMi0xLTEtMTc3NDk5_f83b0a44-21b8-49dd-ad3e-419b1c2744f2" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">112</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic350e7f011e140399cd0dc4e000be76f_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktNC0xLTEtMTc3NDk5_682689f9-9c9d-440b-aecc-25ea92193924" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ic350e7f011e140399cd0dc4e000be76f_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktNi0xLTEtMTc3NDk5_8ea6c62e-a385-44a5-8676-120a04deb988" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic350e7f011e140399cd0dc4e000be76f_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktOC0xLTEtMTc3NDk5_96dd3be2-1943-472e-842c-e6a67c1f45d0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">111</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie5cfad4ed9a64a439f9ea0deb247b1fa_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktMTAtMS0xLTE3NzQ5OQ_fb48a516-5c26-4950-ad55-fa8c78c7b0f9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibe3771447d214224ad95139538d6b12d_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktMTItMS0xLTE3NzQ5OQ_5c9cd340-cfc1-454e-967d-a47044623ced" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">13</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib6e6e6edc5f140b7af062e2677ec4f0a_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMTktMTQtMS0xLTE3NzQ5OQ_313abe38-ed17-4a97-9171-f5aec33b4542" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">98</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i92973fa43c774ebba350e60c55640dba_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtMi0xLTEtMTc3NDk5_a2a2c562-ec0f-4751-9588-7a0a06a43da0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">17,622</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i92973fa43c774ebba350e60c55640dba_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtNC0xLTEtMTc3NDk5_ba596042-38d5-4d57-a266-87132de300cb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i92973fa43c774ebba350e60c55640dba_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtNi0xLTEtMTc3NDk5_5fa16d7d-6ec2-4d3f-8e5c-e33003380ad6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" unitref="usd">52</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i92973fa43c774ebba350e60c55640dba_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtOC0xLTEtMTc3NDk5_b15cc4cc-2b0d-4f8f-b21d-44ab1ef1d68c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">17,570</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7be685d78786434da48ed1683b77affe_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtMTAtMS0xLTE3NzQ5OQ_6d354d7e-a678-42de-939b-ba746a56806f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,848</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if9eecfaf7b9e42549082ead8e922255a_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtMTItMS0xLTE3NzQ5OQ_1cfe05fd-4eb1-4cc0-8a86-9daa9f8363b5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,879</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i407bf3bc0c824b05b0b260d59836cf06_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjM4Y2MzMTA0MmE4ZjQ2ZjQ4OWNhNjk4MjIwMzdhYTQzL3RhYmxlcmFuZ2U6MzhjYzMxMDQyYThmNDZmNDg5Y2E2OTgyMjAzN2FhNDNfMjAtMTQtMS0xLTE3NzQ5OQ_6fb9d03c-efcf-432e-8e35-ff16ba8ac561" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,843</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzcwOQ_67413425-d4fa-4eec-92b5-9b1d5b39aa67" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of available-for-sale securities by contractual maturity at September 30, 2022 and December 31, 2021 were as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfMi0yLTEtMS0xNzc0OTk_3733cd5c-d543-436f-9861-747feab544f4" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" unitref="usd">5,417</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfMi00LTEtMS0xNzc0OTk_b032d1da-8cfd-4cda-9458-b38f6ea8e17b" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" unitref="usd">5,321</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfMy0yLTEtMS0xNzc0OTk_5b51595e-243e-455a-8fb8-92aa9de61931" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" unitref="usd">9,108</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfMy00LTEtMS0xNzc0OTk_9b34c6ce-42dc-4193-8f90-716fc3f33866" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" unitref="usd">8,655</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfNC0yLTEtMS0xNzc0OTk_4e5eb699-2b4f-4907-8d1c-b03e89815fee" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">14,525</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmM5ZjkxM2I2NThmNjRlOGQ5NjlkMjA2N2YyNWQzZWRmL3RhYmxlcmFuZ2U6YzlmOTEzYjY1OGY2NGU4ZDk2OWQyMDY3ZjI1ZDNlZGZfNC00LTEtMS0xNzc0OTk_ba684f24-e81c-4220-b4db-38e2dbd35936" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" unitref="usd">13,976</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfMi0yLTEtMS0xNzc0OTk_d03d11d8-2d6d-410b-a7ae-55922d535ff5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" unitref="usd">3,882</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfMi00LTEtMS0xNzc0OTk_d66cdb9a-06f9-4e78-b7fa-f20b8d6dcae3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" unitref="usd">3,879</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfMy0yLTEtMS0xNzc0OTk_d8a57d32-fe24-4f6f-a52c-ca57f974bfb9" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" unitref="usd">6,892</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfMy00LTEtMS0xNzc0OTk_9e41f969-a868-4659-adef-563d5cf405bc" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" unitref="usd">6,843</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfNC0yLTEtMS0xNzc0OTk_fd193f8f-ec31-4a2c-a0b1-d4c11f221092" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">10,774</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjQ0MDMxZDMwYjlhNzRjZDg4NWMxMDRhM2MxZmQ2YTdjL3RhYmxlcmFuZ2U6NDQwMzFkMzBiOWE3NGNkODg1YzEwNGEzYzFmZDZhN2NfNC00LTEtMS0xNzc0OTk_d50931ee-af96-404d-a1a5-341d2a6c7f70" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" unitref="usd">10,722</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our investment policy, we place investments in investment grade securities with high credit quality issuers, and generally limit the amount of credit exposure to any one issuer. We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation continuedat="i622c6d4053c0453aaa1081927eda94b4" id="i4f109d2610a24d498ccbb863676c28d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. Any impairment that is not credit related is recognized in other comprehensive loss, net of applicable taxes. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. We did <ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTMxOA_8ccf193e-242f-4426-9737-0e6e6a140310" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" scale="6" unitref="usd"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTMxOA_9beceeeb-52cc-42b2-b4f3-6780c8db1896" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" scale="6" unitref="usd"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTMxOA_b43c718e-5334-4220-893b-532d34865000" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" scale="6" unitref="usd"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTMxOA_e82938d9-bc6a-4531-9591-a93a82132a71" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" scale="6" unitref="usd">no</ix:nonfraction></ix:nonfraction></ix:nonfraction></ix:nonfraction>t recognize any impairment charges related to available-for-sale securities for the three and nine months ended September 30, 2022 and 2021. We did <ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTQzOA_4b94cb41-4264-409e-8460-6c8e10daa836" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" unitref="usd"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTQzOA_dca42010-bb97-4568-a0c1-ade69f07e30d" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" unitref="usd">no</ix:nonfraction></ix:nonfraction>t record any credit-related allowance to available-for-sale securities as of September 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzcxNg_811944ad-fe2a-4e1a-a6f9-65700b1ae0a1" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by the length of time the securities have been in an unrealized loss position at September 30, 2022 and December 31, 2021 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of September 30, 2022:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC0yLTEtMS0xNzc0OTk_30675baa-3101-45a7-8ca7-de3291a59974" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC00LTEtMS0xNzc0OTk_3eb74484-9dba-4731-9d52-642943e0f8e3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC02LTEtMS0xNzc0OTk_594dbe47-ed82-411d-a41a-ee54ac65ed3b" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC04LTEtMS0xNzc0OTk_272648fa-0a5b-42f2-8adc-5863a7d00355" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC0xMC0xLTEtMTc3NDk5_e3025781-cb6e-46dd-b057-a229af6fe1b8" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="idb2f7a0d15fb41bf9974f01817b2c5fe_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNC0xMi0xLTEtMTc3NDk5_8dc6538a-394a-48f9-88b5-888e45d06704" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS0yLTEtMS0xNzc0OTk_1e6fbdcd-c2e4-434e-ac4e-236d61733fd7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">166</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS00LTEtMS0xNzc0OTk_e2ae2d16-625b-4e74-86fb-b6ad7a5b8d09" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">5,204</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS02LTEtMS0xNzc0OTk_9fdb0772-a2f0-45fb-ae1b-3f34b82c06dd" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">102</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS04LTEtMS0xNzc0OTk_0d4aac5a-b58c-4d35-8ab8-f8e3ee6822f3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">2,353</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS0xMC0xLTEtMTc3NDk5_07bbe88c-c584-416d-ae90-88a1752d2885" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">268</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibc64b79ecdf142bfbddb01eae0f7b691_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNS0xMi0xLTEtMTc3NDk5_28b49cce-6634-4c21-99b8-a4c82ff6b783" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">7,557</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi0yLTEtMS0xNzc0OTk_ed5f7d74-4381-415e-9af7-3a6eba7224ca" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">204</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi00LTEtMS0xNzc0OTk_ee297a50-94ac-4bb3-80a1-a7f4efe11a64" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">4,404</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi02LTEtMS0xNzc0OTk_dc02b3fe-066b-492e-b618-ccc7ca1639b3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">67</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi04LTEtMS0xNzc0OTk_2e56daf0-d349-4595-9916-92be652bc60d" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">1,200</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi0xMC0xLTEtMTc3NDk5_b6ba8dc6-e26e-4659-897f-fed27e88dad2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">271</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icf4a9d73d3904d60817b19e1588aa823_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNi0xMi0xLTEtMTc3NDk5_0ea31338-fb2a-40a4-812a-3350b1afae3f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">5,604</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy0yLTEtMS0xNzc0OTk_8e10efaa-3807-45ba-baf5-c305bb829441" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">2</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy00LTEtMS0xNzc0OTk_c5cadd91-9ec3-45f0-bb7b-5ef53d0d994e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">46</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy02LTEtMS0xNzc0OTk_3c374b86-8774-41cf-87e1-466f4fa953f2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy04LTEtMS0xNzc0OTk_407f7854-aa61-44e6-b7e4-c1fa0a827dc2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">93</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy0xMC0xLTEtMTc3NDk5_31ff5f73-d081-4619-9229-1aae8325e5d4" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">9</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i81dfcfd3e8704c33b0f11c23fdfb0b6e_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfNy0xMi0xLTEtMTc3NDk5_59792d9d-7cbf-458a-aee1-4dd800931961" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">139</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC0yLTEtMS0xNzc0OTk_ba5c2777-d369-4527-9f44-ff9868ada047" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">373</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC00LTEtMS0xNzc0OTk_3991eee1-2bb4-48cc-986f-d15d8c0b0fcf" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">9,872</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC02LTEtMS0xNzc0OTk_377c542b-ebac-4bfe-b344-f4274e6a475c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">176</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC04LTEtMS0xNzc0OTk_02319699-dba5-4afc-8724-e2e6f71efc1b" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">3,646</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC0xMC0xLTEtMTc3NDk5_94280174-a7da-4ff4-bdea-6b54284f7723" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">549</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfOC0xMi0xLTEtMTc3NDk5_2aa3f234-8894-4d20-8dde-b6b226fd23e4" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">13,518</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2021:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItMi0xLTEtMTc3NDk5_3d5be061-2bcd-46d6-a2c8-faab13320de1" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItNC0xLTEtMTc3NDk5_23894c31-eced-44f3-9fbd-a8c165e017a4" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">329</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItNi0xLTEtMTc3NDk5_907adb73-454f-45dd-8119-488ab88880bf" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItOC0xLTEtMTc3NDk5_093cc4c2-7dfe-406d-8ef1-beafeefaafcf" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItMTAtMS0xLTE3NzQ5OQ_4b212432-1a70-4ee3-a6c8-6bf5caf7998f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9acb9bd246144f459bc1a11a5fbeed7d_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTItMTItMS0xLTE3NzQ5OQ_7888146a-d9c0-4992-8262-744082388561" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">329</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtMi0xLTEtMTc3NDk5_2ab5d828-d1d4-47ac-8cc4-51a7571fa2e1" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">31</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtNC0xLTEtMTc3NDk5_695036e3-6b03-46ce-b9b1-565e37004126" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">6,332</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtNi0xLTEtMTc3NDk5_a68ad0a8-8113-4236-bf63-9b60dc92bd7e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtOC0xLTEtMTc3NDk5_bfa5e53a-96db-4487-95fc-4c0db3673692" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtMTAtMS0xLTE3NzQ5OQ_a8e3a958-1a55-426b-ab11-113b23f4774e" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">31</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i097fc6716d3549d2adfa7284454a95b4_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTMtMTItMS0xLTE3NzQ5OQ_31152c5f-bbf9-4254-97b2-7a6d3898ae71" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">6,332</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtMi0xLTEtMTc3NDk5_5f851081-b27e-4dc4-a5a7-779e97b18d3b" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">20</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtNC0xLTEtMTc3NDk5_4fade185-7037-40f0-b6ab-3f55e8387d02" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">2,573</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtNi0xLTEtMTc3NDk5_f652eaad-d487-46db-8214-2e70f5241094" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtOC0xLTEtMTc3NDk5_c4cbf246-18d7-492b-a422-08497c32e9a9" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtMTAtMS0xLTE3NzQ5OQ_17b637f6-624c-4020-967a-e44d8d29f8d9" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">20</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iacd4870a34a34135bac5af63a2eec8fc_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTQtMTItMS0xLTE3NzQ5OQ_c2e07566-32a7-4e6c-8548-1a9fd1ddc732" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">2,574</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtMi0xLTEtMTc3NDk5_532f58ac-7b47-4991-a80c-7f3cbee01f6e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtNC0xLTEtMTc3NDk5_3b1d6faf-9d18-4dbd-9ed2-ffe307e24957" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">112</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtNi0xLTEtMTc3NDk5_1944ca1f-7876-4999-bf71-ae81a274c47d" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtOC0xLTEtMTc3NDk5_add3c5e6-af7d-4a68-a095-4f42ccd08a2d" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtMTAtMS0xLTE3NzQ5OQ_689dcba1-6129-4bdc-a216-650cd0d1107f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8eb86706f08046f79ffc65a508a65521_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTUtMTItMS0xLTE3NzQ5OQ_cf60c594-aa53-4163-a020-6493bd680b5c" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">112</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtMi0xLTEtMTc3NDk5_f46ea1ff-ecce-41b5-bd03-8289f2d5eb1e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" unitref="usd">52</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtNC0xLTEtMTc3NDk5_cbd96b15-ccb7-438e-afc4-8b543412e624" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" unitref="usd">9,346</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtNi0xLTEtMTc3NDk5_9b004b32-730c-4021-bb2a-fe5cba9e1ef6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtOC0xLTEtMTc3NDk5_4679e761-1973-4f25-a746-74f2d0848b20" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtMTAtMS0xLTE3NzQ5OQ_7d9de808-771f-4a4d-981f-15ecf13dc4f5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" unitref="usd">52</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjI1OGI5MzQ0MmRiNzQ1Zjk5YTFhY2M1MjI3ZjkyN2ZjL3RhYmxlcmFuZ2U6MjU4YjkzNDQyZGI3NDVmOTlhMWFjYzUyMjdmOTI3ZmNfMTYtMTItMS0xLTE3NzQ5OQ_e8096bc9-6090-4a05-9152-82f76429697b" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" unitref="usd">9,347</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and December 31, 2021, we held <ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTgyMQ_92ae5c4d-adb8-474a-b077-252360f7e9cd" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" unitref="security">620</ix:nonfraction> and <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMTgyOA_49120772-9345-4acf-8140-1e89cba355b3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" unitref="security">384</ix:nonfraction> available-for-sale securities, respectively, out of our total investment portfolio that were in a continuous unrealized loss position. We neither intend to sell these investments, nor do we believe that we are more-likely-than-not to conclude we will have to sell them before recovery of their carrying values. We also believe that we will be able to collect both principal and interest amounts due to us at maturity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i622c6d4053c0453aaa1081927eda94b4"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzcxMw_afdfecb0-cb67-4715-b687-26e17a3a432c" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.263%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value at September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ida3dde2ff5d64d60b7553efe4e4c2d3d_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMy0yLTEtMS0xNzc0OTk_70ad689e-79b4-4c2e-97f0-6ddd48c4da97" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">1,937</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7135b8b8df5b4075a613bda58280fb3f_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMy00LTEtMS0xNzc0OTk_e0c11100-27f5-47ea-966e-62cb0a47388a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">1,937</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ieb1f15d69f164867b5743468d41113ba_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMy02LTEtMS0xNzc0OTk_9c928b52-4b3d-4014-99e7-f0168d61024c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2c850f21d05f40b38240925cf8345a2f_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNC0yLTEtMS0xNzc0OTk_af4f50e0-b7a9-413a-9a20-f2dc8c9b0c92" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">208</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i64e50688439c4edb82c400f3390e3fb1_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNC00LTEtMS0xNzc0OTk_88ecb213-6168-4800-9575-a926822768ac" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i839964c244274dba804e482844ea7b39_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNC02LTEtMS0xNzc0OTk_c24aac89-c6c8-406c-bc5b-377eecfda2f0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">208</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i011c62f01b1d4967b9595242f6f658b0_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNS0yLTEtMS0xNzc0OTk_93adc81d-4784-438f-97d0-3d3fa7c38303" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7a1983dcd645464c94c0821bcff86fbd_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNS00LTEtMS0xNzc0OTk_6182e670-da7e-4c92-8209-c76a22101463" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i258464e565d34c078885055519237bb7_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNS02LTEtMS0xNzc0OTk_7a8789b7-709e-4c1d-96c8-0b4bf2f4bf68" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">218</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8366fd495a824350ad51bd08ac4e6c0f_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNi0yLTEtMS0xNzc0OTk_ebc55fc2-944f-4124-96bf-2fd9c2b2e539" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">7,558</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9ea07d0825234c5480276ba1bd0cc2a0_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNi00LTEtMS0xNzc0OTk_555a4853-d87d-4e6e-8d99-01e8d07e95b9" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if3ac3617fba94444822b6cda811d1249_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNi02LTEtMS0xNzc0OTk_1d6e9e7f-99da-4e62-bc7b-6b0384326372" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">7,558</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic39ebfb28a5b4035b7225fd6c9e537ca_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNy0yLTEtMS0xNzc0OTk_22434e80-a72a-4a9a-a518-d401e8222564" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">5,854</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0d92f8c1a58e49119bc3e85cdeb2e810_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNy00LTEtMS0xNzc0OTk_10227632-4d34-4432-87c1-984fde80a63a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ic29e8f2ade564ff2a4e8ffd439fbbd9a_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfNy02LTEtMS0xNzc0OTk_125d9507-5898-4ca2-b028-5aaff608bcb0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">5,854</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iee4192014a764152af105b73d0fe420b_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOC0yLTEtMS0xNzc0OTk_bc8d9a03-b9ff-4f4e-9693-3fa1cd45d026" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">138</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i40a0499df6224d49bbaf0ac61a26a73a_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOC00LTEtMS0xNzc0OTk_7d9cef07-30cb-4869-840a-c1f21329eaac" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i72bb13ef13f4441881a7f73c3ed99b54_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOC02LTEtMS0xNzc0OTk_52dc6a33-dd38-48fb-a857-e95098801a73" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">138</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5fa74c3ce3164030844dfdff1a4efb9b_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOS0yLTEtMS0xNzc0OTk_9c4e7049-acfd-4760-9735-a8439b659c06" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iffd5c4f8d05449aa9e566cea041aeb6a_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOS00LTEtMS0xNzc0OTk_5c945ce2-d2f7-48d7-9253-f643e0ac2451" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb9bfa43713d4d16904fdd3012566158_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfOS02LTEtMS0xNzc0OTk_8f68751f-5334-484e-9758-62e2f9d9683e" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5fa74c3ce3164030844dfdff1a4efb9b_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTAtMi0xLTEtMTc3NDk5_bbf9cd5e-44ef-4802-afc7-f1b09a8a283a" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">15,990</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iffd5c4f8d05449aa9e566cea041aeb6a_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTAtNC0xLTEtMTc3NDk5_bd42b90e-3afa-46d5-877d-9ad0fa0271be" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">1,937</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb9bfa43713d4d16904fdd3012566158_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTAtNi0xLTEtMTc3NDk5_ef920735-6ce5-4ae9-ac47-4dd85e299326" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">14,053</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5fa74c3ce3164030844dfdff1a4efb9b_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTItMi0xLTEtMTc3NDk5_8a987403-8667-4995-b9d0-acd920af1f82" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iffd5c4f8d05449aa9e566cea041aeb6a_I20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTItNC0xLTEtMTc3NDk5_0d6d1600-b011-4932-ada9-212198b06cfc" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifb9bfa43713d4d16904fdd3012566158_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOmE2NGEyM2M2M2VmNjQwOWNhYWE1MmExNjNlMmM4ZjNhL3RhYmxlcmFuZ2U6YTY0YTIzYzYzZWY2NDA5Y2FhYTUyYTE2M2UyYzhmM2FfMTItNi0xLTEtMTc3NDk5_d18b890e-f072-4986-8dec-aefa9fffa5e9" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">6</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value at December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i62562d434b5f47c384a6d94dd5fe1d53_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMy0yLTEtMS0xNzc0OTk_45047bfb-c5e9-40fd-a37d-356c8b6642be" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">2,329</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9c58aac1ea6b4b8382a89e01ee04951c_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMy00LTEtMS0xNzc0OTk_9cbdee2e-1df6-4746-bd39-e2d83dc68229" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">2,329</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id950879642ba444eab03b507bed707b9_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMy02LTEtMS0xNzc0OTk_6b217548-2b7a-4118-aea2-828643bed00e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9ce7ba9f513c4e60bfee1fbbbcc93f16_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNC0yLTEtMS0xNzc0OTk_6a3aa3bc-67c0-4e68-8445-7f4568f97356" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i5a4179e3e3ad4c8aaef5a36c41b219c4_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNC00LTEtMS0xNzc0OTk_e134635f-e8cd-44d8-8c2a-ac1805862e47" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib6a5d3436d204169ac69a1d50051d7d1_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNC02LTEtMS0xNzc0OTk_c2b24f63-08fd-4850-a0f3-21be520e545b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">80</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id3b1f47bfaa040779043d794f090ec23_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNS0yLTEtMS0xNzc0OTk_712fa3d3-d319-4e23-8dcf-ce78589c3b47" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">479</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i88af5cd39d554f97926b95f76b32efcd_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNS00LTEtMS0xNzc0OTk_71fe44b1-6a79-4153-9c86-9bd09fd11333" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iaba7828cc18444b7befe9088b776fa0b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNS02LTEtMS0xNzc0OTk_c916a31d-1bd2-4bcf-8e19-cd40a38e6caa" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">479</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib235f424563f4a47930e142d28b37683_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNi0yLTEtMS0xNzc0OTk_8a004918-2e01-4568-9c80-7c551fff3a99" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,564</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i478dd8954a7744c6ba4b36346a848e04_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNi00LTEtMS0xNzc0OTk_c3be5364-dec0-4838-870c-15a229bda68a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie47696c7596f42698f6ba273f8860fb5_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNi02LTEtMS0xNzc0OTk_f249c21d-b73e-4369-be0b-501598ec6039" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">6,564</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6eb0508598e24d7f894c03f715dc3eac_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNy0yLTEtMS0xNzc0OTk_7cf94ce7-e882-4ad6-8457-d4629ad5bb78" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,488</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0e5e44728fd4452da07985dd78ab046a_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNy00LTEtMS0xNzc0OTk_379845b3-dde9-46a7-8f9f-8c53cf4e99ea" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie3fdfa24a81f48568588503523296352_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfNy02LTEtMS0xNzc0OTk_1b8349e2-71cc-496a-b3cc-9f87f245896e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">3,488</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if04fd7f1cf5e4b81b693d636bfdd5c48_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOC0yLTEtMS0xNzc0OTk_15192d73-27fe-4da3-b128-8c97364e8008" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">111</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i12d5e3bff24e431a972a3173f42fb76f_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOC00LTEtMS0xNzc0OTk_28accc76-692f-44f5-8b30-b9e808490478" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i16a82ae8948446cdb85750d5be59a3f6_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOC02LTEtMS0xNzc0OTk_ab1efe75-6dae-4dc7-bae1-7fdf45e97b03" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" unitref="usd">111</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7c2d96d72b4c477c96864711ebcdb0f1_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOS0yLTEtMS0xNzc0OTk_b8a75339-bb8d-4c72-9f77-b619d0c87384" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">21</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2254ca8fd397429eb443e596a667399c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOS00LTEtMS0xNzc0OTk_cc1cc995-271d-4971-9d37-2d54cf320265" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8010829c22074131940685702c66cfe3_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfOS02LTEtMS0xNzc0OTk_9e7c7fce-c0cf-463b-b4ff-d914cc19ad25" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">21</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7c2d96d72b4c477c96864711ebcdb0f1_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTAtMi0xLTEtMTc3NDk5_f82159e3-00b0-4f4a-9a85-713ccd55e52c" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">13,072</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2254ca8fd397429eb443e596a667399c_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTAtNC0xLTEtMTc3NDk5_bac92fc5-e979-409a-9a6e-d00883baecb7" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">2,329</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8010829c22074131940685702c66cfe3_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTAtNi0xLTEtMTc3NDk5_15321487-8203-45dc-b97f-92527604c24a" name="us-gaap:AssetsFairValueDisclosure" scale="6" unitref="usd">10,743</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7c2d96d72b4c477c96864711ebcdb0f1_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTItMi0xLTEtMTc3NDk5_b775459d-b11a-4f13-b7b7-d3bee03285bc" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2254ca8fd397429eb443e596a667399c_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTItNC0xLTEtMTc3NDk5_69f9792f-f212-4de1-a683-7c4d6f74b011" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8010829c22074131940685702c66cfe3_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RhYmxlOjIyODA2Yjc0NjA0NDQ4MDliZjg1OWY3MTNlMDk2NTRkL3RhYmxlcmFuZ2U6MjI4MDZiNzQ2MDQ0NDgwOWJmODU5ZjcxM2UwOTY1NGRfMTItNi0xLTEtMTc3NDk5_12cee2d1-8a73-4d60-af9e-ad1ad7dadf9a" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, we did not have non-financial assets or liabilities measured at fair value on a recurring basis and did not have any Level 3 financial assets or financial liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of September 30, 2022, we had $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzQ0MQ_0227b29b-1c5d-4475-9930-03ac8146c2f7" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" unitref="usd">30</ix:nonfraction>&#160;million in equity investments without readily determinable fair values, which are recorded within other non-current assets in our condensed consolidated balance sheets and excluded from the fair value measurement tables above. We did <ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV81OC9mcmFnOjMyYWJmNmIxMDYwMDQyZjE4YTVhZGU3ODJiZDhlNWNjL3RleHRyZWdpb246MzJhYmY2YjEwNjAwNDJmMThhNWFkZTc4MmJkOGU1Y2NfMzY3MA_ea845462-03d1-4955-aad3-d48cdb0d2e10" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="0" unitref="usd">not</ix:nonfraction> have equity investments as of December 31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i32473df1c3f84b92b909ff9319f7f9c8" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RleHRyZWdpb246ZThjMmE2ZDcyYjk0NGRiY2EwZmRkOTY2NDcyMWM2NDNfNDkxNA_b7c2639e-e794-4567-a025-9ffa8af82a9e" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">Derivative Financial Instruments</ix:nonnumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation continuedat="i67729b9d76e24fe5a0055bdf8521cc70" id="i32473df1c3f84b92b909ff9319f7f9c8">We transact business in various foreign currencies and have international sales and expenses denominated in foreign currencies. Therefore, we are exposed to certain risks arising from both our business operations and economic conditions. Our risk management strategy includes the use of derivative financial instruments to hedge: (1) forecasted product sales that are denominated in foreign currencies and (2) foreign currency exchange rate fluctuations on monetary assets or liabilities denominated in foreign currencies. We do not enter into derivative financial contracts for speculative or trading purposes. We do not believe that we are exposed to more than a nominal amount of credit risk in our foreign currency hedges, as counterparties are large, global and well-capitalized financial institutions. We classify cash flows from our derivative transactions as cash flows from operating activities in our condensed consolidated statements of cash flows.</ix:continuation></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation continuedat="if706186932d14904b43870e37b3e68e6" id="i67729b9d76e24fe5a0055bdf8521cc70"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We mitigate the foreign exchange risk arising from the fluctuations in foreign currency denominated product sales in Euro through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that do not exceed <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RleHRyZWdpb246ZThjMmE2ZDcyYjk0NGRiY2EwZmRkOTY2NDcyMWM2NDNfMTI2OQ_b38ca8a0-d08b-45b3-acc1-42ce7c1e7c8e" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1">15</ix:nonnumeric> months in duration. We hedge these cash flow exposures to reduce the risk that our earnings and cash flows will be adversely affected by changes in exchange rates. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative assets or liabilities associated with our hedging activities are recorded at fair value in other current assets or other current liabilities, respectively, in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated balance sheets</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gains or losses resulting from changes in the fair value of these hedges are initially recorded as a component of accumulated other comprehensive income (loss) (AOCI) in stockholders&#8217; equity and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequently reclassified to product sales in the period during which the hedged transaction affects earnings.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, within the defined hedge period, we reclassify the gains or losses on the related cash flow hedge from AOCI to other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our condensed consolidated statements of income</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We evaluate hedge effectiveness at the inception of the hedge prospectively, and on an on-going basis both retrospectively and prospectively. If we do not elect hedge accounting, or the contract does not qualify for hedge accounting treatment, the changes in fair value from period to period are recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a component of other expense, net in our condensed consolidated statements of income</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, we had net deferred gains of $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RleHRyZWdpb246ZThjMmE2ZDcyYjk0NGRiY2EwZmRkOTY2NDcyMWM2NDNfMjkxMg_74e0b78c-78e9-4a4e-9cf7-cd913566945a" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" unitref="usd">70</ix:nonfraction>&#160;million on our foreign currency forward contracts included in AOCI that are expected to be recognized into product sales within the next 12 months.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily accounts receivable, accounts payable and lease liabilities in Euro, Japanese Yen and Swiss Franc, that are not designated for hedge accounting treatment. Therefore, these forward contracts are accounted for as derivatives whereby the fair value of the contracts are reported as other current assets or other current liabilities in our condensed consolidated balance sheets, and gains and losses resulting from changes in the fair value are recorded as a component of other expense, net in our condensed consolidated statements of income. The gains and losses on these foreign currency forward contracts generally offset the gains and losses in the underlying foreign currency denominated assets and liabilities, which are also recorded to other expense, net in our condensed consolidated statements of income. </span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i443bea3a418a4a23b07577cef2bd435e" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RleHRyZWdpb246ZThjMmE2ZDcyYjk0NGRiY2EwZmRkOTY2NDcyMWM2NDNfNDkxNQ_8e3b8fc5-ad42-420c-b1d0-2822db79542d" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross notional amount and fair value of our foreign currency derivatives were as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7bcf293f6c1e4500abf112cd8d57560d_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNC0yLTEtMS0xNzc0OTk_4b829a8e-dccd-4359-8636-94c6d4aa26d7" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">789</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7bcf293f6c1e4500abf112cd8d57560d_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNC00LTEtMS0xNzc0OTk_50dbe7c7-f1fa-48ea-8191-6d79154cade1" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">68</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7bcf293f6c1e4500abf112cd8d57560d_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNC02LTEtMS0xNzc0OTk_c11c35bc-4eac-4e5d-bb93-57590e6a9bf7" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02cd293df5b04727a0d9c76474421137_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNy0yLTEtMS0xNzc0OTk_3dd37e4a-89a5-47b8-a389-387068f4557a" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">833</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02cd293df5b04727a0d9c76474421137_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNy00LTEtMS0xNzc0OTk_7ac1361b-5cd5-42a0-b4b4-75301cb69a8b" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i02cd293df5b04727a0d9c76474421137_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfNy02LTEtMS0xNzc0OTk_35535a3a-3800-4cd6-9712-60157240a058" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfOC0yLTEtMS0xNzc0OTk_924c8e77-5346-4b17-83b4-e641b4c8f272" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">1,622</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfOC00LTEtMS0xNzc0OTk_0db6f0e9-b362-4b50-a952-6b9ace072dd1" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmMwZGZjYWNjZjcyNzQzZmJiZWMzZTUyNGMwNDFlNzJjL3RhYmxlcmFuZ2U6YzBkZmNhY2NmNzI3NDNmYmJlYzNlNTI0YzA0MWU3MmNfOC02LTEtMS0xNzc0OTk_a3a18ba1-dc6d-4557-8627-be376d6dd2a9" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span></div></ix:nonnumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation id="if706186932d14904b43870e37b3e68e6"><ix:continuation id="i443bea3a418a4a23b07577cef2bd435e"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i51b88bec3ba7480e861f6dd273dc04e0_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNC0yLTEtMS0xNzc0OTk_40d64b30-91bd-4b93-afdb-3205bd917cfa" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">565</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i51b88bec3ba7480e861f6dd273dc04e0_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNC00LTEtMS0xNzc0OTk_4f3721bc-0a4e-47e1-a071-cfea6e83f500" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">20</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i51b88bec3ba7480e861f6dd273dc04e0_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNC02LTEtMS0xNzc0OTk_f0c2793a-31ed-4c99-be54-7920849fd31e" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i320c88cd83354a5da6789edbd31bbffa_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNy0yLTEtMS0xNzc0OTk_4b57d755-3720-4814-a06d-38192f5fc1e3" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">1,370</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i320c88cd83354a5da6789edbd31bbffa_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNy00LTEtMS0xNzc0OTk_e40cf74f-2e4a-49cc-bbf0-fd8068f4007c" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i320c88cd83354a5da6789edbd31bbffa_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfNy02LTEtMS0xNzc0OTk_f49c73ef-8b9e-4271-946a-db746a4863ce" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfOC0yLTEtMS0xNzc0OTk_f2430e08-ea72-4a3e-b836-89736fdd0f3c" name="us-gaap:DerivativeNotionalAmount" scale="6" unitref="usd">1,935</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfOC00LTEtMS0xNzc0OTk_03415e53-e5bb-4933-8ff7-c6c2c6302985" name="us-gaap:DerivativeAssets" scale="6" unitref="usd">21</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjY3YzZmNGVlN2VmODRjODM5ZjQ0NGYwZmNlZWY1NTczL3RhYmxlcmFuZ2U6NjdjNmY0ZWU3ZWY4NGM4MzlmNDQ0ZjBmY2VlZjU1NzNfOC02LTEtMS0xNzc0OTk_3e500c6c-0443-4b46-8509-af0360b66017" name="us-gaap:DerivativeLiabilities" scale="6" unitref="usd">7</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">_________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As presented in the condensed consolidated balance sheets within prepaid expenses and other current assets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As presented in the condensed consolidated balance sheets within other current liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains on our foreign currency derivatives, net of tax recognized in our condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2022 and 2021 were as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmJiYWIwNTFhOWIwZjRjMmFiMjA2MzNlNGEzY2E4ZjA2L3RhYmxlcmFuZ2U6YmJhYjA1MWE5YjBmNGMyYWIyMDYzM2U0YTNjYThmMDZfMy0yLTEtMS0xNzc0OTk_a0c289fd-b7c8-43d5-81d2-e2a7086f0cb3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">62</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmJiYWIwNTFhOWIwZjRjMmFiMjA2MzNlNGEzY2E4ZjA2L3RhYmxlcmFuZ2U6YmJhYjA1MWE5YjBmNGMyYWIyMDYzM2U0YTNjYThmMDZfMy00LTEtMS0xNzc0OTk_e6207fda-460f-4291-9d38-38580dcd7b63" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">30</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmJiYWIwNTFhOWIwZjRjMmFiMjA2MzNlNGEzY2E4ZjA2L3RhYmxlcmFuZ2U6YmJhYjA1MWE5YjBmNGMyYWIyMDYzM2U0YTNjYThmMDZfMy02LTEtMS0xNzc0OTk_34f63e72-344e-423c-baf2-0e895980c2a7" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">133</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOmJiYWIwNTFhOWIwZjRjMmFiMjA2MzNlNGEzY2E4ZjA2L3RhYmxlcmFuZ2U6YmJhYjA1MWE5YjBmNGMyYWIyMDYzM2U0YTNjYThmMDZfMy04LTEtMS0xNzc0OTk_6da584cc-927f-485a-8546-dae7755b1319" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" unitref="usd">51</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effect of our foreign currency derivatives in our condensed consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 was as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Statement of Income Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain reclassified from AOCI into income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i507b7eb2dc9541bb91ef82a5042ca1ac_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfNC00LTEtMS0xNzc0OTk_57f2c3bb-1659-4182-985f-4e645a55ed28" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">50</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6848a7b26a564abf8de6896740f8fde2_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfNC02LTEtMS0xNzc0OTk_39fcd117-5bf7-451f-9d95-2fcf87db3f3c" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iced0b2295c0848f1892ca7aa2a7ec064_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfNC04LTEtMS0xNzc0OTk_b06595a5-3513-4594-a73d-fd7e772cc36b" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">94</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i924eb2e676214b7f9eb252e5787c7325_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfNC0xMC0xLTEtMTc3NDk5_8b159cd6-72f8-4e36-b9e5-8c5701fb5d0a" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i46e44c79f45e4e6d960bdf236ea501f6_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfOC00LTEtMS0xNzc0OTk_a1401e4c-f5b4-4f68-8fc6-8107fbb42132" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" unitref="usd">26</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib412ac789b604276ae380b0f24f33aa2_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfOC02LTEtMS0xNzc0OTk_5346345b-4378-4c73-925e-c75a98966367" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if86136e626eb43eebb383b6de603bb5d_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfOC04LTEtMS0xNzc0OTk_2484c12a-74ac-4da5-8bec-3860c25998e9" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" unitref="usd">95</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i19d0b2e9184c4525867e8a363293954f_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82MS9mcmFnOmU4YzJhNmQ3MmI5NDRkYmNhMGZkZDk2NjQ3MjFjNjQzL3RhYmxlOjFlMGQxOGUyYTE0NDQ1MzE5OWY2MDhkZGIxYWVlODAxL3RhYmxlcmFuZ2U6MWUwZDE4ZTJhMTQ0NDUzMTk5ZjYwOGRkYjFhZWU4MDFfOC0xMC0xLTEtMTc3NDk5_b77db7da-d8d7-470b-b163-dd8c95ebf05b" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" sign="-" unitref="usd">16</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">8. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i5be32254aef14cbfb40ea274d8f02fa0" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMjYxMA_08c37a85-cb9d-496d-b018-ecfc917379d3" name="us-gaap:InventoryDisclosureTextBlock">Inventory</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="i794295c6b0b9461ebc7cb01d4d90e6a4" id="i5be32254aef14cbfb40ea274d8f02fa0"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMjYxMQ_b787307e-2410-4aaf-9e26-a4a20bc1335f" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of September 30, 2022 and December 31, 2021 consisted of the following (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfMi0yLTEtMS0xNzc0OTk_b04f4515-a384-4527-b862-684f1d462511" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" unitref="usd">1,541</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfMi00LTEtMS0xNzc0OTk_772456a8-dd41-46aa-b485-9df2e341f08d" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" unitref="usd">870</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfMy0yLTEtMS0xNzc0OTk_b5763c28-2b39-4ac4-a28c-29844eaa2962" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" unitref="usd">366</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfMy00LTEtMS0xNzc0OTk_7c4c6f19-1c2c-49de-8503-7c0f42e28d8d" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" unitref="usd">338</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfNC0yLTEtMS0xNzc0OTk_568c1149-2e65-4550-8990-03bca91dda1e" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" unitref="usd">170</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfNC00LTEtMS0xNzc0OTk_d4db9861-2fa8-4c5d-8ac3-43a2cbdaed23" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" unitref="usd">233</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfNS0yLTEtMS0xNzc0OTk_611ad8b6-c03b-4d7c-adba-300392b9a29a" name="us-gaap:InventoryNet" scale="6" unitref="usd">2,077</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RhYmxlOjdiOWEzMTllNTBjZjQ5MTM4N2QzOGU5ZWRmYjM5YzBmL3RhYmxlcmFuZ2U6N2I5YTMxOWU1MGNmNDkxMzg3ZDM4ZTllZGZiMzljMGZfNS00LTEtMS0xNzc0OTk_4842ba8c-1779-42b0-9df7-78d0d44ab690" name="us-gaap:InventoryNet" scale="6" unitref="usd">1,441</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is recorded at the lower of cost or net realizable value. On a quarterly basis, we evaluate the composition of inventory to identify excess, obsolete, slow-moving or otherwise unsaleable items. We also assess whether we have any excess firm, non-cancelable, purchase commitment liabilities, resulting from our supply agreements with third-party vendors on a quarterly basis. The determination of net realizable value of inventory and firm purchase commitment liabilities requires judgment, including consideration of many factors, such as estimates of future product demand, current and future market conditions, potential product obsolescence, expiration and utilization of raw materials under firm purchase commitments and contractual minimums, among others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory write-downs as a result of excess, obsolescence, scrap or other reasons, and losses on firm purchase commitments are recorded as a component of cost of sales in our condensed consolidated statements of income. For the three and nine months ended September 30, 2022, inventory write-downs were $<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTEzNw_80980532-4040-4ec6-9e3b-b0ff14259c2a" name="us-gaap:InventoryWriteDown" scale="6" unitref="usd">333</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTE0NA_28460285-a98d-43b0-b48c-5c95fea6e237" name="us-gaap:InventoryWriteDown" scale="9" unitref="usd">1.0</ix:nonfraction>&#160;billion, respectively. Inventory write-downs were <ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="0" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTE4OQ_2d4098de-e9dc-4318-bbd0-1ac6dabaa26a" name="us-gaap:InventoryWriteDown" scale="0" unitref="usd"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="0" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTE4OQ_4ef4e1e6-857b-49e2-a225-9b0866349da3" name="us-gaap:InventoryWriteDown" scale="0" unitref="usd">immaterial</ix:nonfraction></ix:nonfraction> for the three and nine months ended September 30, 2021. For the three and nine months ended September 30, 2022, losses on firm purchase commitments were $<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTI4OQ_4e180a93-47df-486f-95d5-5e3e9a09d724" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" scale="6" unitref="usd">7</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTI5Ng_27dfbdc0-8ce3-4e36-bb87-550fd74e9da7" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" scale="6" unitref="usd">349</ix:nonfraction>&#160;million, respectively. As of September 30, 2022, the accrued liability for losses on firm future purchase commitments in our condensed consolidated balance sheets was $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTQ0Mg_57329163-8b28-4f59-80de-2e6dcb298f27" name="mrna:LegalContingencyFutureFirmPurchaseCommitments" scale="6" unitref="usd">349</ix:nonfraction>&#160;million. There were <ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTQ1Nw_48f3b8a0-4880-4526-adf8-7f5e9cec2c1e" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" scale="0" unitref="usd"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTQ1Nw_983ac55b-d0a3-44dd-bc12-9ac0218d5059" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" scale="0" unitref="usd"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="INF" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMTQ1Nw_ef716ac9-c539-49b1-ac53-9afef826c3f0" name="mrna:LegalContingencyFutureFirmPurchaseCommitments" scale="0" unitref="usd">no</ix:nonfraction></ix:nonfraction></ix:nonfraction> such charges in 2021 or accrued liabilities at December 31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-launch Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs relating to raw materials and production of inventory in preparation for product launch prior to regulatory approval are capitalized when future commercialization is considered probable, the future economic benefit is expected to be realized, and we believe that material uncertainties related to the ultimate regulatory approval have been significantly reduced. For pre-launch inventory that is capitalized, we consider a number of factors based on the information available at the time, including the product candidate&#8217;s current status in the drug development and regulatory approval process, results from the related clinical trials, results from meetings with relevant regulatory agencies prior to the filing of regulatory applications, potential impediments to the approval process such as product safety or efficacy, historical experience, viability of commercialization and market trends. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i794295c6b0b9461ebc7cb01d4d90e6a4">During the second quarter of 2022, we capitalized pre-launch inventory relating to our BA.1 Omicron-targeting booster candidate (mRNA-1273.214). As of June 30, 2022, we had pre-launch inventory of $<ix:nonfraction contextref="i22c92b775c9b47f88c9025bc7daf45b5_I20220630" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV82Ny9mcmFnOjBhNzk0MjU2MjMwNDQyYzc5ZjRlMDI4YTc0NTdmNGU5L3RleHRyZWdpb246MGE3OTQyNTYyMzA0NDJjNzlmNGUwMjhhNzQ1N2Y0ZTlfMjU2MQ_d23a45cf-b20f-452d-90b1-dcee1814eec9" name="us-gaap:OtherInventoryCapitalizedCosts" scale="6" unitref="usd">155</ix:nonfraction>&#160;million in our condensed consolidated balance sheets. Subsequent to June 30, 2022, we received authorization for the use of mRNA-1273.214 in several countries and commenced supply of this vaccine to customers.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="ic2d0ef3a1a29492faa2b60fe705a6bb5" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfMzA4_0cc40890-a46d-4edc-b796-fd98c0b59dda" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock">Property and Equipment, Net</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation id="ic2d0ef3a1a29492faa2b60fe705a6bb5"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfMzA5_eaec3a10-f55b-464d-84ad-e1b59009c187" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, as of September 30, 2022 and December 31, 2021 consisted of the following (in&#160;millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and laboratory equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i17c30799804c4954a85aae813e48b539_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMi0yLTEtMS0xNzc0OTk_f48e9743-ef53-4746-9222-d1a409d0e723" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">239</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie2135690b7cc4964aae5d94b864cd570_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMi00LTEtMS0xNzc0OTk_4de752a2-4571-45d6-986e-a019ac5354ce" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">175</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iede3a740030e4ec89d3532d1f16721bc_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMy0yLTEtMS0xNzc0OTk_b5979954-a6c2-4b54-b08f-69027eed9058" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">388</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i07b0bba8bc7a459a990908142354d88b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMy00LTEtMS0xNzc0OTk_01f2dc18-b375-4e52-bde8-2a93571b003d" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">313</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iee1c796ce23c483385b156af2292590f_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNC0yLTEtMS0xNzc0OTk_2b0924b6-d172-4eb5-9c38-c18d71b5910d" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">18</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7ed2780eb4034b539a660615f608c2db_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNC00LTEtMS0xNzc0OTk_21c06b35-3d7b-4635-8a1c-a426a664f904" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i84357de901a34ed7b8e1d69cfe534dd0_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNS0yLTEtMS0xNzc0OTk_fee6a579-2c5d-4964-9664-62d6cb0ab75e" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">23</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i740fea2392774a5db643ec29b58d8a30_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNS00LTEtMS0xNzc0OTk_97bc677a-2313-4119-a01b-ec5b304c268d" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6eb6a7b869bd4ba8ad8e38dfba6ab7b2_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNi0yLTEtMS0xNzc0OTk_35211f2e-3325-4270-98e7-e9709835bdc0" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8e4a1185ceee4458ae10f28d781f5bdb_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNi00LTEtMS0xNzc0OTk_a82af7ed-b946-463d-b1d6-4a55442fdb93" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, financing (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if58781399ae548b3af55b7d5db4008fa_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNy0yLTEtMS0xNzc0OTk_ddef5c87-f6be-40ad-a67d-3380d26baa3e" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">1,585</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i6d7763d012f94e328d9ec4824365870a_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfNy00LTEtMS0xNzc0OTk_09106adc-e712-47af-809e-eecf5512c786" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">857</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i52befc0ca95441a6b6364a6b33c53802_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfOC0yLTEtMS0xNzc0OTk_3b9e786a-0a30-48b1-9453-1fd944ef70d4" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">338</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if52e15a691134dac86ab79105b2a0669_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfOC00LTEtMS0xNzc0OTk_85decef0-2139-494a-917b-8785b4e4219a" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">212</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfOS0yLTEtMS0xNzc0OTk_8d4ad79e-f7cc-47ed-a38f-fd985d637559" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">2,599</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfOS00LTEtMS0xNzc0OTk_58de84c2-cffb-49e2-aad8-09890b4773fb" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">1,593</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMTAtMi0xLTEtMTc3NDk5_16c1b644-c78a-4266-a5b7-2d377c61f6ea" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">580</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMTAtNC0xLTEtMTc3NDk5_a250d2c6-f3aa-48c3-8f77-c4a2d7c3122c" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">352</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMTEtMi0xLTEtMTc3NDk5_266922d3-0240-4a7d-b338-e891ce8f9666" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">2,019</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RhYmxlOjViNzU4NGI2NmRjOTQxNTVhYzlmNGRkYzYwNThkZWM0L3RhYmxlcmFuZ2U6NWI3NTg0YjY2ZGM5NDE1NWFjOWY0ZGRjNjA1OGRlYzRfMTEtNC0xLTEtMTc3NDk5_5de4e96a-cc96-400f-8f53-7b46942d2805" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" unitref="usd">1,241</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the three and nine months ended September 30, 2022 was $<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfMTkz_8f8c2962-e014-4ed7-9958-863981533d7f" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">113</ix:nonfraction> million and $<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfMjAw_120929c1-b2cf-49b2-a52c-a5b9676e8cd2" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">268</ix:nonfraction> million, respectively. Depreciation and amortization expense for the three and nine months ended September 30, 2021 was $<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfNTQ5NzU1ODE0MjAy_8f735b5d-256b-40bf-bd81-0f340e4a4ce9" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">70</ix:nonfraction> million and $<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83MC9mcmFnOmRkZmU5NGJmNzBkZTRjMTdiOGVjNjk5ZDQyMzhmOTc4L3RleHRyZWdpb246ZGRmZTk0YmY3MGRlNGMxN2I4ZWM2OTlkNDIzOGY5NzhfMjkx_eae673eb-e5fb-4d5e-bb53-bb68cb7ae788" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" unitref="usd">154</ix:nonfraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i3f44dc2481dc4de6a2216406b0fd62c2" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RleHRyZWdpb246OTRkZTJmMDY4ZGExNDMyYjg3OTA2NmUyYTExYTdmZDNfNjcz_0d7d958d-f59b-48dc-9ffe-b69286fcb543" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock">Other Balance Sheet Components</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="ic688deefe63e4ac3894628d7daf2b2a9" id="i3f44dc2481dc4de6a2216406b0fd62c2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RleHRyZWdpb246OTRkZTJmMDY4ZGExNDMyYjg3OTA2NmUyYTExYTdmZDNfNjY3_46598195-7b4c-4271-b1b6-e9fb309b6890" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets, as of September 30, 2022 and December 31, 2021 consisted of the following (in&#160;millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down payments for materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMi0yLTEtMS0xNzc0OTk_0b24dd93-4ed3-4cdd-b22e-0869c93f6052" name="mrna:OtherPrepaidExpenseMaterialsAndSupplies" scale="6" unitref="usd">180</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMi00LTEtMS0xNzc0OTk_74aaa3ac-e409-4907-aa47-8a6dd26335f5" name="mrna:OtherPrepaidExpenseMaterialsAndSupplies" scale="6" unitref="usd">287</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down payments to manufacturing vendors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMy0yLTEtMS0xNzc0OTk_3e4dbc07-207a-4061-9180-1247bc393c82" name="mrna:OtherPrepaidExpenseManufacturing" scale="6" unitref="usd">169</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMy00LTEtMS0xNzc0OTk_134a3216-ce5f-4fe5-9cd1-b795cbd080b5" name="mrna:OtherPrepaidExpenseManufacturing" scale="6" unitref="usd">118</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNC0yLTEtMS0xNzc0OTk_09544dc9-d0aa-4dbc-a09b-d5eb4cd1fe78" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" unitref="usd">277</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNC00LTEtMS0xNzc0OTk_9e215a8b-386a-44b3-ba12-91a1f076046c" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" unitref="usd">126</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value added tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNS0yLTEtMS0xNzc0OTk_f6f33398-c773-4a42-9441-e535f97fc558" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" unitref="usd">21</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNS00LTEtMS0xNzc0OTk_b0e585fb-eb3b-44e2-b674-f49bc7da91fc" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" unitref="usd">70</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvement allowance receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNi0yLTEtMS0xNzc0OTk_6def6e66-0826-46c5-863e-d881f85f0a00" name="mrna:TenantImprovementAllowanceReceivableCurrent" scale="6" unitref="usd">51</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNi00LTEtMS0xNzc0OTk_c4352977-6ea1-494c-87b8-ea464fcfb88d" name="mrna:TenantImprovementAllowanceReceivableCurrent" scale="6" unitref="usd">51</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNy0yLTEtMS0xNzc0OTk_bc733781-74a6-4116-a266-d398d39b20d1" name="us-gaap:InterestReceivableCurrent" scale="6" unitref="usd">54</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfNy00LTEtMS0xNzc0OTk_4a6137ef-cc3b-4c98-8988-1f3732ff3f12" name="us-gaap:InterestReceivableCurrent" scale="6" unitref="usd">27</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfOC0yLTEtMS0xNzc0OTk_7102e3ae-f0d6-4691-bf13-8c2b25d1217c" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfOC00LTEtMS0xNzc0OTk_95121b02-baef-4d9a-8d9b-bf8d6a065138" name="us-gaap:DerivativeAssetsCurrent" scale="6" unitref="usd">21</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfOS0yLTEtMS0xNzc0OTk_7d4323b0-7c2f-484a-9053-ab1b64ef104e" name="us-gaap:PrepaidTaxes" scale="6" unitref="usd">263</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfOS00LTEtMS0xNzc0OTk_eb23c6eb-1b69-4b34-9d03-e9930053f1ca" name="us-gaap:PrepaidTaxes" scale="6" unitref="usd">23</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMTAtMi0xLTEtMTc3NDk5_325052d9-c467-4e40-8f1f-15f430940620" name="us-gaap:OtherAssetsCurrent" scale="6" unitref="usd">85</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMTAtNC0xLTEtMTc3NDk5_4805f1f5-f7a0-4cbd-a081-f9cfc6b41cb0" name="us-gaap:OtherAssetsCurrent" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMTEtMi0xLTEtMTc3NDk5_c5c38520-9a58-4c08-b059-7fd6f7b17fae" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" unitref="usd">1,177</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmRmNmU4NmNiNjJjMDRiYjRiMTJiZjliNDZlMzI4ODBlL3RhYmxlcmFuZ2U6ZGY2ZTg2Y2I2MmMwNGJiNGIxMmJmOWI0NmUzMjg4MGVfMTEtNC0xLTEtMTc3NDk5_6f5b905c-5c67-4d10-9f27-1c03216bd369" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" unitref="usd">728</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="ic688deefe63e4ac3894628d7daf2b2a9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RleHRyZWdpb246OTRkZTJmMDY4ZGExNDMyYjg3OTA2NmUyYTExYTdmZDNfNjY5_a83a89f2-6f8b-499b-99ad-68a120b2f245" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities, as of September 30, 2022 and December 31, 2021 consisted of the following (in&#160;millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMi0yLTEtMS0xNzc0OTk_6c4b2dd1-17ea-474c-bb7f-7dcbc7c12544" name="mrna:AccruedClinicalTrials" scale="6" unitref="usd">269</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMi00LTEtMS0xNzc0OTk_d0fb21d0-fd95-4ce1-901e-f976a5f87cdc" name="mrna:AccruedClinicalTrials" scale="6" unitref="usd">283</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMy0yLTEtMS0xNzc0OTk_e7e7f8ec-6fd6-4399-98f9-ad213216b9e2" name="mrna:RawMaterialsAccountsPayable" scale="6" unitref="usd">246</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMy00LTEtMS0xNzc0OTk_40fca923-d091-45c5-a273-e54ec9271083" name="mrna:RawMaterialsAccountsPayable" scale="6" unitref="usd">260</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNC0yLTEtMS0xNzc0OTk_afad5e77-79a5-4b9c-aef4-abbfbdc4e878" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="6" unitref="usd">106</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNC00LTEtMS0xNzc0OTk_14ae1eef-83ea-464a-a4cc-bfa8f57d7bf1" name="us-gaap:AccruedRoyaltiesCurrentAndNoncurrent" scale="6" unitref="usd">241</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNS0yLTEtMS0xNzc0OTk_f6b46761-1e9f-4450-9844-00eabaa5df28" name="mrna:AccruedDevelopmentOperation" scale="6" unitref="usd">96</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNS00LTEtMS0xNzc0OTk_dd59c3c1-cbb5-4303-8e8b-29c835497fff" name="mrna:AccruedDevelopmentOperation" scale="6" unitref="usd">137</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNi0yLTEtMS0xNzc0OTk_12646b38-ce4c-4650-82f0-73e732c96065" name="mrna:AccruedManufacturing" scale="6" unitref="usd">411</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNi00LTEtMS0xNzc0OTk_ea77175d-92ab-4b5c-85a6-9d3022c83f96" name="mrna:AccruedManufacturing" scale="6" unitref="usd">227</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external goods and services </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNy0yLTEtMS0xNzc0OTk_4bfb5a0a-3590-4486-8daf-e0ffe2d16ff9" name="mrna:AccruedOtherExternalGoodsAndServicesCurrent" scale="6" unitref="usd">108</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfNy00LTEtMS0xNzc0OTk_e5167cc9-c991-4d99-aff5-8dea219174d8" name="mrna:AccruedOtherExternalGoodsAndServicesCurrent" scale="6" unitref="usd">79</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on future firm purchase commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfOC0yLTEtMS0xNzc0OTk_57329163-8b28-4f59-80de-2e6dcb298f27" name="mrna:LegalContingencyFutureFirmPurchaseCommitments" scale="6" unitref="usd">349</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfOC00LTEtMS0xNzc0OTk_7ab9c9ef-3104-4eae-80fe-59fbb4d33062" name="mrna:LegalContingencyFutureFirmPurchaseCommitments" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfOS0yLTEtMS0xNzc0OTk_db60bc12-9543-4e20-be1c-36e378de7573" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" unitref="usd">141</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfOS00LTEtMS0xNzc0OTk_677cc3d0-a2b6-4554-ac6b-cff91dd9ce42" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" unitref="usd">126</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMTAtMi0xLTEtMTc3NDk5_d2385dcc-fbe1-4e9c-bde8-2a35849a0885" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" unitref="usd">130</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMTAtNC0xLTEtMTc3NDk5_f0a007c9-019c-4db3-961b-fa17ba6232ef" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" unitref="usd">119</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMTMtMi0xLTEtMTc3NDk5_0f991267-6c28-43d6-bc18-18b296d88017" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" unitref="usd">1,856</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOmI1NjI4MDQwZmVkMTRiOTA5Mzc5MjAzNzkyMTNmNjIwL3RhYmxlcmFuZ2U6YjU2MjgwNDBmZWQxNGI5MDkzNzkyMDM3OTIxM2Y2MjBfMTMtNC0xLTEtMTc3NDk5_86bc7b41-aff4-4d38-9edc-54025e2a9f34" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" unitref="usd">1,472</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to losses that are expected to arise from firm, non-cancellable, commitments for future raw material purchases (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_67" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:nonnumeric><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RleHRyZWdpb246OTRkZTJmMDY4ZGExNDMyYjg3OTA2NmUyYTExYTdmZDNfNjcx_ff8d33bc-6434-48a9-b1f6-27259b6e28ad" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities, as of September 30, 2022 and December 31, 2021 consisted of the following (in&#160;millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - financing (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfMi0yLTEtMS0xNzc0OTk_77eafe45-0232-4c0f-aa27-31b08f32f1e2" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" unitref="usd">224</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfMi00LTEtMS0xNzc0OTk_93ae9453-414a-4999-96fc-5b229298b759" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" unitref="usd">165</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - operating (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfMy0yLTEtMS0xNzc0OTk_4556f3e1-f015-4b9c-9001-ed263eed241a" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" unitref="usd">36</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfMy00LTEtMS0xNzc0OTk_8c8e48bb-70b5-4dfd-9a86-5b59a072a504" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" unitref="usd">46</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfNS0yLTEtMS0xNzc0OTk_0c8b655d-b2e4-4f7c-b5b7-3eef62271728" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" unitref="usd">293</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfNS00LTEtMS0xNzc0OTk_aba04d86-7974-4cca-b1b0-0702eb65570a" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" unitref="usd">14</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfNi0yLTEtMS0xNzc0OTk_065961a0-3138-46e8-b23e-17b5ba36417e" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">553</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE2MWY4Yzk4ZDk5YjQ1NjY5MmJjN2FkMDQwN2FlYzkzL3RhYmxlcmFuZ2U6MTYxZjhjOThkOTliNDU2NjkyYmM3YWQwNDA3YWVjOTNfNi00LTEtMS0xNzc0OTk_e9d6ecdd-3b4f-4de1-9891-587588a5c269" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">225</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Includes $<ix:nonfraction contextref="ib16716b58a4849959129b0cbaa77416f_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RleHRyZWdpb246OTRkZTJmMDY4ZGExNDMyYjg3OTA2NmUyYTExYTdmZDNfNTQ5NzU1ODE1MjA5_96b8c80b-281a-4fd3-829e-7544532ebb7f" name="us-gaap:OtherLiabilitiesCurrent" scale="6" unitref="usd">250</ix:nonfraction>&#160;million related to Merck&#8217;s participation election as of September 30, 2022 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">).</span></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue </span></div><div><span><br/></span></div><ix:continuation id="iac7b6cc548e24b8c9853b7321227786b"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activities in deferred revenue for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> September 30, 2022 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifc81e71b9e784d99a75bfc6a17069c49_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMS0yLTEtMS0xNzc0OTk_f9160bd8-6356-42d0-a707-f5f854845309" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">6,658</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i2825268232174cd49a36dc4e6b636b75_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMS00LTEtMS0xNzc0OTk_2e85eae6-ba2d-45a1-9c44-ac63d8345d2c" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" unitref="usd">2,467</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i2825268232174cd49a36dc4e6b636b75_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMS02LTEtMS0xNzc0OTk_44a9cdc8-d0fc-439d-bf2e-68fa1a74c8e5" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="6" unitref="usd">5,030</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i09e609fc9ed243109f9df0a5e539b574_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMS04LTEtMS0xNzc0OTk_ef7a19b7-6b79-4390-8ccf-8ec588c7f11c" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">4,095</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib5e5021002234ef2ab9badcda9d18f6d_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMi0yLTEtMS0xNzc0OTk_9ed9838b-8dd0-4eb7-a0d1-1600a6979033" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">6</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i520e0eee9473493e9b84200f966551a6_D20220101-20220930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMi00LTEtMS0xNzc0OTk_2cad57e9-7f02-40e2-aef4-eaa2a7c73095" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" unitref="usd">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i520e0eee9473493e9b84200f966551a6_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMi02LTEtMS0xNzc0OTk_c63249de-114d-4240-853c-1bd887ac586f" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="6" unitref="usd">1</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iec7ec2c40ba3453486827e1df91bae41_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMi04LTEtMS0xNzc0OTk_51fb0718-8cb8-4ebf-aa58-10ce15b9ea62" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">5</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i853249c02e5c455a9b179af2153eb1bd_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMy0yLTEtMS0xNzc0OTk_3e2726d4-4db2-4020-978f-ac07674c57f4" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">204</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i15aeaadcbb4f4464bc324b97ba7aaf25_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMy00LTEtMS0xNzc0OTk_df27e6d6-1ae3-43f2-8eb8-dedde4afc35a" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" unitref="usd">8</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i15aeaadcbb4f4464bc324b97ba7aaf25_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMy02LTEtMS0xNzc0OTk_5c9932ec-71d8-48a3-83ae-e1e331661b48" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="6" unitref="usd">135</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i8fc31d7c5471411290cf62d763c852be_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfMy04LTEtMS0xNzc0OTk_7d353082-a6db-42a4-8ff0-bfbf07bc5b94" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">77</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfNC0yLTEtMS0xNzc0OTk_0e0ca0a2-8eb4-4f98-98c3-87490bb42a46" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">6,868</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfNC00LTEtMS0xNzc0OTk_5667933a-6f21-4183-8e7a-4529ec08286d" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" unitref="usd">2,475</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfNC02LTEtMS0xNzc0OTk_206c97fd-c592-49cd-a584-03de529cc351" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="6" unitref="usd">5,166</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83Ni9mcmFnOjk0ZGUyZjA2OGRhMTQzMmI4NzkwNjZlMmExMWE3ZmQzL3RhYmxlOjE0MjkxYjY2MDg1MzQ2Njc5YWFhYjM1ZjNiY2UxMDVkL3RhYmxlcmFuZ2U6MTQyOTFiNjYwODUzNDY2NzlhYWFiMzVmM2JjZTEwNWRfNC04LTEtMS0xNzc0OTk_86e40a0b-07a1-4b7d-8c47-89209e8cb51d" name="us-gaap:ContractWithCustomerLiability" scale="6" unitref="usd">4,177</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i6ee37575524445e2a415869673f4d924" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzE4MQ_c2734230-2b6a-4bb9-9111-b1bf47931ea0" name="us-gaap:LesseeOperatingLeasesTextBlock"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i610ffe1a4e064909b1c2ab69a7ae3aa4" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzE4Mg_5d26e4b0-5d1a-44ea-af28-3a3e7cce2cba" name="us-gaap:LesseeFinanceLeasesTextBlock">Leases</ix:nonnumeric></ix:nonnumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation continuedat="i42fafe8031064c9c93076f43c7712e9d" id="i6ee37575524445e2a415869673f4d924"><ix:continuation continuedat="if54e6171f1984f26950e6ce9b86461bd" id="i610ffe1a4e064909b1c2ab69a7ae3aa4">We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2042. Certain of these arrangements have free rent periods or escalating rent payment provisions. We recognize lease cost under such arrangements on a straight-line basis over the life of the lease. We have <ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzY0_8977ee7a-5edf-41a2-9554-7cebf5c112dd" name="mrna:OperatingLeaseNumberOfProperties" scale="0" unitref="campus">two</ix:nonfraction> campuses in Massachusetts, our Cambridge campus and our Moderna Technology Center (MTC), an industrial technology center located in Norwood. We also lease other office and lab spaces globally for our business operations. </ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation continuedat="i754b5af5012345cb819897edb7c106e0" id="i42fafe8031064c9c93076f43c7712e9d"><ix:continuation continuedat="i06dcadfbf9484570b133bda452db0707" id="if54e6171f1984f26950e6ce9b86461bd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambridge Campus</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occupy a multi-building campus in Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately <ix:nonfraction contextref="ie9034417678a4c7cada3e41d5223153a_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfNzg0_cd33d083-e468-49bf-be05-9be3c89f6ece" name="us-gaap:AreaOfRealEstateProperty" scale="0" unitref="sqft">261,000</ix:nonfraction>&#160;square feet. Our Cambridge campus leases have expiry ranges from 2024 to 2029. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are investing in a new Moderna Science Center (MSC) in Cambridge, to create a purpose-built space to support our next chapter of discovery (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In connection with our MSC investment, in September 2021, we entered into amendments to our lease agreements to allow for an option for early termination of the leases, either in part or full. Notification of the intent to exercise the option must be provided by August 2023. We have not elected to exercise this option.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MTC comprises <ix:nonfraction contextref="i3dca3fd0c2004511b3bfe06f5a8967f0_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTQyMQ_1000f1d0-ea5b-43b8-b8a4-51e84f314d90" name="mrna:FinanceLeaseNumberOfProperties" scale="0" unitref="numberofbuilding">three</ix:nonfraction> main buildings: MTC South, MTC North and MTC East. Each of MTC South and MTC North is approximately <ix:nonfraction contextref="i22babd4a5b2a48eba7e496277e9b8f31_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTUyNA_5ee4d4f1-afde-4dab-8458-ed87395e284c" name="us-gaap:AreaOfRealEstateProperty" scale="0" unitref="sqft"><ix:nonfraction contextref="i2a76029db19c4f39b6f386b4f547c005_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTUyNA_62f107c5-c2bd-4146-bfec-e7c7d2beeba5" name="us-gaap:AreaOfRealEstateProperty" scale="0" unitref="sqft">200,000</ix:nonfraction></ix:nonfraction> square feet and provides office, laboratory and light manufacturing space, directly supporting improvement in our manufacturing capabilities. MTC East is approximately <ix:nonfraction contextref="i739f5ec9f83a4fd186320d2099fc3be7_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTY5NQ_e65adb37-2f10-4357-ab68-0269ae3bc4eb" name="us-gaap:AreaOfRealEstateProperty" scale="0" unitref="sqft">240,000</ix:nonfraction> square feet for commercial and clinical activities. The MTC campus is leased through 2042 and we have the option to extend the term for <ix:nonfraction contextref="i29feed86eef546c3803626f63212f7e2_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTgzNA_4c73030f-7135-465a-a732-ccb0f9423bf4" name="mrna:LesseeOperatingLeaseNumberOfExtension" scale="0" unitref="numberofextensionperiod">three</ix:nonfraction> extension periods of <ix:nonnumeric contextref="i29feed86eef546c3803626f63212f7e2_I20220930" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMTg1OA_56fda94e-44ca-4152-b56e-78fdfa1ad09a" name="us-gaap:LesseeOperatingLeaseRenewalTerm">five years</ix:nonnumeric>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. These leases expire from 2022 through 2026. As of September 30, 2022 and December 31, 2021, we had lease liabilities of $<ix:nonfraction contextref="ice049e97694d429c886345f11a164fbc_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMjEyMA_46305e16-4e57-44c2-a718-22b166273edc" name="us-gaap:OperatingLeaseLiability" scale="6" unitref="usd">513</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i87eb76882a154ae09e6b8b5798c5ca19_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMjEyNw_fa9cf495-e1ef-47c3-bad7-790e07716ceb" name="us-gaap:OperatingLeaseLiability" scale="6" unitref="usd">166</ix:nonfraction>&#160;million, respectively, related to the embedded leases. As of September 30, 2022 and December 31, 2021, we had right-of-use assets of $<ix:nonfraction contextref="ice049e97694d429c886345f11a164fbc_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMjIyNA_b8d8699c-c039-4ce1-9255-907798c69829" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">695</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i87eb76882a154ae09e6b8b5798c5ca19_I20211231" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMjIzMQ_15ad70bf-b343-4f51-ac0e-c6575a4dcf9f" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">173</ix:nonfraction>&#160;million, respectively, related to the embedded leases.</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzE3Nw_7c23439a-2007-4efd-bc5b-0d085a0e76a8" name="mrna:AssetsAndLiabilitiesLesseeTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating and financing lease right-of-use assets and lease liabilities as of September 30, 2022 and December 31, 2021 were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMy0yLTEtMS0xNzc0OTk_59584102-2bb6-4b4b-82aa-a4d57db0b75b" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">113</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMy00LTEtMS0xNzc0OTk_4e62edc9-c991-4299-928d-1dbf56e85f56" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" unitref="usd">142</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, financing, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfNC0yLTEtMS0xNzc0OTk_0e08ebf7-5087-4931-b7d2-ef4edd85c6c9" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" unitref="usd">1,209</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfNC00LTEtMS0xNzc0OTk_be27c54b-a5cc-45db-85fe-40988840115e" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" unitref="usd">665</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfNS0yLTEtMS0xNzc0OTk_cbe30eb2-34df-42f0-8959-35238eb4c21a" name="mrna:OperatingAndFinanceLeaseRightOfUseAsset" scale="6" unitref="usd">1,322</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfNS00LTEtMS0xNzc0OTk_c8c7a433-3ef6-450f-b2a0-568d6806dd20" name="mrna:OperatingAndFinanceLeaseRightOfUseAsset" scale="6" unitref="usd">807</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS0wLTEtMS0xNzc0OTk_63bc6e23-3da9-42b3-a848-5bc0391847ef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS0wLTEtMS0xNzc0OTk_e716b09f-3fa4-4675-81dc-de6d128f2571"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS0yLTEtMS0xNzc0OTk_69a79263-53a3-451b-a5fa-534f5bbe5c9f" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" unitref="usd">36</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfOS00LTEtMS0xNzc0OTk_f7987ba1-ecff-4081-9551-b6fa03b366e6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" unitref="usd">46</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtMC0xLTEtMTc3NDk5_5d47a644-16e7-4224-8fe0-0ed593507be1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtMC0xLTEtMTc3NDk5_9a7351ff-9d66-4bd9-99be-15fa6c2c8fd3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtMi0xLTEtMTc3NDk5_9f90a8b8-827f-484c-a9ae-5de9840a689d" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" unitref="usd">224</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTAtNC0xLTEtMTc3NDk5_3a2faa71-1a0e-4600-99fe-79a8c08c4052" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" unitref="usd">165</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTEtMi0xLTEtMTc3NDk5_84536b87-06d3-4881-91a5-dff8fff72bff" name="mrna:OperatingAndFinanceLeaseLiabilityCurrent" scale="6" unitref="usd">260</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTEtNC0xLTEtMTc3NDk5_da4c58b4-b8de-4f96-9a10-814e61c547e0" name="mrna:OperatingAndFinanceLeaseLiabilityCurrent" scale="6" unitref="usd">211</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTMtMi0xLTEtMTc3NDk5_34c10bad-0799-4ac1-9577-a1b56cb5cfe5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" unitref="usd">79</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTMtNC0xLTEtMTc3NDk5_67409b4d-a03e-4791-85ca-2ce084382ae3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" unitref="usd">106</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTQtMi0xLTEtMTc3NDk5_7f5b188a-3510-4acd-a029-a49a6fa62e3a" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">922</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTQtNC0xLTEtMTc3NDk5_9014adb4-b98e-4719-8051-69b6d335481a" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">599</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTUtMi0xLTEtMTc3NDk5_70e8d3b1-3f66-4180-893a-cf085528c394" name="mrna:OperatingAndFinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">1,001</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTUtNC0xLTEtMTc3NDk5_d1d57e08-f7af-4d20-99f6-e27007acd860" name="mrna:OperatingAndFinanceLeaseLiabilityNoncurrent" scale="6" unitref="usd">705</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTYtMi0xLTEtMTc3NDk5_a0af15b9-ba9b-469c-a2b0-64487ca88499" name="mrna:OperatingAndFinanceLeaseLiability" scale="6" unitref="usd">1,261</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ie7c252d307fe48d68a9165a4306b367b_I20211231" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjA3NmUwZDFiYWNjNjRkZmE5YTBiNzA5MzFlYzY1MTg1L3RhYmxlcmFuZ2U6MDc2ZTBkMWJhY2M2NGRmYTlhMGI3MDkzMWVjNjUxODVfMTYtNC0xLTEtMTc3NDk5_f93c3134-d704-44e4-8412-4c471d1a0267" name="mrna:OperatingAndFinanceLeaseLiability" scale="6" unitref="usd">916</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are real estate related assets, which include land, office, and laboratory spaces.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of accumulated amortization.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are&#160;real estate assets related to the MTC leases as well as assets related to contract manufacturing service agreements.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in property and equipment in the condensed consolidated balance sheets, net of accumulated depreciation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other current liabilities in the condensed consolidated balance sheets.</span></div></ix:nonnumeric></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i754b5af5012345cb819897edb7c106e0"><ix:continuation id="i06dcadfbf9484570b133bda452db0707"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzE3OQ_80745124-307d-423a-82d5-ce4fdc461970" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzE4MA_e1b1f755-e1fb-4645-9e97-48015e955ef0" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Future minimum lease payments under our non-cancelable lease agreements as of September 30, 2022, were as follows (in&#160;millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(remainder of the year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMS0yLTEtMS0xNzc0OTk_562b1dbe-a412-4fb0-b0df-6e23481ebb89" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" unitref="usd">11</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMS00LTEtMS0xNzc0OTk_e6be40b3-f13c-436a-aec6-2b3802159878" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" unitref="usd">153</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMi0yLTEtMS0xNzc0OTk_091eca68-f07f-4fe0-a90b-3f68f631a844" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" unitref="usd">39</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMi00LTEtMS0xNzc0OTk_362ff2d5-588c-42b3-a900-cb22afeee530" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" unitref="usd">136</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMy0yLTEtMS0xNzc0OTk_07e1ca65-b3ae-4ef6-8bce-3c29e35a3a5c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" unitref="usd">15</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfMy00LTEtMS0xNzc0OTk_2faf7b63-4d03-4a41-802e-dbb294e0c1a9" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" unitref="usd">120</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNC0yLTEtMS0xNzc0OTk_bf740e58-6b81-49f4-b581-f6d396af5476" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNC00LTEtMS0xNzc0OTk_46560f1a-b5ff-4dab-bb1e-b10576c7bd9c" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" unitref="usd">121</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNS0yLTEtMS0xNzc0OTk_bab1aef1-9556-4611-a27a-fab1f3a28001" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" unitref="usd">16</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNS00LTEtMS0xNzc0OTk_fcefe88e-adb4-45e9-9835-9c64e3e5e37d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" unitref="usd">101</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNi0yLTEtMS0xNzc0OTk_3c09bb38-3963-415a-894b-a60d3288b9cf" name="mrna:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="6" unitref="usd">51</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNi00LTEtMS0xNzc0OTk_43a2b110-ee31-4821-9f38-6dd8e1ba3ed1" name="mrna:FinanceLeaseLiabilityToBePaidAfterYearFour" scale="6" unitref="usd">1,111</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNy0yLTEtMS0xNzc0OTk_2ca7bd55-17c4-45dc-ae6b-87ca2964e5fa" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" unitref="usd">148</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfNy00LTEtMS0xNzc0OTk_21304483-07d9-4dd4-a527-85a583e552d0" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" unitref="usd">1,742</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfOC0yLTEtMS0xNzc0OTk_9982399f-2e3b-4c68-8e68-d0b14993bde4" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" unitref="usd">33</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfOC00LTEtMS0xNzc0OTk_88dd0bb7-691e-4cd4-b34b-13ba1d94d203" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" unitref="usd">596</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfOS0yLTEtMS0xNzc0OTk_659465f8-b243-4ec0-a611-9b10f929a48c" name="us-gaap:OperatingLeaseLiability" scale="6" unitref="usd">115</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RhYmxlOjEzZmZlMmUxNjFhZTQwMTVhNDVkMTI4ZTRiMjg3ZGU5L3RhYmxlcmFuZ2U6MTNmZmUyZTE2MWFlNDAxNWE0NWQxMjhlNGIyODdkZTlfOS00LTEtMS0xNzc0OTk_adb9357f-565f-4861-8a2d-4951e8dd5834" name="us-gaap:FinanceLeaseLiability" scale="6" unitref="usd">1,146</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes certain optional lease term extensions, predominantly related to the MTC leases, which represent a total of $<ix:nonfraction contextref="i3dca3fd0c2004511b3bfe06f5a8967f0_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV83OS9mcmFnOmU3MzAxZmM2M2FlNzQzY2U5MjBhZmU2Yjg3OWU1NDhiL3RleHRyZWdpb246ZTczMDFmYzYzYWU3NDNjZTkyMGFmZTZiODc5ZTU0OGJfMzEzNg_432bfb35-7d98-4542-97d2-b6708809c3e2" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" unitref="usd">662</ix:nonfraction> million of undiscounted future lease payments.</span></div></ix:nonnumeric></ix:nonnumeric></ix:continuation></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i0c2009d581cc441284d0dc1c9b8046cc" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjMzNQ_b92398c4-2da6-48c6-a2bf-393ba4086162" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock">Commitments and Contingencies </ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="ide1b52c41adb49afa0845adf0afd3d8c" id="i0c2009d581cc441284d0dc1c9b8046cc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various claims and legal proceedings of a nature considered ordinary course in our business. The outcome of any such proceedings, regardless of the merits, is inherently uncertain; therefore, assessing the likelihood of loss and any estimated damages is difficult and subject to considerable judgment. We are not currently a party to any legal proceedings for which a material loss is probable, or for which a loss is reasonably estimable at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law, we indemnify our officers, directors, and employees for certain events, occurrences while the officer, or director is, or was, serving at our request in such capacity. The term of the indemnification is for the officer&#8217;s or director&#8217;s lifetime.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have standard indemnification arrangements in our leases for laboratory and office space that require us to indemnify the landlord against any liability for injury, loss, accident, or damage from any claims, actions, proceedings, or costs resulting from certain acts, breaches, violations, or non-performance under our leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into indemnification provisions under our agreements with counterparties in the ordinary course of business, typically with business partners, contractors, clinical sites and customers. Under these provisions, we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the three and nine months ended September 30, 2022 and the year ended December 31, 2021, we had not experienced any material losses related to these indemnification obligations, and no material claims were outstanding. We do not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.<br/></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><ix:continuation id="ide1b52c41adb49afa0845adf0afd3d8c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Purchase Orders<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements in the normal course of business with vendors and contract manufacturing organizations for raw materials and manufacturing services and with vendors for preclinical research studies, clinical trials and other goods or services. As of September 30, 2022, we had $<ix:nonfraction contextref="iceb89e8ede0444089b3fb792fd5ca92d_I20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfMjQ2OQ_c319c81c-4434-4e47-950f-9487f68ea803" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="9" unitref="usd">3.0</ix:nonfraction> billion of non-cancelable purchase commitments related to raw materials and manufacturing agreements, which are expected to be paid through 2026. As of September 30, 2022, $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfMjYxOA_57329163-8b28-4f59-80de-2e6dcb298f27" name="mrna:LegalContingencyFutureFirmPurchaseCommitments" scale="6" unitref="usd">349</ix:nonfraction>&#160;million of the purchase commitments related to raw materials was recorded as an accrued liability for loss on future firm purchase commitments. As of September 30, 2022, we had $<ix:nonfraction contextref="i10a322f1992648f9a9860e7d4c522085_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfMjc3NA_61557ace-f002-47a9-a71a-b68114f63743" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="6" unitref="usd">178</ix:nonfraction> million o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f non-c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ancelable purchase commitments related to clinical services and other goods and services which are expected to be paid through 2026. These amounts represent our minimum contractual obligations, including termination fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to purchase commitments, we have agreements with third parties for various goods and services, including services related to clinical operations and support and contract manufacturing, for which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments to vendors, mainly, to reimburse them for their unrecoverable outlays incurred prior to cancellation. At September 30, 2022, we had cancelable open purchase orders of $<ix:nonfraction contextref="i39ed47b05fcd467eaf9b0123e9bd76c9_I20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfMzY1OQ_a7ecad01-ca04-48cf-96eb-c98cbbaca306" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="9" unitref="usd">2.9</ix:nonfraction>&#160;billion in total under such agreements for our significant clinical operations and support and contract manufacturing. These amounts represent only our estimate of those items for which we had a contractual commitment to pay at September 30, 2022, assuming we would not cancel these agreements. The actual amounts we pay in the future to the vendors under such agreements may differ from the purchase order amounts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><br/>Licenses to Patented Technology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2017, we entered into sublicense agreements with Cellscript, LLC and its affiliate, mRNA RiboTherapeutics, Inc., to sublicense certain patent rights. Pursuant to each agreement, we are required to pay certain license fees, annual maintenance fees, minimum royalties on future net sales and milestone payments contingent on achievement of certain development, regulatory and commercial milestones for specified products, on a product-by-product basis. Commercial milestone payments and royalties based on annual net sales of licensed products for therapeutic and prophylactic products are accounted for as additional expense of the related product sales in the period in which the corresponding sales occur. For the three and nine months ended September 30, 2022, we recognized $<ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNDg0OQ_717746ed-9155-4151-aabd-f3f4b1e4cc94" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" unitref="usd">106</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNDg1Ng_60e6e779-42e9-463e-bbbc-04aae61cd767" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" unitref="usd">470</ix:nonfraction>&#160;million, respectively, of royalty expenses associated with our product sales, which was recorded to cost of sales in our condensed consolidated statements of income. For the three and nine months ended September 30, 2021, we recognized $<ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNTA1OQ_e568b310-e73a-483a-a1b8-428effa59b04" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" unitref="usd">168</ix:nonfraction>&#160;million and $<ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNTA2Ng_ae8d9382-f8fc-4737-9889-4eae74527fdd" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" unitref="usd">400</ix:nonfraction>&#160;million, respectively, of royalty expenses associated with our product sales, which was recorded to cost of sales in our condensed consolidated statements of income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have other in-license agreements with third parties which require us to make future development, regulatory and commercial milestone payments and sales-based royalties for specified products associated with the agreements. The achievement of these milestones was not deemed probable as of September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Moderna Science Center</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we announced an investment in the MSC in Cambridge, Massachusetts. The MSC is expected to integrate scientific and non-scientific spaces, including our principal executive offices and will be built to support our growth as we continue to advance our pipeline of mRNA medicines. In relation to the investment, we entered into a lease agreement for approximately <ix:nonfraction contextref="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930" decimals="-3" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNTk0NA_81a8b07a-a591-4827-8217-d36ce5816b49" name="us-gaap:AreaOfRealEstateProperty" scale="0" unitref="sqft">462,000</ix:nonfraction> square feet and will undergo an approximately <ix:nonnumeric contextref="i4203b6020dbe48ea939f42b58051c22d_D20220101-20220930" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjMzMQ_a36c38b1-cbc5-4131-a912-0f491b81cc13" name="mrna:LesseeOperatingLeaseLeaseAgreementForBuildingProjectTerm">two-year</ix:nonnumeric> building project. Following the building project, the lease term is <ix:nonnumeric contextref="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjA2OQ_1f4fdec9-75ed-4d8f-a830-ff0f1bb94464" name="us-gaap:LesseeOperatingLeaseTermOfContract">15</ix:nonnumeric> years, subject to our right to extend the lease for up to <ix:nonfraction contextref="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930" decimals="INF" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjEyNA_76a2ae2b-962f-4425-aa94-76c2f8161ec2" name="mrna:LesseeOperatingLeaseNumberOfExtensionPeriods" scale="0" unitref="numberofoption">two</ix:nonfraction> additional <ix:nonnumeric contextref="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjMyOQ_8f039dc6-8efc-4974-97eb-969757ce5f69" name="us-gaap:LesseeOperatingLeaseRenewalTerm">seven-year</ix:nonnumeric> terms. Pursuant to this lease agreement, we are committed to approximately $<ix:nonfraction contextref="i0b07fae30ed248b294e2bbcbcd74dabb_I20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV84NS9mcmFnOjRkYWY4NTg4ZTM5ZDRhNjg5YTE4YTlkYzUzMTNiMzgxL3RleHRyZWdpb246NGRhZjg1ODhlMzlkNGE2ODlhMThhOWRjNTMxM2IzODFfNjIyMQ_47624d12-e9f7-408c-86bb-3433b6e73785" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="9" unitref="usd">1.1</ix:nonfraction>&#160;billion non-cancellable rent payments for the initial lease term. We expect to begin the move-in process in 2023.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="ia308640a3e834cf08a73a7560b591ae6" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTg2MQ_14c8dfbf-e554-4d31-92bf-52c40242849a" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Stock-Based Compensation and Share Repurchase Programs</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="i6c7fadf636d4479a94451e5e044e1e28" id="ia308640a3e834cf08a73a7560b591ae6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTg2Mw_709e4550-8f6f-4ade-9d78-6fd9a7e61136" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021 as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id8fa3b2d98bc44b9a82aa71312d2b496_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMi0yLTEtMS0xNzc0OTk_43ed17bd-ea34-409d-ab5c-83878d39fda2" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">15</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i191ff6caafcd49b2903f1d4ddbc910b5_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMi00LTEtMS0xNzc0OTk_de548609-6ce8-48e2-9911-c096cfa35a02" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">27</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ibf76cb4302514bb493b0549b76dcef1b_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMi02LTEtMS0xNzc0OTk_343a6429-f527-49f0-a6e7-b71be022e9c1" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">67</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i4cecb9f9dcc64a3aa0f1eb99a85234a5_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMi04LTEtMS0xNzc0OTk_7070b451-508b-4ac9-9373-e5c1a76ca01c" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">73</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Common Stock (RSUs) and Performance Stock Units (PSUs)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i78f48f5fe86643c6a210a22022cc43f0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMy0yLTEtMS0xNzc0OTk_57d96a24-c95e-4605-9380-72ab2e87f9ae" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">54</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i0ab25603f7f74bdebdb3b89605b422d6_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMy00LTEtMS0xNzc0OTk_cc9abb79-2b9d-429b-9f84-47330d615622" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">12</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i90af8c6a89d3424d9989a349abbb333e_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMy02LTEtMS0xNzc0OTk_a5ab49bb-f7d5-4dd0-955e-64218d2bb4b8" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">93</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="icbe31b20b39343f9b19288e929bb95f2_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMy04LTEtMS0xNzc0OTk_3ca46ea6-b103-49ec-ab21-a2a6e8148518" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">29</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan (ESPP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iac54e32b74be443ca002d7bb49be1581_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNC0yLTEtMS0xNzc0OTk_51741549-4e5d-48d1-a0ed-bc66ea6e917a" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i31b2a25af5094b4eaf70ab5cdbfcb903_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNC00LTEtMS0xNzc0OTk_0f526f67-08bb-4cc3-b966-ac8292d7c01c" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i794309fb1add48838369d48aeda44c68_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNC02LTEtMS0xNzc0OTk_581c4733-7cab-4420-b98c-5cc74057e6e7" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ifc12427415fa44f98b4f35dc38d10980_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNC04LTEtMS0xNzc0OTk_2bed923a-e4c3-4404-8419-34c99f4a28bf" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNS0yLTEtMS0xNzc0OTk_fda39540-b91d-4ed8-818a-d507c5ad8592" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">70</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNS00LTEtMS0xNzc0OTk_26d4a241-1d6e-4566-8f2c-da22ad26184d" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNS02LTEtMS0xNzc0OTk_de9d45f4-33fd-4d99-9a71-9eade9f00c3a" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">164</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNS04LTEtMS0xNzc0OTk_6fbe221d-4edf-4f72-851b-6c5609e7dd90" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">105</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3262345fa3994caeb03b2670e86e8c4e_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNy0yLTEtMS0xNzc0OTk_56c18ac0-862c-49fd-ab0d-175e6e0cf1eb" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">10</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i7e5a263cbd404a9b88fdb681a681367d_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNy00LTEtMS0xNzc0OTk_a5d9c361-63c1-48df-b8e2-62221cca9f0e" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">1</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ib7a0725d470544d8b7325ffc65f6b837_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNy02LTEtMS0xNzc0OTk_174929c5-3a5a-4fe6-8117-07dd1a131ec5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">31</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i869e9d23c84e447aad9d284fd5e3410d_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfNy04LTEtMS0xNzc0OTk_c04365cd-4928-47b6-ad0f-ef8f85206f48" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">13</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i42b23a44541740f8a33ee413a8126998_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOC0yLTEtMS0xNzc0OTk_25aad69d-dc87-4797-9239-05d5b1fb96bc" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">28</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i1ed7a877238e481284ef8ca19e289cd5_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOC00LTEtMS0xNzc0OTk_b7d12c62-26db-4b00-90e9-0ddebc721074" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">25</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i659b1956b33b4a1c92e71a7838047793_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOC02LTEtMS0xNzc0OTk_86ae87e7-ef6d-4201-95cb-1f7f2665d787" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">67</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i9f34a708873644a38a02797354e9510b_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOC04LTEtMS0xNzc0OTk_6a291568-0c57-40a1-9d45-198f4d283ce5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">54</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i878b2dbb3a0c4281817703e5c75899ac_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOS0yLTEtMS0xNzc0OTk_33dfa386-a32f-43e5-b3d6-6398fe0aa20f" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">32</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="if3e5425a2fa645a280b170ae2cd3673a_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOS00LTEtMS0xNzc0OTk_31084743-e8b7-4fb0-adea-b20b07fd18b2" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">14</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="iea3628e168b0408eb5140b455599ba81_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOS02LTEtMS0xNzc0OTk_8c1d2853-2679-48cc-b193-d917765b4e1c" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">66</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i3f4a07a427024cdf83b4e9bb14b5d198_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfOS04LTEtMS0xNzc0OTk_ca5bf7a5-2c66-41a1-9abb-c1c2a52301d7" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">38</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMTAtMi0xLTEtMTc3NDk5_e9610f5d-ac11-4f05-aede-a1f5bbdc6a4a" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">70</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMTAtNC0xLTEtMTc3NDk5_b9b4ea24-bbca-4779-95df-a75739b9fcc3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">40</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMTAtNi0xLTEtMTc3NDk5_fc66c655-6625-489d-9e63-68800a925736" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">164</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RhYmxlOjUxZGY4NzE0NTE5ZTQxYzE4ZjE5MzVmYjNkOWJiM2U5L3RhYmxlcmFuZ2U6NTFkZjg3MTQ1MTllNDFjMThmMTkzNWZiM2Q5YmIzZTlfMTAtOC0xLTEtMTc3NDk5_3ac7ffca-0fba-407e-826c-0dbaec45443a" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitref="usd">105</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, there was $<ix:nonfraction contextref="i7713f51c155d41bd94ee6586b1354a57_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMjc0_0bcac8e3-6cc6-4556-b2f0-f3695ad56b6f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitref="usd">529</ix:nonfraction>&#160;million of total unrecognized compensation cost related to unvested stock-based compensation with respect to options, RSUs and PSUs granted. That cost is expected to be recognized over a weighted-average period of <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfNDgz_fc8c3b51-1dc6-4dfe-99c3-95772d264913" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">3.0</ix:nonnumeric> years at September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Programs </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, our Board of Directors authorized a share repurchase program (2021 Repurchase Program) of our common stock. Pursuant to the 2021 Repurchase Program, we were authorized to repurchase up to $<ix:nonfraction contextref="iebf7f7b6db364d9099d104a33951e9ac_I20210802" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfNzI5_d4db0214-a4d2-47a8-8130-d0dfdc9b65db" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">1.0</ix:nonfraction>&#160;billion of our outstanding common stock, with an expiration date no later than August 2, 2023. By the end of January 2022, we had repurchased the entire $<ix:nonfraction contextref="iebf7f7b6db364d9099d104a33951e9ac_I20210802" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfODc3_d4db0214-a4d2-47a8-8130-d0dfdc9b65db" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">1.0</ix:nonfraction>&#160;billion of common stock that was authorized under the 2021 Repurchase Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2022, our Board of Directors authorized an additional share repurchase program of our common stock, with no expiration date, for up to $<ix:nonfraction contextref="ie6636b09b2dc4b208d5fc43d0e99eaf1_I20220222" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfNTQ5NzU1ODE2MTc2_88b0d2a5-5f46-4c19-be43-4403f2ddf4a9" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">3.0</ix:nonfraction>&#160;billion. On August 1, 2022, our Board of Directors authorized an increase of $<ix:nonfraction contextref="i2c0f687a00734672a85b3a4e7b078175_I20220801" decimals="INF" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfNTQ5NzU1ODE2MTc5_af897903-f2c6-4b5a-b0e1-380f40c570ff" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" unitref="usd">3.0</ix:nonfraction>&#160;billion under the repurchase program for our common stock, with no expiration date (collectively with the February 22, 2022 authorization, the 2022 Repurchase Programs). The timing and actual number of shares repurchased under the 2022 Repurchase Programs will depend on a variety of factors, including price, general business and market conditions, and other investment opportunities, and shares may be repurchased through open market purchases through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c7fadf636d4479a94451e5e044e1e28">During the nine months ended September 30, 2022, we repurchased <ix:nonfraction contextref="ic942cbc2fa484a0cbf8eb0e80bc009e4_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTYxMw_977224c7-e802-417f-9496-fd132f2f2f9c" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" unitref="shares"><ix:nonfraction contextref="id129f6cc36ce41478c928857e7a58190_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTYxMw_c780e735-1d38-48f5-9b1e-917faa987c03" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" unitref="shares">20</ix:nonfraction></ix:nonfraction>&#160;million shares of our common stock under the 2021 and 2022 Repurchase Programs for an aggregate of $<ix:nonfraction contextref="ic942cbc2fa484a0cbf8eb0e80bc009e4_D20220101-20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTcwNg_29a97a69-67cf-4316-a3c7-4a955bd25766" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="9" unitref="usd"><ix:nonfraction contextref="id129f6cc36ce41478c928857e7a58190_D20220101-20220930" decimals="-8" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTcwNg_35ff9b8f-b952-4a92-8246-b52fa03b0a30" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="9" unitref="usd">2.9</ix:nonfraction></ix:nonfraction>&#160;billion, including commissions and fees. As of September 30, 2022, there was a total of $<ix:nonfraction contextref="i7f7271a4a08e4cbe89d4f17b81188469_I20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85MS9mcmFnOjlhZmFlNTExNmVkNzQ3NGM4NWZmMTk3NjQwZTRjOTc2L3RleHRyZWdpb246OWFmYWU1MTE2ZWQ3NDc0Yzg1ZmYxOTc2NDBlNGM5NzZfMTc3Mw_973e9bea-31d0-4782-af74-27b556450157" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" unitref="usd">3.2</ix:nonfraction>&#160;billion remaining for repurchases of our common stock under the 2022 Repurchase Programs.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i7260dfcce9dd4536a3d1b8b222f492af" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RleHRyZWdpb246YzkyMzVkZjMxNzE3NDA5MmJlOTY5MWJkOGNhZTQ3OTRfMTM2Mw_32c02888-82fb-4a86-a9f7-b9e5cdd2240f" name="us-gaap:IncomeTaxDisclosureTextBlock">Income Taxes</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation continuedat="i40a462b03c1142769b28f2dbe533e9d4" id="i7260dfcce9dd4536a3d1b8b222f492af"><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RleHRyZWdpb246YzkyMzVkZjMxNzE3NDA5MmJlOTY5MWJkOGNhZTQ3OTRfMTM2Mg_73230088-a120-4286-ac69-ca988e4067d0" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our income tax expense for the periods presented (in millions, except for percentages): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMi0yLTEtMS0xNzc0OTk_e53f3e5f-5ca7-42ca-8c73-424bfea7d5a2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">1,217</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMi00LTEtMS0xNzc0OTk_fb968b6f-fc67-4162-9f41-af28e3743a89" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">3,552</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMi02LTEtMS0xNzc0OTk_61c21b06-44f5-4e2b-8866-abc1404580ce" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">7,920</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMi04LTEtMS0xNzc0OTk_4d04bd45-90a4-447c-ac4c-96c2c0669871" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" unitref="usd">7,875</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMy0yLTEtMS0xNzc0OTk_865c8606-6c9f-414c-a4ea-2c6b3b9b2ab2" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">174</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMy00LTEtMS0xNzc0OTk_c18f34f5-554b-4cdf-a23d-91891f0df133" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">219</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMy02LTEtMS0xNzc0OTk_59f1c59f-e47e-47a8-9fb2-14c9df9c511b" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">1,023</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfMy04LTEtMS0xNzc0OTk_532d0375-9302-4252-be88-ec7e1b674f35" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" unitref="usd">541</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfNC0yLTEtMS0xNzc0OTk_709455c6-0f9e-4bd8-830b-fb27c92fed2e" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitref="number">14.3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfNC00LTEtMS0xNzc0OTk_bab34efb-73d3-4c23-8094-4efc92cf0311" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitref="number">6.2</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfNC02LTEtMS0xNzc0OTk_35b81bbe-1c47-4474-901d-6ea369738fb5" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitref="number">12.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV85NC9mcmFnOmM5MjM1ZGYzMTcxNzQwOTJiZTk2OTFiZDhjYWU0Nzk0L3RhYmxlOjQ4YTRiMzM4NTdlZTQ1NjRhYzljYjhmZGJlNDZhM2U2L3RhYmxlcmFuZ2U6NDhhNGIzMzg1N2VlNDU2NGFjOWNiOGZkYmU0NmEzZTZfNC04LTEtMS0xNzc0OTk_e83ccb97-49fa-4886-b07c-15c805e0d4ba" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitref="number">6.9</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonnumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three and nine months ended September 30, 2022 was lower than the U.S. statutory tax rate, primarily due to the benefit of the foreign derived intangible income deduction (FDII) and a discrete item for excess tax benefits related to stock-based compensation. The increased effective tax rate for the three and nine months ended September 30, 2022, compared to the same periods in 2021, was mainly due to the tax benefit recorded in 2021 related to the release of the valuation allowance on the majority of our deferred tax assets and a decrease in excess windfall benefits from stock-based compensation, partially offset by an increase in the FDII benefit in 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file U.S. federal income tax returns and income tax returns in various state, local and foreign jurisdictions. We are not currently subject to any tax assessment from an income tax examination in the United States or any other major taxing jurisdiction.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i40a462b03c1142769b28f2dbe533e9d4">Effective January 1, 2022, research and development expenses are required to be capitalized and amortized for U.S. tax purposes. Unless modified or repealed, and based on current assumptions, the mandatory capitalization increases our cash tax liabilities, but also increases our FDII deduction resulting in a decrease to our effective tax rate.</ix:continuation> </span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" continuedat="i129d180cc6664a679d0b7d19cae218ee" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90ZXh0cmVnaW9uOjI0MWEwZWNhNGEzMzQ2ZmU5MGM2YWM5YzAwMTM5NGUyXzQ4OQ_adcebcca-bd73-47c1-987b-756ce702703d" name="us-gaap:EarningsPerShareTextBlock">Earnings per Share</ix:nonnumeric></span></div><div><span><br/></span></div><ix:continuation id="i129d180cc6664a679d0b7d19cae218ee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computation of basic earnings per share (EPS) is based on the weighted-average number of our common shares outstanding. The computation of diluted EPS is based on the weighted-average number of our common shares outstanding and potential dilutive common shares during the period as determined by using the treasury stock method.</span></div><div><span><br/></span></div><ix:nonnumeric contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" escape="true" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90ZXh0cmVnaW9uOjI0MWEwZWNhNGEzMzQ2ZmU5MGM2YWM5YzAwMTM5NGUyXzQ5Mg_4bb6bfeb-e23e-46ff-a542-331c3e84f8c2" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted EPS for the three and nine months ended September 30, 2022 and 2021 were calculated as follows (in millions, except per share data):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzMtMi0xLTEtMTc3NDk5_e12763cf-cd74-4c21-b02e-d2ac0e498692" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">1,043</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzMtNC0xLTEtMTc3NDk5_d204334d-378a-4266-9ad5-9f580dfaa34c" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">3,333</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzMtNi0xLTEtMTc3NDk5_4a7c7674-9751-4279-b2f0-ab28d94c4223" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">6,897</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzMtOC0xLTEtMTc3NDk5_89346912-de70-4747-aade-cb4fb179dcc5" name="us-gaap:NetIncomeLoss" scale="6" unitref="usd">7,334</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;text-indent:-18pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzUtMi0xLTEtMTc3NDk5_6a8a19c7-bc0c-4d30-a30d-2a0bbbf7de3c" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">390</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzUtNC0xLTEtMTc3NDk5_67a2ba7c-ad96-40a6-af74-9f50f2d3ef0e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">404</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzUtNi0xLTEtMTc3NDk5_b8c4587d-ddf4-4fa3-92e3-23c69b830969" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">396</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzUtOC0xLTEtMTc3NDk5_ce1168df-ab7d-41a4-b4b8-73bab7b075d3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" unitref="shares">402</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzYtMi0xLTEtMTc3NDk5_345141f7-a9e0-41cf-9a0b-de60a02eaaa6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" unitref="shares"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzYtMi0xLTEtMTc3NDk5_b2734c31-f22d-4a34-be16-71517c042182" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" unitref="shares">22</ix:nonfraction></ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzYtNC0xLTEtMTc3NDk5_d3002b3c-2a3e-4417-add1-2272153fc8f9" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" unitref="shares">30</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzYtNi0xLTEtMTc3NDk5_a8f03cc2-3fdf-4e6b-a2c7-75e296ae3bca" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" unitref="shares">23</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzYtOC0xLTEtMTc3NDk5_de72dd8e-4972-4285-a1bd-0c51f889718b" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" unitref="shares">29</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzctMi0xLTEtMTc3NDk5_9745fe56-9e23-459c-94d8-f7d3ea452fd0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">412</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzctNC0xLTEtMTc3NDk5_f10edbbc-172f-437a-bf59-03a28a7fa263" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">434</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzctNi0xLTEtMTc3NDk5_ae0de844-ebab-44cf-8c27-de8634725097" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">419</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzctOC0xLTEtMTc3NDk5_8fbc2419-7ecc-4116-91c1-60a384be25f4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" unitref="shares">431</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzktMi0xLTEtMTc3NDk5_379f94a2-f41c-4403-84c4-9a770a0be31c" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">2.67</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzktNC0xLTEtMTc3NDk5_c814eb09-e4c4-4bd2-862c-aef0867b053a" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">8.27</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzktNi0xLTEtMTc3NDk5_b9376681-ed36-4544-864e-c6d57f92d05d" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">17.41</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzktOC0xLTEtMTc3NDk5_1c571f6f-da8f-401f-a1f9-7ef633851685" name="us-gaap:EarningsPerShareBasic" scale="0" unitref="usdPerShare">18.25</ix:nonfraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEwLTItMS0xLTE3NzQ5OQ_16184722-b5e7-4569-822a-c526f2cce328" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">2.53</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEwLTQtMS0xLTE3NzQ5OQ_9c75e37f-6afb-4d3c-ad4b-3804d745e1cf" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">7.70</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEwLTYtMS0xLTE3NzQ5OQ_5b1d53cc-df8b-497b-b854-cdaa4ece4f37" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">16.46</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEwLTgtMS0xLTE3NzQ5OQ_5fa04c66-78de-4416-b1de-5d69db7830a6" name="us-gaap:EarningsPerShareDiluted" scale="0" unitref="usdPerShare">17.00</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive potential common shares excluded from the EPS computation above </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i87683f05d1764b9ca9d7ca8d383208e0_D20220701-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEyLTItMS0xLTE3NzQ5OQ_ec6604ae-0e93-4669-94ff-0de690ee950b" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" unitref="shares">4</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="id31eeb4a59a3425891b9f6872d28e1ad_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEyLTQtMS0xLTE3NzQ5OQ_589dd0be-6a0a-476a-88e6-563009ee167b" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" unitref="shares">&#8212;</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="i59b47d9694194e9b8d272194eb633600_D20220101-20220930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEyLTYtMS0xLTE3NzQ5OQ_e58ce49f-145a-491e-b3f8-59a8a32055ac" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" unitref="shares">3</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction contextref="ica9bb09d598b41b6a2210a5241c104c9_D20210101-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjllNDdiYjlmMzg2ODQwNDE4Yjg3NDcwOTQ5MTJiYTk1L3NlYzo5ZTQ3YmI5ZjM4Njg0MDQxOGI4NzQ3MDk0OTEyYmE5NV8xMDAvZnJhZzoyNDFhMGVjYTRhMzM0NmZlOTBjNmFjOWMwMDEzOTRlMi90YWJsZTowYjQ1OWM1MTgyZTI0NjI5YTBlMTBjZGNmNzUyZTc5My90YWJsZXJhbmdlOjBiNDU5YzUxODJlMjQ2MjlhMGUxMGNkY2Y3NTJlNzkzXzEyLTgtMS0xLTE3NzQ5OQ_5c7e0700-cd62-4bbf-87ed-64c370480c54" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" unitref="shares">1</ix:nonfraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonnumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited financial information and related notes included in this Form 10-Q and our consolidated financial statements and related notes and other financial information in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the Securities and Exchange Commission (the SEC) on February 25, 2022 (the 2021 Form 10-K). Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in Part II, Item 1A - Risk Factors in this Form 10-Q, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines to improve the lives of patients. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune diseases and cardiovascular diseases, independently and with our strategic collaborators. Within our platform, we develop technologies that enable the development of mRNA medicines for diverse applications. When we identify technologies that we believe could enable a new group of potential mRNA medicines with shared product features, we call that group a &#8220;modality.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have created seven modalities to date:</span></div><div><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">prophylactic vaccines;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">systemic secreted and cell surface therapeutics;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">cancer vaccines;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">intratumoral immuno-oncology;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">localized regenerative therapeutics;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">systemic intracellular therapeutics; and</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">inhaled pulmonary therapeutics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the emergency use of the Moderna COVID-19 Vaccine (also referred to as mRNA-1273 and marketed under the brand name Spikevax) as a two-dose, 100 &#181;g primary series in individuals 18 years of age or older. In January 2022, we received full commercial approval for Spikevax as a two-dose, 100 &#181;g primary series to prevent COVID-19 in individuals 18 years of age and older in the United States. Spikevax is approved or authorized in individuals 18 years and older in more than 70 countries. In addition, Spikevax is authorized by the FDA and global regulators in more than 50 countries as a two-dose 100 &#181;g primary series in adolescents ages 12 to 17 years old and as a two-dose 50 &#181;g primary series in children ages 6 to 11 years old. Additionally, a two-dose, 25 &#181;g primary series of Spikevax is authorized in young children ages 6 months to 5 years old in the United States, Canada, Australia, and other jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, European Medicines Agency (EMA), Swissmedic and other health agencies around the world have authorized a booster dose of Spikevax at the 50 &#181;g dose level for adults ages 18 years and older. In March 2022, the FDA and other health agencies authorized a second booster dose at the 50 &#181;g dose level for adults 50 years and older and adults over 18 years of age with certain kinds of immunocompromise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2022, we received the first authorization for our BA.1 Omicron-targeting bivalent COVID-19 booster vaccine (Spikevax Bivalent Original/Omicron, mRNA-1273.214) from the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, given as a 50 &#181;g booster dose for individuals 18 years of age and older who have received either a primary series or an initial booster of any of the authorized or approved COVID-19 vaccines. The EMA in the European Union provided a similar authorization for mRNA-1273.214 as a booster vaccine for individuals 12 years and older on September 2, 2022. During the third quarter of 2022, authorizations for mRNA-1273.214 as a booster vaccine were also received in the United Kingdom, the European Union, Japan, Australia, Canada and Switzerland.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, we received an EUA from the FDA for our BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine (mRNA-1273.222), given as a 50 &#181;g booster dose for individuals 18 years of age and older who have received either a primary series or an initial booster of any of the authorized or approved COVID-19 vaccines. On October 12, 2022, we received an EUA from the FDA for mRNA-1273.222 as a 50 &#181;g booster dose for adolescents 12 to 17 years old and as a 25 &#181;g booster dose for children 6 to 11 years old, each following a completed primary series of any authorized COVID-19 vaccine or a previous booster. The EMA in the European Union, the MHRA in the United Kingdom and other countries worldwide have provided similar authorizations for mRNA-1273.222. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Highlights and Recent Developments </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Moderna COVID-19 Vaccine Clinical Studies</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Omicron-targeting bivalent boosters (mRNA-1273.214/.222):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have received authorization from regulatory agencies around the globe for two different Omicron-targeting bivalent booster vaccines against COVID-19, including in the United States, Australia, Canada, Europe, Japan, Switzerland, South Korea, Taiwan and the UK, with additional regulatory submissions completed worldwide.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mRNA-1273.214 is a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax. mRNA-1273.222 is a bivalent vaccine targeting the BA.4/BA.5 Omicron variants, combined with Spikevax. Both boosters are administered as a single dose of 50 &#181;g in individuals ages 12 and older, and as a single 25 &#181;g dose in pediatric populations, ages six to 11. mRNA-1273.214 is being studied to evaluate its immunogenicity, safety and reactogenicity as a single booster dose in adults aged 18 years and older. mRNA-1273.214 is being evaluated in an ongoing registrational, Phase 2/3 study in the U.S. and a Phase 3 study in the UK. A Phase 2/3 clinical trial for mRNA-1273.222 is fully enrolled and currently underway, with initial data expected later this year.<br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Based on clinical trial data from the Phase 2/3 trial, mRNA-1273.214 met all primary endpoints, including superior neutralizing antibody response against Omicron (BA.1) when compared to the currently authorized 50 &#181;g booster dose of Spikevax (mRNA-1273) in previously uninfected participants. A booster dose of mRNA-1273.214 increased neutralizing geometric mean titers (GMT) against Omicron approximately 8-fold above baseline levels. In addition, mRNA-1273.214 elicited higher neutralizing antibody titers against the Omicron subvariants BA.4 and BA.5 when compared to Spikevax (mRNA-1273) regardless of prior infection status or age, including in those aged 65 and older. mRNA-1273.214 was generally well tolerated, with a reactogenicity and safety profile consistent with the currently authorized booster. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the third quarter of 2022, we recognized product sales of $3.1 billion from sales of our COVID-19 vaccines, compared to $4.8 billion in the third quarter of 2021. </span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Key Updates for our Other Development Candidates </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Seasonal influenza (flu) (mRNA-1010):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As part of our influenza vaccine development strategy, we are developing five different influenza vaccines. mRNA-1010 is a single investigational vaccine consisting of four distinct mRNA sequences that encode the A H1N1, H3N2 and influenza B Yamagata and Victoria lineages in our proprietary LNP. mRNA-1011 and mRNA-1012 are investigational vaccines that will include the four WHO-recommended strains and aim to add additional hemagglutinin (HA) antigens (e.g. H3N2, H1N1). mRNA-1020 and mRNA-1030 are investigational vaccines that will aim to add neuraminidase (NA) antigens.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, an interim analysis of a Phase 2 study of mRNA-1010 identified no significant safety concerns, and the immunogenicity data is consistent with a potential for superiority to standard dose vaccine for influenza A strains (which drives the majority of disease in adults). The interim data is consistent with potential for non-inferiority to standard dose vaccine in influenza B strains (primarily a concern in pediatrics). A Phase 3 immunogenicity and safety study of mRNA-1010 in the Southern Hemisphere is fully enrolled with approximately 6,000 participants. Initial regulatory feedback supports an accelerated pathway for approval. We also launched a Phase 3 efficacy trial in the Northern Hemisphere, which is ongoing and expected to enroll approximately 23,000 participants. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Respiratory syncytial virus (RSV) vaccine (mRNA-1345):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mRNA-1345 is a vaccine against RSV encoding for a prefusion F glycoprotein, which elicits a superior neutralizing antibody response compared to the postfusion state. The Phase 1 study of mRNA-1345 to evaluate the tolerability, reactogenicity and immunogenicity of mRNA-1345 in younger adults, older adults, women of child-bearing age, older adults of Japanese descent and children is ongoing. All cohorts are fully enrolled. Phase 1 interim data from the older adult cohort showed that a single mRNA-1345 vaccination at 50 &#181;g, 100 &#181;g or 200 &#181;g boosted neutralizing antibody titers against RSV-A by approximately 14-fold and against RSV-B by approximately 10-fold. The pivotal global Phase 3 study of mRNA-1345 with approximately 37,000 participants is currently enrolling. The original 34,000 participants are fully enrolled; 3,000 additional participants were added to the study to assess additional symptoms. Additionally, a Phase 3 study to evaluate the safety, tolerability and immunogenicity of mRNA-1345, when given alone or co-administered with a seasonal influenza vaccine, in adults 50 years of age or older is fully enrolled. The FDA has granted Fast Track designation for mRNA-1345 in adults older than 60 years of age. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Respiratory combination vaccines (mRNA-1073, mRNA-1230 and mRNA-1045): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are evaluating several respiratory combination vaccines in the clinic. mRNA-1073 is a combination vaccine that encodes for the COVID spike protein and the influenza HA glycoproteins. A Phase 1/2 study comparing mRNA-1073 to co-administered mRNA-1010 and mRNA-1273, and to mRNA-1010 and mRNA-1273 alone is ongoing in approximately 1,050 participants aged 18-75 years, and the trial is fully enrolled. mRNA-1230 is a combination vaccine that encodes for the COVID spike protein, the influenza HA glycoproteins and the RSV prefusion F protein. mRNA-1045 is a combination vaccine that encodes for the influenza HA glycoproteins and the RSV prefusion F protein. A Phase 1/2 study comparing mRNA-1230 and mRNA-1045 to individual respiratory vaccines, mRNA-1010, mRNA-1345 and mRNA-1273.214 is ongoing.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Propionic acidemia (PA) (mRNA-3927):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Phase 1/2 clinical trial for mRNA-3927, our therapy for the treatment of propionic acidemia, or PA, is ongoing, and the second cohort is fully enrolled. We are enrolling other patients into additional cohorts. The Phase 1/2 study is designed to evaluate the safety and tolerability of mRNA-3927 in patients with PA. PA is a rare, life-threatening, inherited metabolic disorder due to a defect in the mitochondrial enzyme propionyl-CoA carboxylase (PCC). It primarily affects the pediatric population. In September 2022, we announced that several critical milestones have been reached in the trial. Over 120 repeated intravenous doses have been administered to ten patients. mRNA-3927 has been well-tolerated at the doses tested to date, and there have been no dose-limiting toxicities, discontinuations due to safety, or drug-related serious adverse safety events. Three of the ten study participants have been dosed with over one year of continuous treatment and all eligible participants have decided to continue with treatment by participating in the Open Label Extension Study. PA is characterized by recurrent life-threatening metabolic decompensation events (MDEs) which are clinical crises that occur when there is a build-up of toxic metabolites. Due to the objective and disease-defining nature of MDEs, regulators have provided initial support for MDE as a clinically meaningful, preferred primary clinical endpoint for development. Based on preliminary data, there was a decrease in the number of MDEs post-mRNA-3927 treatment. The trial will continue with testing the next dose level (0.6 mg/kg IV every two weeks). There is no approved therapy for PA, including no approved enzyme replacement therapy. We have received Rare Pediatric Disease Designation and Orphan Drug Designation from the FDA and Orphan Drug Designation from the European Commission for the PA program. The FDA has also granted Fast Track designation to mRNA-3927. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Methylmalonic acidemia (MMA) (mRNA-3705):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Phase 1/2 clinical trial for mRNA-3705, our therapy for the treatment of methylmalonic acidemia, or MMA, is ongoing and the second cohort has been fully enrolled. The study is enrolling additional cohorts across the UK, Canada and the U.S. The Phase 1/2 study is designed to evaluate the safety and tolerability of mRNA-3705 in patients with MMA. MMA is a rare, life-threatening, inherited metabolic disorder that is primarily caused by a defect in the mitochondrial enzyme methylmalonyl-coenzyme A mutase (MUT). It primarily affects the pediatric population. There is no approved therapy that addresses the underlying disorder, including no approved enzyme replacement therapy, due to the complexity of the protein and its mitochondrial localization. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Glycogen storage disease type 1a (GSD1a) (mRNA-3745): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 1/2 clinical trial for mRNA-3745, our therapy for the treatment of GSD1a is ongoing. Individuals with GSD1a have a deficiency in glucose-6-phosphatase resulting in pathological blood glucose imbalance. mRNA-3745 is an IV-administered mRNA encoding human G6Pase enzyme, designed to restore the deficient or defective intracellular enzyme activity in patients with GSD1a. In September 2022, we announced that early data on safety and pharmacodynamics for mRNA-3745 have been consistent and encouraging. In two patients, intravenous infusion of mRNA-3745 was well-tolerated to date, and showed extension of fast duration and normalization of glucose during fast. The FDA has granted mRNA-3745 Orphan Drug Designation.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">IL-12 (MEDI1191)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In August 2022, AstraZeneca notified us that it was terminating the development of the IL-12 program (MEDI1191) and that they were returning the rights to the program to us. AstraZeneca is continuing to lead the ongoing, open-label multicenter Phase 1 clinical trial of intratumoral injections of MEDI1191 alone and in combination with the checkpoint inhibitor, durvalumab. In April 2022, AstraZeneca presented updated Phase 1 data at the American Association for Cancer Research (AACR) conference. Intratumoral MEDI1191 combined with durvalumab was safe and the combination showed preliminary evidence of clinical benefit, with 29% of patients exhibiting partial responses or stable disease &#8805;12 weeks as best overall response. We are evaluating the next steps for the program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Personalized cancer vaccine (mRNA-4157): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our personalized cancer vaccine (PCV) is currently being evaluated in a Phase 1 and Phase 2 study. The randomized, placebo-controlled Phase 2 study investigating a 1 mg dose of mRNA-4157 in combination with Merck&#8217;s pembrolizumab (KEYTRUDA&#174;), compared to pembrolizumab alone, for the adjuvant treatment of high-risk resected melanoma is fully enrolled (n=150). The primary endpoint of the Phase 2 study is recurrence-free survival. The Phase 1 in multiple cohorts is ongoing. In September 2022, Merck exercised its option to jointly develop and commercialize mRNA-4157. We and Merck will share costs and any profits related to mRNA-4157 equally under our worldwide collaboration.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Pipeline</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart shows our current pipeline of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> development programs, grouped by respiratory vaccines, latent &amp; public health vaccines and therapeutics.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:center"><img alt="mrna-20220930_g2.jpg" src="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/mrna-20220930_g2.jpg" style="height:776px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Abbreviations: AZ, AstraZeneca; BARDA, Biomedical Advanced Research and Development Authority; CMV, Cytomegalovirus; DARPA, Defense Advanced Research Projects Agency; EBV, Epstein-Barr virus; HIV, human immunodeficiency virus; hMPV, human metapneumovirus; ILCM, Institute for Life Changing Medicines; IL-12, interleukin 12; IL-23, interleukin 23; IL-36&#947;, interleukin-36 gamma; NIH, National Institutes of Health; OX40L, wildtype OX40 ligand; RSV, respiratory syncytial virus; VEGF-A, vascular endothelial growth factor A.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed seven modalities, which are summarized as follows: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prophylactic vaccines:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our prophylactic vaccines modality currently includes 33 development programs, 26 of which have entered into clinical trials. We have ongoing Phase 1 trials for our RSV vaccine in pediatrics (mRNA-1345), flu vaccines (mRNA-1020 and mRNA-1030), combined COVID and flu vaccine (mRNA-1073), combined COVID, flu and RSV vaccine (mRNA-1230), combined flu and RSV vaccine (mRNA-1045), hMPV/PIV3 vaccine (mRNA-1653), EBV vaccine (mRNA-1189), HIV vaccines (mRNA-1644 and mRNA-1574) and Nipah vaccine (mRNA-1215). We have an ongoing Phase 2 study for our Zika vaccine (mRNA-1893). We have ongoing Phase 3 studies for our flu vaccine (mRNA-1010), RSV vaccine in older adults (mRNA-1345) and CMV vaccine (mRNA-1647). Our COVID-19 vaccine (mRNA-1273) is described in detail above. Our seven preclinical programs within our prophylactic vaccines modality are for a combined, pediatric RSV and hMPV vaccine (mRNA-1365), pan-HCoV vaccine (mRNA-1287), seasonal flu vaccines (mRNA-1011 and mRNA-1012), EBV vaccine to prevent long-term sequelae (mRNA-1195), VZV vaccine (mRNA-1468), and HSV vaccine (mRNA-1608). Three other vaccines as part of public health programs have had positive Phase 1 readouts &#8211; H10N8 vaccine (mRNA-1440), H7N9 flu vaccine (mRNA-1851), and Chikungunya vaccine (mRNA-1388) &#8211; but are not being further developed without government or other funding. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Systemic secreted and cell surface therapeutics: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two systemic secreted and cell surface therapeutics development candidates in our pipeline. Our secreted programs include Relaxin (mRNA-0184) for cardiac disorders and PD-L1 (mRNA-6981) for autoimmune hepatitis, which are currently in preclinical development. We previously announced positive data from our Chikungunya Antibody program (mRNA-1944) within this modality; however, we do not expect to advance our Chikungunya Antibody program without outside funding, and we are not currently pursuing further development of it at this time.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Cancer vaccines:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are currently developing three programs within our cancer vaccines modality. Our personalized cancer vaccine program (mRNA-4157) is being developed in collaboration with Merck and is in a multiple-arm Phase 1 trial and a randomized Phase 2 trial, which is fully enrolled. Our second program within this modality is a KRAS vaccine (mRNA-5671). We have retained all rights to our KRAS vaccine from Merck and we are evaluating next steps for the program. Our third program is our checkpoint vaccine (mRNA-4359), which has dosed the first patient in a Phase 1 clinical trial.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Intratumoral immuno-oncology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have two programs in this modality. Our first program, OX40L/IL-23/IL-36&#947; (Triplet) (mRNA-2752), is currently in a Phase 1 study that is designed as an open-label, multicenter study of intratumoral injections of Triplet (mRNA-2752) alone or in combination with durvalumab (anti-PD-L1). Our second program, IL-12 (MEDI1191), was developed in collaboration with AstraZeneca. In August 2022, AstraZeneca notified us that it was terminating the development of the IL-12 program (MEDI1191) and that they were returning the rights to the program to us. We are evaluating next steps for the program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Localized regenerative therapeutics:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our localized VEGF-A program, AZD8601, which was developed in collaboration with AstraZeneca, has completed a Phase 1a/b trial to describe its safety, tolerability, protein production, and activity in diabetic patients. The study has met its primary objectives of describing safety and tolerability and secondary objectives of demonstrating protein production and changes in blood flow post AZD8601 administration. We believe these data provide clinical proof of mechanism for our mRNA technology outside of the vaccine setting. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Phase 2 study met the primary endpoint of safety and tolerability of AZD8601 for the 3 mg dose. In the study of 11 patients, seven were treated with AZD8601 VEGF-A mRNA and four received placebo injections. Numerical trends were observed in endpoints in the heart failure efficacy domains compared with placebo, including increase in left ventricular ejection fraction (LVEF) and patient reported outcomes. In addition, all seven patients treated with AZD8601 had NT-proBNP (a biomarker that measures the level of a hormone that is elevated in patients with heart failure) levels below heart failure limit at 6 months follow-up compared to one of four patients treated with place</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bo. After a portfolio review, AstraZeneca has returned the rights to AZD8601 to us. We are evaluating next steps for the program.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Systemic intracellular therapeutics: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have six systemic intracellular therapeutics development candidates in our pipeline. Our intracellular programs address propionic acidemia, or PA (mRNA-3927), methylmalonic acidemia (MMA) (mRNA-3705), glycogen storage disorder type 1a (GSD1a) (mRNA-3745), ornithine transcarbamylase deficiency (OTC) (mRNA-3139), phenylketonuria (PKU) (mRNA-3283), and Crigler-Najjar Syndrome Type 1 (CN-1) (mRNA-3351). We have ongoing Phase 1 clinical trials for PA (mRNA-3927), MMA (mRNA-3705) and GSD1a (mRNA-3745). OTC (mRNA-3139), PKU (mRNA-3283) and CN-1 (mRNA-3351) are currently in preclinical development. We have entered into a collaboration agreement with the Institute for Life Changing Medicines (ILCM) to license mRNA-3351 to ILCM with no upfront fees, and without any downstream payments. ILCM will be responsible for the clinical development of mRNA-3351.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Inhaled pulmonary therapeutics:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have one inhaled pulmonary therapeutic development candidate in our pipeline. Our program addresses cystic fibrosis, or CF (VXc-522), in collaboration partnership with Vertex Pharmaceuticals. VXc-522 is an mRNA therapeutic designed to treat the underlying cause of CF by enabling cells in the lungs to produce functional cystic fibrosis transmembrane conductance regulator (CFTR) protein for the treatment of the 10% of patients who do not produce any CFTR protein. IND-enabling studies are underway and Vertex expects to submit an IND for this program in 2022. Moderna has licensed worldwide commercial rights to VXc-522 to Vertex.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue for the periods presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022, we recognized $3.1&#160;billion of product sales from our COVID-19 vaccines, of which $1.0&#160;billion was generated in the United States and $2.1&#160;billion was generated from Europe and the rest of the world. For the three months ended September 30, 2021, we recognized $4.8&#160;billion of product sales from our COVID-19 vaccines, of which $1.2&#160;billion was generated in the United States and $3.6&#160;billion was generated from Europe and the rest of the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, we recognized $13.6&#160;billion of product sales from our COVID-19 vaccines, of which $3.4&#160;billion was generated in the United States and $10.2&#160;billion was generated from Europe and the rest of the world. For the nine months ended September 30, 2021, we recognized $10.7&#160;billion of product sales from our COVID-19 vaccines, of which $4.6&#160;billion was generated in the United States and $6.1&#160;billion was generated from Europe and the rest of the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, we had deferred revenue of $4.1&#160;billion associated with customer deposits received or billable under supply agreements for delivery of our COVID-19 vaccines into 2023. We anticipate that product sales will be greater in the fourth quarter of 2022 than the third quarter of 2022, driven by the timing of marketing authorizations and release of our Omicron-targeting bivalent booster vaccines. Based upon currently signed supply agreements for delivery of our COVID-19 vaccines in 2022 and our supply chain forecast, we expect that our COVID-19 vaccine product sales will be slightly lower in the second half of 2022 than in the first half of 2022, in part due to deferrals of deliveries into the first quarter of 2023 that we originally expected to make in 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than product sales, our revenue has been primarily derived from government-sponsored and private organizations including BARDA, DARPA and the Gates Foundation and from strategic alliances with AstraZeneca, Merck and Vertex to discover, develop, and commercialize potential mRNA medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue was comprised as follows for the periods presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022, $135&#160;million of BARDA grant revenue was related to our mRNA-1273 program and $6&#160;million was related to our Zika vaccine program. For the nine months ended September 30, 2022, $430&#160;million of BARDA grant revenue was related to our mRNA-1273 program and $12&#160;million was related to our Zika vaccine program. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue from our strategic alliances was comprised as follows for the periods presented (in millions): </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, AstraZeneca elected to terminate our collaborations with them, effective on November 21, 2022. As a result of the termination, we recognized the remaining deferred revenue of $76&#160;million as collaboration revenue during the three months ended September 30, 2022. Please refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note </a><a href="#i9e47bb9f386840418b8747094912ba95_55" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the remaining available funding, net of revenue earned under our agreement with BARDA for the development of our mRNA-1273 vaccine was $67&#160;million. To the extent that existing or potential future products generate revenue, our revenue may vary due to many uncertainties in the future product demand, the development of our mRNA medicines and other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our employee and infrastructure resources for the advancement of our platform, and for discovering and developing programs. Due to the number of ongoing programs and our ability to use resources across several projects, indirect or shared operating costs incurred for our research and development programs are generally not recorded or maintained on a program- or modality-specific basis. The following table reflects our research and development expenses, including direct program-specific expenses summarized by modality and indirect or shared operating costs summarized under other research and development expenses during the three and nine months ended September 30, 2022 and 2021 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program expenses by modality:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prophylactic vaccines</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic secreted and cell surface therapeutics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer vaccines</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intratumoral immuno-oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic intracellular therapeutics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inhaled pulmonary therapeutics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total program-specific expenses by modality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other research and development expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discovery programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platform research</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical development and unallocated manufacturing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shared discovery and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Inhaled pulmonary therapeutics modality was added in the fourth quarter of 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a total of 44 and 34 development candidates at September 30, 2022 and 2021, respectively. Program-specific expenses include external costs and allocated manufacturing costs of pre-launch inventory, mRNA supply and consumables, and are reflected as of the beginning of the period in which the program was internally advanced to development or removed if development was ceased. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;modality&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> refers to a group of programs with common product features and the associated combination of enabling mRNA technologies, delivery technologies, and manufacturing processes. The program-specific expenses by modality summarized in the table above include expenses we directly attribute to our programs, which consist primarily of external costs, such as fees paid to outside consultants, central laboratories, investigative sites, and contract research organizations (CROs) in connection with our preclinical studies and clinical trials, contract manufacturing organizations, and allocated manufacturing costs of pre-launch inventory, mRNA supply and consumables. Costs to acquire and manufacture pre-launch inventory, mRNA supply for preclinical studies and clinical trials are recognized and included in unallocated manufacturing expenses when incurred, and subsequently allocated to program-specific manufacturing costs after completion of the program-specific production. The timing of allocating manufacturing costs to the specific program varies depending on the program development and production schedule. We generally do not allocate personnel-related costs, including stock-based compensation, costs associated with our general platform research, technical development, and other shared costs on a program-specific basis. These costs were therefore excluded from the summary of program-specific expenses by modality. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discovery program expenses are costs associated with research activities for our programs in the preclinical discovery stage, and primarily consist of external costs for CROs and lab services, and allocated manufacturing cost of preclinical mRNA supply and consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Platform research expenses are mainly costs to develop technical advances in mRNA science, delivery science, and manufacturing process design. These costs include personnel-related costs, computer equipment, facilities, preclinical mRNA supply and consumables, and other administrative costs to support our platform research. Technology development and unallocated manufacturing expenses are primarily related to non-program-specific manufacturing process development and manufacturing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shared discovery and development expenses are research and development costs such as personnel-related costs and other costs, which are not otherwise included in development programs, discovery programs, platform research, technical development and unallocated manufacturing expenses, stock-based compensation, and other expenses.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The largest component of our total operating expenses has historically been our investment in research and development activities, including preclinical and clinical development of our product candidates, development of our platform, mRNA technologies, and manufacturing technologies. As we continue to develop variant-specific and next-generation COVID-19 vaccine candidates, we expect to continue to incur significant additional expenses. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in expectations or outcomes of any of the known or unknown risks and uncertainties may materially impact our expected research and development expenditures. Continued research and development is central to the ongoing activities of our business. Investigational medicines in later stages of clinical development, such as our CMV vaccine, RSV vaccine, flu vaccine and our COVID-19 vaccines, generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect our research and development costs to continue to increase in the foreseeable future as our investigational medicines progress through the development phases and identify and develop additional programs. There are numerous factors associated with the successful commercialization of any of our investigational medicines, including future trial design and various regulatory requirements, many of which cannot be determined with accuracy at this time due to the early stage of development of our investigational medicines. Moreover, future commercial and regulatory factors beyond our control will impact our clinical development programs and plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies and significant judgments and estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during&#160;the three months ended September 30, 2022&#160;compared to those disclosed in our 2021 Form 10-K.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our condensed consolidated statements of income for each period presented (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,690)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,335)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,290)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)%</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,260&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,920&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,897&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue decreased by $1.6&#160;billion, or 32%, for the three months ended September 30, 2022, compared to the same period in 2021, mainly due to a decrease in product sales of our COVID-19 vaccines. Product revenue decreased by $1.7&#160;billion, or 35%, for the three months ended September 30, 2022, compared to the same period in 2021, primarily due to lower sales volume driven by the timing of marketing authorizations for our Omicron-targeting COVID-19 bivalent boosters and the related manufacturing ramp up. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $2.9 billion, or 26%, for the nine months ended September 30, 2022, compared to the same period in 2021, mainly due to an increase in product sales of our COVID-19 vaccines. Product revenue increased by $2.8 billion, or 26%, for the nine months ended September 30, 2022, compared to the same period in 2021, largely driven by a favorable customer mix and higher manufacturing capacity to fulfill customer demand for the first half of 2022 compared to early 2021. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the three months ended September 30, 2022 was $1.1&#160;billion, including third-party royalties of $106 million. Cost of sales for the three months ended September 30, 2022 increased by $378 million, or 52%, compared to the same period in 2021. Cost of sales as a percentage of product sales for the three months ended September 30, 2022 was 35%, compared to 15% for the same period in 2021. These increases were primarily attributable to write-downs for excess and obsolete inventory related to our COVID-19 vaccine, unutilized manufacturing capacity, and losses on firm purchase commitments of raw materials and related cancellation charges, driven by a shift in product demand to our Omicron-targeting COVID-19 bivalent boosters. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the nine months ended September 30, 2022 was $3.5&#160;billion, including third-party royalties of $470&#160;million. Cost of sales for the nine months ended September 30, 2022 increased by $1.8 billion, or 110%, compared to the same period in 2021. Cost of sales as a percentage of product sales for the nine months ended September 30, 2022 was 26%, compared to 16% for the same period in 2021. These increases were mainly due to write-downs for excess and obsolete inventory related to our COVID-19 vaccines, unutilized manufacturing capacity and losses on firm purchase commitments of raw materials, driven by a shift in product demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our manufacturing costs to increase as we move from a pandemic to a seasonal market environment for our COVID-19 vaccines.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that this shift will cause our cost of sales for the full year of 2022 to represent a higher percentage of our product sales than the percentage experienced in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $299 million, or 57%, for the three months ended September 30, 2022, compared to the same period in 2021. The increase was primarily attributable to increases in clinical trial expenses of $200 million and manufacturing costs for clinical trial materials of $49 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $741 million, or 55%, for the nine months ended September 30, 2022, compared to the same period in 2021. The increase was primarily attributable to increases in clinical trial expenses of $400 million, personnel-related costs of $110 million, manufacturing costs for clinical trial materials of $76 million, consulting and outside services of $74 million, and technology and facility-related costs of $42 million. These increases for the three and nine month periods in 2022 were largely driven by increased clinical development, particularly our COVID-19 vaccines, RSV, flu and CMV programs, and headcount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that research and development expenses will increase in 2022, as compared to 2021, as we continue to progress the development of variant-specific and next-generation COVID-19 vaccine candidates and continue to develop our pipeline and advance our product candidates into later-stage development, in particular those in ongoing Phase 3 studies: our RSV, flu and CMV vaccine programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by $110 million, or 65%, for the three months ended September 30, 2022, compared to the same period in 2021. The increase was mainly due to increases in consulting and outside services of $43 million and personnel-related costs of $28 million. These increases for the three month period in 2022 were primarily driven by our COVID-19 vaccine commercialization-related activities and increased headcount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by $391 million, or 107%, for the nine months ended September 30, 2022, compared to the same period in 2021. The increase was mainly due to increases in personnel-related costs of $86 million, consulting and outside services of $80 million, distributor fees of $44 million, marketing expenses of $41 million, and an endowment to the Moderna Charitable Foundation (the Foundation) of $50 million. These increases for the nine month period in 2022 were primarily driven by our COVID-19 vaccine commercialization-related activities, increased headcount, and the launch of the Foundation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that selling, general and administrative expenses will increase in 2022, as compared to 2021, as we continue to build out our global commercial, regulatory, sales and marketing infrastructure, and continue to expand the number of programs and our business operations.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased by $54 million for the three months ended September 30, 2022, compared to the same period in 2021. Interest income increased by $102 million for the nine months ended September 30, 2022, compared to the same period in 2021. The increases in interest income from our investments in marketable securities for the three and nine month periods in 2022 were mainly driven by an overall higher interest rate environment and increased investment balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other expense, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes other expense, net for each period presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net decreased by $3 million, or 30%, for the three months ended September 30, 2022, compared to the same period in 2021. Total other expense, net increased by $11 million, or 50%, for the nine months ended September 30, 2022, compared to the same period in 2021. The decrease in other expense, net for the three months ended September 30, 2022 was primarily due to a net gain related to our foreign currency balance sheet hedging activities, foreign currency transactions and remeasurements, partially offset by realized losses on available-for-sale debt securities and an increase in interest expense. The increase in other expense, net for the nine months ended September 30, 2022 was primarily due to realized losses on available-for-sale debt securities and an increase in interest expense, partially offset by a net gain related to our foreign currency balance sheet hedging activities, foreign currency transactions, and remeasurements. Our interest expense is primarily related to our finance leases. Please refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes decreased by $45 million, or 21%,  for the three months ended September 30, 2022, compared to the same period in 2021, primarily due to a decrease in pre-tax income, partially offset by a higher effective tax rate. Provision for income taxes increased by $482 million, or 89%, for the nine months ended September 30, 2022, compared to the same period in 2021, primarily due to a higher effective tax rate. The increase in effective tax rate for the three and nine months ended September 30, 2022 was mainly due to the tax benefit recorded in 2021 related to the release of the valuation allowance on the majority of our deferred tax assets and a decrease in excess windfall benefits from stock-based compensation, partially offset by an increase in foreign derived intangible income benefit in 2022. We expect that our effective tax rate will increase for the full year 2022 compared to 2021, mainly driven by the release of the valuation allowance on the majority of the deferred tax assets in 2021.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash, cash equivalents, investments and working capital for each period presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and investments are invested in accordance with our investment policy, primarily with a view to liquidity and capital preservation. Investments, consisting primarily of government and corporate debt securities, are stated at fair value. Cash, cash equivalents and investments as of September 30, 2022 decreased by $567 million, or 3%, compared to December 31, 2021. During the nine months ended September 30, 2022, we generated cash from operations of $3.3 billion, partially offset by repurchases of our common stock of $2.9 billion, unrealized losses on available-for-sale debt securities of $497 million, and purchases of property and equipment of $308 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital, which is current assets less current liabilities, as of September 30, 2022 increased by $547 million, or 8%, compared to December 31, 2021, primarily due to a decrease in short-term deferred revenue of $2.3 billion, mainly driven by revenue recognized from deferred revenue in excess of customer deposits received, and a decrease in income taxes payable of $810 million. This was partially offset by a decrease in cash, cash equivalents and short-term investments of $2.4 billion, primarily due to purchases of long-term marketable securities, repurchases of our common stock, and income tax payments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, we did not have any off-balance sheet arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the primary sources and uses of cash for each period presented (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,010)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,819)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive cash flows from operations primarily from cash collected from customer deposits and accounts receivable related to our COVID-19 vaccine supply agreements, as well as certain government-sponsored and private organizations and strategic alliances. Our cash flows from operating activities are significantly affected by our use of cash for operating expenses and working capital to support the business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the third quarter of 2020, we entered into supply agreements with the U.S. Government, other international governments, and Gavi for the supply of our COVID-19 vaccines and received upfront deposits. As of September 30, 2022, we had $4.1&#160;billion in deferred revenue related to customer deposits received or billable. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities for the nine months ended September 30, 2022 was $3.3 billion and consisted of net income of $6.9 billion and non-cash adjustments of $30 million, partially offset by a net change in assets and liabilities of $3.6 billion. Non-cash items primarily included deferred income taxes of $473 million, depreciation and amortization of $268 million, and stock-based compensation of $164 million. The net change in assets and liabilities was mainly due to a decrease in deferred revenue of $2.7 billion, a decrease in income taxes payable of $810 million, an increase in prepaid expenses and other assets of $669 million, and an increase in inventory of $636 million, partially offset by a decrease in accounts receivable of $480 million, an increase in accrued liabilities of $354 million, and an increase in other liabilities of $273 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities decreased by $7.0 billion, or 68%, during the nine months ended September 30, 2022, compared to the same period in 2021, primarily attributable to revenue recognized from deferred revenue in excess of customer deposits received and increased income tax payments, partially offset by higher collection of receivables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary investing activities consist of purchases, sales, and maturities of our investments and capital expenditures for leasehold improvements, manufacturing, laboratory, computer equipment and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the nine months ended September 30, 2022 was $4.1 billion, which primarily included purchases of marketable securities of $8.9 billion and purchases of property and equipment of $308 million, partially offset by proceeds from sales of marketable securities of $2.9 billion and proceeds from maturities of marketable securities of $2.2 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities decreased by $3.3 billion, or 44%, during the nine months ended September 30, 2022, compared to the same period in 2021, primarily reflecting timing differences related to purchases, sales, and maturities of marketable debt securities and changes in our investment portfolio mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities for the nine months ended September 30, 2022 was $3.0 billion, primarily due to repurchase of common stock of $2.9 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities increased by $3.0 billion during the nine months ended September 30, 2022, compared to the same period in 2021, mainly due to repurchase of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operation and funding requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of funding as of September 30, 2022 consisted of cash and cash equivalents, investments, and cash we expect to generate from operations. We generated net income of $12.2 billion for the year ended 2021, following the authorization of our first commercial product in December 2020. From our inception to the end of 2020, we incurred significant losses from operations due to our significant research and development expenses. We have retained earnings of $16.9 billion as of September 30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant future capital requirements including expected operating expenses to conduct research and development activities, operate our organization, meet capital expenditure needs, and fund our share repurchase programs (refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_91" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements). We expect our expenses to increase in connection with our ongoing activities, particularly as we continue research and development of our development candidates and clinical activities for our investigational medicines. We also expect our expenses to increase associated with manufacturing costs, including our arrangements with our international supply and manufacturing partners. Our ongoing work on our COVID-19 vaccines, including development of any new generations of boosters and vaccines against variants of SARS-CoV-2, and buildout of global commercial, regulatory, sales and marketing infrastructure will require significant cash outflows during 2022, most of which will not be reimbursed or otherwise paid for by our partners or collaborators. In addition, we have substantial facility, lease and purchase obligations (refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements). We have entered into certain collaboration and licensing agreements with third parties that include the funding of certain research and development activities and potential future milestone and royalty payments by us.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and investments as of September 30, 2022, together with cash expected to be generated from operations, will be sufficient to enable us to fund our projected operations, capital expenditures and stock repurchases through at least the next 12&#160;months from the issuance of these financial statements included in this Form 10-Q. We are subject to all the risks related to the development and commercialization of novel medicines, and we may encounter unforeseen expenses, difficulties, complications, delays, and other unknown factors, which may adversely affect our business. Our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we currently expect.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, other than disclosed within </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements, there have been no material changes to our contractual obligations and commitments from those described under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our 2021 Form 10-K.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_124"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our market risks, and the way we manage them, are summarized in Part II, Item 7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; of our 2021 Form 10-K. There have been no material changes to our market risk or to our management of such risks for the three and nine months ended September 30, 2022.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_127"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of&#160;September 30, 2022. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of&#160;September 30, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September 30, 2022, which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by the collusion of two or more people or by a management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_130"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i9e47bb9f386840418b8747094912ba95_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various claims and legal proceedings of a nature considered ordinary course in our business, including the intellectual property litigation described below and in our quarterly report on Form 10-Q for the quarter ended June 30, 2022. Most of the issues raised by these claims are highly complex and subject to substantial uncertainties. For a description of risks relating to these and other legal proceedings we face, see Part I, Item 1A, &#8220;Risk Factors,&#8221; of our 2021 Form 10-K, including the discussion under the headings entitled &#8220;Risks related to our intellectual property,&#8221; and &#8220;Risks related to the manufacturing of our commercial products, development candidates, investigational medicines and our future pipeline.&#8221; The outcome of any such proceedings, regardless of the merits, is inherently uncertain; therefore, assessing the likelihood of loss and any estimated damages is difficult and subject to considerable judgment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pfizer/BioNTech Patent Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 26, 2022, Moderna filed a lawsuit in the U.S. District Court for the District of Massachusetts against (1) Pfizer Inc. (Pfizer) and (2) BioNTech SE, BioNTech Manufacturing GmbH, and BioNTech US Inc. (collectively BioNTech). This lawsuit seeks damages for infringement of U.S. Patent Nos. 10,898,574, 10,702,600 and 10,933,127 in Pfizer and BioNTech&#8217;s manufacture and sale of their messenger RNA, or mRNA, COVID-19 vaccines. The complaint seeks a judgment of infringement of the asserted patents, monetary damages (together with interest), costs and expenses of the lawsuit, and attorneys&#8217; fees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on August 26, 2022, Moderna initiated patent infringement proceedings in the Dusseldorf Regional Court in Germany against Pfizer, BioNTech and related entities with respect to European patents EP 3 718 565 B1 and EP 3 590 949 B1, which also concern Moderna&#8217;s mRNA platform technology and disease-specific vaccine designs, including coronaviruses. Moderna has also initiated similar proceedings in the Netherlands and UK. As in the U.S. action, Moderna seeks a judgment of infringement of the asserted patents, monetary damages (together with interest), costs and expenses of the lawsuit, and attorneys&#8217; fees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.K., Pfizer Inc. and BioNTech SE, have also filed an action seeking revocation of EP 3 718 565 B1 and EP 3 590 949 B1 in the U.K., along with costs (together with interest).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Moderna patents being asserted in the European actions are subject to notices of opposition, including by BioNTech SE, seeking to revoke EP 3 718 565 B1 and EP 3 590 949 B1, which have been filed at the European Patent Office (EPO). The periods for filing such oppositions for EP 3 718 565 B1 and EP 3 590 949 B1 end on January 27, 2023 and February 18, 2023, respectively.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_136"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding risk and uncertainties related to our business appears in Part I, Item 1A. &#8220;Risk Factors&#8221; of our 2021 Form 10-K. There have been no material changes from the risk factors previously disclosed in the 2021 Form 10-K other than those set forth in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 and filed with the SEC on May 4, 2022.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_139"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information with respect to the shares of common stock repurchased by us during the three months ended September 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Program </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,485,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,499,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,115,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average price paid per share includes related expenses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On February 22, 2022, our Board of Directors authorized a share repurchase program for our common stock of up to $3.0 billion, with no expiration date. This share repurchase program was increased by the Board of Directors by an additional $3.0 billion on August 1, 2022, also with no expiration date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_91" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to condensed consolidated financial statements for information regarding our share repurchase programs.</span></div><div><span><br/></span></div><div id="i9e47bb9f386840418b8747094912ba95_142"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Exhibits listed below are filed or incorporated by reference as part of this Form 10-Q.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Index</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit101-directorcompens.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amended and Restated Non-Employee Director Compensation Policy, effective October 1, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit102-mockofferletter.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Offer Letter by and between ModernaTX, Inc. and James Mock, dated as of August 15, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit103-pz0025andp00026.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. PZ0025 and P00026 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated August 9, 2020.</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit3119302022.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit3129302022.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000051/exhibit3219302022.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Link Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit (indicated by asterisks) have been omitted in accordance with the rules of the Securities and Exchange Commission.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or any compensatory plan, contract or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The certification furnished in Exhibit 32.1 hereto is deemed to accompany this Form 10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certification will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.</span></td></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i9e47bb9f386840418b8747094912ba95_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e47bb9f386840418b8747094912ba95_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MODERNA, INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ St&#233;phane Bancel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St&#233;phane Bancel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James M. Mock</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Mock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div></body></html>
